UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

þANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended:December 31 2017, 2023

or

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

☐  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from: _____________ to _____________

HEALTHIER CHOICES MANAGEMENT CORP.

(Exact name of registrant as specified in its charter)

Delaware001-3646984-1070932

(State or Other Jurisdiction of

Incorporation or Organization)

(Commission

File Number)

(I.R.S. Employer

Identification No.)

Address of Principal Executive Office:3800 North 28th28th WayHollywood FL , Florida33020

Registrant’s telephone number, including area code:(305)600-5004

Securities registered pursuant to Section 12(b) of the Act:Common Stock, par value $0.0001

Title of each classTrading SymbolName of each exchange on which registered
Common Stock, par value $0.0001 per shareHCMCOTC Pink Marketplace

Securities registered pursuant to Section 12(g) of the Act:

None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. ☐ Yes þNo

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. ☐ Yes þNo

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.þYes ☐ No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).þYes ☐ No

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐Accelerated filer
Non-accelerated filer   ☐(Do not check if a smaller reporting company)Smaller reporting companyþ
Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant has filed a report on and attestation to its management assessment of the effectiveness of its internal controls over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐  þNo

The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold as of the last business day of the registrant’s most recently completed second fiscal quarter was approximately $2,922,951.24$46.3 million based on the June 30, 20172023 closing price of $0.0001 per share.

Indicate the number of shares outstanding of each of the registrant’s classes of common stock, as of the latest practicable date: 29,348,867,108478,266,632,384 shares outstanding as of March 13, 2018.27, 2024.

 

 

INDEX

Page
PART I
Item 1. Business.PART I3
Item 1. Business1
Item 1A. Risk Factors.Factors1314
Item 1B. Unresolved Staff Comments.Comments1314
Item 2. Properties.1C. Cybersecurity1314
Item 2. Properties15
Item 3. Legal Proceedings.Proceedings1315
Item 4. Mine Safety Disclosures.Disclosures1315
PART II
PART II
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.Securities1416
Item 6. Selected Financial Data.Data16
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.Operations16
Item 7A. Quantitative and Qualitative Disclosures About Market Risk.Risk1921
Item 8. Financial Statements and Supplementary Data.Data2021
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.Disclosure2021
Item 9A. Controls and Procedures.Procedures2021
Item 9B. Other Information.Information2122
PART III
PART III
Item 10. Directors, Executive Officers and Corporate Governance2123
Item 11. Executive Compensation.Compensation2426
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholders Matters.Matters2629
Item 13. Certain Relationships and Related Transactions, and Director Independence.Independence2730
Item 14. Principal Accounting Fees and Services.Services2731
PART IV
PART IV
Item 15. Exhibits, Financial Statement Schedules.Schedules2831
SIGNATURESExhibit Index2932
Exhibit IndexSIGNATURES3034

2 

 

PART I

Item 1. Business.

Healthier Choices Management Corp. (the “Company”) is a holding company focused on providing consumers with healthier daily choices with respect to nutrition and other lifestyle alternatives. The

Through its wholly owned subsidiary HCMC Intellectual Property Holdings, LLC, the Company currently operates thirteen retail vape stores inmanages its intellectual property portfolio.

Through its wholly owned subsidiaries, Healthy Choice Markets, Inc., Healthy Choice Markets 2, LLC, Healthy Choice Markets 3, LLC, Healthy Choice Markets 3 Real Estate, LLC, Healthy Choice Markets IV, LLC, and Healthy Choice Markets V, LLC respectively, the Southeast region of the United States, through which it offers e-liquids, vaporizers and related products. The Company also operates Ada’s Natural Market, a natural and organic grocery store, throughoperates:

Ada’s Natural Market, a natural and organic grocery store offering fresh produce, bulk foods, vitamins and supplements, packaged groceries, meat and seafood, deli, baked goods, dairy products, frozen foods, health & beauty products, and natural household items (www.Adasmarket.com)
Paradise Health & Nutrition’s three stores that likewise offer fresh produce, bulk foods, vitamins and supplements, packaged groceries, meat and seafood, deli, baked goods, dairy products, frozen foods, health & beauty products and natural household items, (www.ParadiseHealthDirect.com)
Mother Earth’s Storehouse, a two-store organic and health food and vitamin chain in New York’s Hudson Valley, which has been in existence for over 40 years (www.MotherEarthStorehouse.com).
Greens Natural Foods’ eight stores in New York and New Jersey, offering a selection of 100% organic produce and all-natural, non-GMO groceries & bulk foods; a wide selection of local products; an organic juice and smoothie bar; a fresh foods department, which offers fresh and healthy “grab & go” foods; a full selection of vitamins & supplements; as well as health and beauty products (www.Greensnaturalfoods.com).
Ellwood Thompson’s, an organic and natural health food and vitamin store located in Richmond, Virginia. (www.ellwoodthompsons.com).

Through its wholly owned subsidiary, Healthy Choice Markets,Wellness, LLC, the Company operates a Healthy Choice Wellness Center in Kingston, NY and has a licensing agreement for a Healthy Choice Wellness Center located at the Casbah Spa and Salon in Fort Lauderdale, FL.

Through its wholly owned subsidiary, Healthy Choice Wellness II, LLC, the Company entered into a joint venture with an established healthcare provider, and the joint venture is in the process of creating a structure whereby it will engage in telemedicine evaluations of patients for semaglutide therapy. The operation will encompass, generally: medical evaluations of patients; treatment of patients with semaglutide; coordination with providers and patients.

Through its wholly owned subsidiary, Healthy U Wholesale, the Company sells vitamins and supplements, as well as health, beauty and personal care products on its website www.TheVitaminStore.com.

Additionally, through its wholly owned subsidiary, The Vape Store, Inc., the Company markets its patented Q-Unit™ and Q-Cup® technology. Information on these products and the technology is available on the Company’s website at www.theQcup.com.

NATURAL AND ORGANIC GROCERIES AND DIETARY SUPPLEMENTS BUSINESS

Local. Organic. Fresh. Three words that define Healthy Choice Markets! With Ada’s Natural Market, offers fresh produce, bulk foods,a full-service grocery store and Greenleaf Grill, Ada’s flagship fast casual in-store restaurant, serving Fort Myers, FL, along with the eight Greens Natural Foods Stores in New Jersey and New York, three Paradise Health & Nutrition locations in the greater Melbourne, FL area, two Mother Earth’s Storehouse locations in Hudson Valley, NY, and the Ellwood Thompson store located in Richmond Virginia all serving their respective local communities, our stores provide all-natural and organic products in a friendly and helpful atmosphere, with aisles of traditional grocery complete with frozen, healthy home, vitamins and& supplements, packaged groceries, meat and seafood, deli, baked goods, dairy products, frozen foods, health & beauty, fresh produce, hormone and antibiotic free meats and bulk foods. Ada’s Natural Market, Greens Natural Foods, Paradise Health & Nutrition, Mother Earth’s Storehouse, and Ellwood Thompson’s all offer chef-prepared ready-to-go foods and fresh-baked-daily baked goods. All store locations, with the exception of Saugerties, NY and Malabar, FL, offer a 100% organic juice & smoothie bar.

1

Collectively, we focus on providing high-quality products at affordable prices, exceptional customer service, nutrition education and community outreach. We strive to generate long-term relationships with our customers based on quality and service by:

selling only all-natural and organic groceries;

offering affordable prices and a shopper-friendly retail environment; and

providing dine-in options at our Greenleaf Grill, Organic Juice Bar, and our free-trade coffee bar.

Our History and Founding Principles

We are committed to maintaining the following founding principles, which have helped foster our growth:

Quality. Every product on our shelves must go through a rigorous screening and approval process. Our mission includes providing the highest quality groceries and supplements, Natural Grocers branded products, European and United States Department of Agriculture (USDA) certified organic and fresh produce at the best prices in the industry.

Community. The Ada’s, Paradise, Mother Earth’s Storehouse, Green’s Natural Foods and now Ellwood Thompson’s brands have each been serving their respective communities for 40+ years.

Employees. Our employees make our companies great. We work hard to ensure that our employees are able to live a healthy, balanced lifestyle. We support them with free nutrition education programs, competitive pay and excellent benefits.

Our Market

We operate within the natural products retail industry, which is a subset of the United States grocery industry and the dietary supplement business. This industry includes conventional supermarkets, natural, gourmet and specialty food markets, mass and discount retailers, warehouse clubs, independent health food stores, dietary supplement retailers, drug stores, farmers’ markets, food co-ops, mail order and online retailers and multi-level marketers. Industry-wide sales of natural and organic foods and dietary supplements have experienced meaningful growth over the past several years, and we believe that growth will continue for the foreseeable future.

We believe the growth in sales of natural and organic foods and dietary supplements continues to be driven by numerous factors, including:

greater consumer focus on high-quality nutritional products;

an increased awareness of the importance of good nutrition to long-term wellness;

aging communities that are seeking healthy lifestyle alternatives;

heightened consumer awareness about the importance of food quality and a desire to avoid pesticide residues, growth hormones, artificial ingredients and genetically engineered ingredients in foods;

growing consumer concerns over the use of harmful chemical additives in body care and household cleaning supplies;

well-established natural and organic brands, which generate additional industry awareness and credibility with consumers; and

the growth in the number of consumers with special dietary requirements as a result of allergies, chemical sensitivities, auto-immune disorders and other conditions.

2

Our Competitive Strengths

We are well-positioned to capitalize on favorable natural and organic grocery and dietary supplement industry dynamics as a result of the following competitive strengths:

Strict focus on high-quality natural and organic grocery products. We offer high-quality products and brands, including an extensive selection of widely-recognized natural household items.and organic food, dietary supplements, body care products, pet care products and books. We offer our customers approximately 10,000 Stock Keeping Units (SKUs) of natural and organic products. We believe our broad product offering enables our customers to shop our stores for substantially all of their grocery and dietary supplement purchases. In our grocery departments, we primarily sell USDA certified organic produce and do not approve for sale grocery products that are known to contain artificial colors, flavors, preservatives or sweeteners or partially hydrogenated or hydrogenated oils. In addition, we only sell pasture-raised, humanely-raised dairy products. Consistent with this strategy, our product selection does not include items that do not meet our strict quality guidelines. Our store managers enhance our robust product offering by customizing their stores’ selections to address the preferences of local customers.

Engaging customer service experience based on education and empowerment. We strive to offer consistently exceptional customer service in a shopper-friendly environment, which we believe creates a differentiated shopping experience, enhances customer loyalty and generates repeat visits from our clientele. A key aspect of our customer service model is to provide free nutrition education to our customers. We believe this focus provides an engaging retail experience while also empowering our customers to make informed decisions about their health. We offer our science-based nutrition education through our trained employees, our newsletter and sales flyer, community out-reach programs, one-on-one nutrition health coaching, nutrition classes and cooking demonstrations.

Our Growth Strategies

We expect to pursue several strategies to help return the overall business to profitable growth, including:

Expand our store base. We intend to expand our store base through the acquisition of new stores.

Increase sales from existing customers. In order to increase our average ticket and the number of customer transactions, we plan to continue offering an engaging customer experience by providing science-based nutrition education and a differentiated merchandising strategy that delivers affordable, high-quality natural and organic grocery products and dietary supplements. We also plan to continue to utilize targeted marketing efforts to reach our existing customers, which we anticipate will drive customer transactions and convert occasional, single-category customers into core, multi-category customers.

Grow our customer base. We plan to implement several measures aimed at building our brand awareness and growing our customer base, including: (i) continuously improving the design of all our websites to enhance functionality, create a more engaging user experience and increase its reach and effectiveness; (ii) introducing customer appreciation programs at all our stores; and (iii) developing new collateral marketing materials. We believe offering nutrition education has historically been one of our most effective marketing strategies for reaching new customers and increasing the demand for natural and organic groceries and dietary supplements in our markets.

Improve operating margins. We expect to continue to improve our operating margins as we benefit from investments we have made or are making in fixed overhead and information technology. As we add additional stores, we expect to achieve greater economies of scale through sourcing and distribution. To achieve additional operating margin expansion, we intend to further optimize performance, maintain appropriate store labor levels and effectively manage product selection and pricing.

3

 

In September 2017, Hurricane Irma struck Florida

Our Products

Product Selection Guidelines. We have a set of strict quality guidelines covering all products we sell. For example:

we do not approve for sale food known to contain artificial colors, flavors, preservatives or sweeteners or partially hydrogenated or hydrogenated oils or phthalates or parabens, regardless of the proportion of its natural or organic ingredients;

we sell USDA certified organic produce; and

we sell meats naturally raised without hormones, antibiotics or treatments and that were not fed animal by-products.

Our product review team analyzes all new products and caused major power outagesapproves them for sale based on ingredients, price and uniqueness within the current product set. We actively research new products in the marketplace through our product vendors, private label manufacturers, scientific findings, customer requests and general trends in popular media. Our stores are able to severalfully merchandise all departments by providing an extensive assortment of natural and organic products. We do not believe we need to sell conventional products to fill our selection, increase our margins or attract more customers.

What We Sell. We operate both a full-service natural and organic grocery stores and dietary supplement stores within our retail locations. The following is a breakdown of our product mix:

Grocery. We offer a broad selection of natural and organic grocery products with an emphasis on minimally processed and single ingredient products that are not known to contain artificial colors, flavors, preservatives or sweeteners or partially hydrogenated or hydrogenated oils. Additionally, we carry a wide variety of products associated with special diets such as gluten free, vegetarian and non-dairy.

Produce. We sell USDA-certified organic produce and source from local, organic producers whenever feasible. Our selection varies based on seasonal availability, and we offer a variety of organic produce offerings that are not typically found at conventional food retailers.

Bulk Food and Private Label Products. We sell a wide selection of private label repackaged bulk and other products, including nuts, water, pasta, canned seafood, dried fruits, grains, granolas, honey, eggs, herbs, spices and teas.

Dry, Frozen and Canned Groceries. We offer a wide variety of natural and organic dry, frozen and canned groceries, including cereals, soups, baby foods, frozen entrees and snack items. We offer a broad selection of natural chocolate bars, and energy, protein and food bars.

Meats and Seafood. We offer naturally-raised or organic meat products. The meat products we offer come from animals that have never been treated with antibiotics or hormones or fed animal by-products. Additionally, we only buy from companies we believe employ humane animal-raising practices. Our seafood items are generally frozen at the time of processing and sold from our freezer section, thereby ensuring freshness and reducing food spoilage and safety issues.

Dairy Products and Dairy Substitutes. We offer a broad selection of natural and organic dairy products such as milk, eggs, cheeses, yogurts and beverages, as well as non-dairy substitutes made from almonds, coconuts, rice and soy.

Prepared Foods. Our stores have a convenient selection of refrigerated prepared fresh food items, including salads, sandwiches, salsa, humus and wraps. The size of this offering varies by location.

Bread and Baked Goods. We receive regular deliveries of a wide selection of bakery products for our bakery section, which includes an extensive selection of gluten-free items.

Beverages. We offer a wide variety of non-alcoholic and alcoholic beverages containing natural and organic ingredients.

4

Dietary Supplements. We offer a wide selection of vitamins, supplements and natural remedies. Our staff is well educated and trained on multiple aspects of natural medicine.

Health, Beauty, and Personal Care. We offer a full range of cosmetics, skin care, hair care, fragrance and personal care products containing natural and organic ingredients. Our body care offerings range from bargain-priced basics to high-end formulations.

Household and General Merchandise. Our offerings include sustainable, hypo-allergenic and fragrance-free household products, including cleaning supplies, paper products, dish and laundry soap and other common household products, including diapers.

Quality Assurance. We endeavor to ensure the quality of the Company’sproducts we sell. We work with reputable suppliers we believe are compliant with established regulatory and industry guidelines. Our purchasing department requires a complete supplier and product profile as part of the approval process. Our dietary supplement suppliers must follow Food and Drug Administration (FDA) current good manufacturing practices supported by quality assurance testing for both the base ingredients and the finished product. We expect our suppliers to comply with industry best practices for food safety.

Many of our suppliers are inspected and certified under the USDA National Organic Program, voluntary industry associations, and other third-party auditing programs with regards to additional ingredients, manufacturing and handling standards. We operate all our stores in compliance with the National Organic Program standards, which restricts the use of certain substances for cleaning and pest control and requires rigorous recordkeeping, among other requirements.

Our Pricing Strategy

We believe our pricing strategy allows our customers to shop our stores on a regular basis for their groceries and dietary supplements.

The key elements of our pricing strategy include:

heavily advertised discounts supported by manufacturer participation;

in-store specials generally lasting for 30 days and not advertised outside the store;

managers’ specials, such as clearance, overstock, short-dated or promotional incentives; and

specials on seasonally harvested produce.

As we expand our store base, we believe there are opportunities for increased leverage in fixed costs, such as administrative expenses, as well as increased economies of scale in sourcing products. We strive to keep our product, operating facilities. Dueand general and administrative costs low, which allows us to continue to offer attractive pricing for our customers.

Store Management and Staffing. Our store staffing includes a manager and assistant manager, with department managers in each of the dietary supplement, grocery, dairy and frozen, produce, body care and receiving departments, as well as several non-management employees. Our regional manager is responsible for monthly store profit and loss, of electricity, which lasted approximately one week, the Company suffered lost salesincluding labor, merchandising and inventory spoilage. The Company submitted insurance claimscosts.

To ensure a high level of service, all employees receive training and guidance on customer service skills, product attributes and nutrition education. Employees are carefully trained and evaluated based on a requirement that they present nutrition information in an appropriate and legally compliant educational context while interacting with customers. Additionally, store employees are cross-trained in various functions, including cashier duties, stocking and receiving product.

5

Inventory. We use a robust merchandise management and perpetual inventory system that values goods at the lower of cost and net realizable value using the average cost method. We manage shelf stock based on weeks-on-hand relative to recover a portion of the cost of lost sales, resupply time and inventory spoilage ofminimum economic order quantity.

Sourcing and Vendors. We source from approximately $41,000.1,000 suppliers and offer over 4,000 brands. These suppliers range from small independent businesses to multi-national conglomerates. As of December 31, 2017,2023, we purchased approximately 73% of the goods we sell from our top 20 suppliers. For the year ended December 31, 2023, approximately 40% of our total purchases were from one vendor. We maintain good relations with all our suppliers and believe we have adequate alternative supply methods, including self-distribution.

We have longstanding relationships with our suppliers, and we require disclosure from them regarding quality, freshness, potency and safety data information. Our bulk food private label products are packaged by us in pre-packed sealed bags to help prevent contamination while in transit and in our stores. Unlike most of our competitors, most of our private label nuts, trail mix and flour are refrigerated in our warehouse and stores to maintain freshness.

Our Employees

Commitment to our employees is one of our founding principles. Employees are eligible for health, long-term disability, vision and dental insurance claimscoverage, as well as Company paid short-term disability and life insurance benefits, after they meet eligibility requirements. Additionally, our employees are offered a 401(k) retirement savings plan with discretionary contribution matching opportunities. This further offers our employees the opportunity to become more familiar with our products, which we believe improves the customer service our employees are able to provide. We believe these and other factors result in higher retention rates and encourage our employees to appreciate our culture, which helps them better promote our brand.

Our Customers

The growth in the natural and organic grocery and dietary supplement industries and growing consumer interest in health and nutrition have been acceptedled to an increase in our core customer base. We believe the demands for affordable, nutritious food and dietary supplements are shared attributes of our core customers, regardless of their socio-economic status. Additionally, we believe our core customers prefer a retail store environment that offers carefully selected natural and organic products and dietary supplements. Our customers tend to be interested in health and nutrition, and expect our store employees to be highly knowledgeable about these topics and related products.

Competition

The grocery and dietary supplement retail business is a large, fragmented and highly competitive industry, with few barriers to entry. Our competition varies by market and includes conventional supermarkets such as Publix and Winn-Dixie, mass or discount retailers such as Sprout’s Farmers Market, Wal-Mart and Target, natural and gourmet markets such as Whole Foods and The Fresh Market, specialty food retailers such as Trader Joe’s, independent health food stores, dietary supplement retailers, drug stores, farmers’ markets, food co-ops, mail order and online retailers and multi-level marketers. These businesses compete with us for customers on the basis of price, selection, quality, customer service, shopping experience or any combination of these or other factors. They also compete with us for products and locations. In addition, some of our insurance carriercompetitors are expanding to offer a greater range of natural and organic foods. We believe our commitment to carrying only carefully vetted, affordably priced and high-quality natural and organic products and dietary supplements, as well as our focus on providing nutritional education, differentiate us in the industry and provide a competitive advantage.

HEALTHY CHOICE WELLNESS CENTERS and HEALTHY CHOICE WELLNESS II

Healthier choices extend past just healthy eating. HCMC, through its Healthy Choice Wellness Centers, offers premium and optimized whole person-centered care and services, tailored to promote and maximize one’s general health and well-being. Healthy Choice Wellness Centers’ services are designed to address one or more common concerns, including but not limited to immunity, anxiety, mental fortitude, sports recovery, and more. Through these services, which include IV Nutrient Drip Infusions and Intramuscular (IM) Injection Treatments, Healthy Choice Wellness Centers seek to provide healthy alternatives that treat the mind and body to its core, thus offering optimized healthier living.

Through its wholly owned subsidiary, Healthy Choice Wellness II, LLC, the Company entered into a joint venture with an established healthcare provider, and the joint venture is in the process of creating a structure whereby it will engage in telemedicine evaluations of patients for semaglutide therapy. The operation will encompass, generally: medical evaluations of patients; treatment of patients with semaglutide; coordination with providers and patients.

6

Defining Healthy Choice Wellness

HEALTHY an adjective

indicative of, conducive to, or promoting good health

CHOICE – a noun

an act of selecting or making a decision when faced with two or more possibilities

WELLNESS – a noun

the state of being in good health, especially as an actively pursued goal

Our Mission

To assist in one’s achievement of personal well-being, which is an optimal and dynamic state that allows people to achieve their full potential through both the individual pursuit of wellness and the commitment and support of the communities to which they belong.

To assist in maximizing overall individual wellness, which is an active process that helps individuals reach their optimal well-being by integrating all the dimensions of wellness into their lives; physical, social, emotional, spiritual, environmental, intellectual, occupational, and financial.

To provide the highest standards of professionalism, emphasizing on quality of care, ethical behavior, ensuring client confidentiality, and the treatment of all individuals with respect and dignity.

To provide clients an immaculate wellness facility designed for the optimal benefit of the clients to receive their desired treatments in a clean and sterile environment that fosters a tranquil space to maximize one’s overall wellness and well-being.

To continue the powerful pursuit of knowledge and education by all of our professionals and practitioners, to better provide consult to our clients for them to best maximize their overall wellness and well-being.

Our Vision

Life comes with a lot of choices - some easier to make than others. Healthier Living should be the easiest of those choices, and so Healthy Choice Wellness Centers offers Health & Wellness services that assist in making those choices a lot easier. Healthy Choice Wellness Centers seek to continue the commitment of its parent company, Healthier Choices Management Corp., in providing consumers with healthier alternatives to everyday lifestyle choices.

Healthy Choice Wellness Centers offer premium and optimized whole person-centered care and services, tailored to promote and maximize one’s general health and well-being. All of our services are designed to address one or more common concerns, including but not limited to immunity, anxiety, mental fortitude, sports recovery, and more. Through these services, Healthy Choice Wellness Centers seek to provide healthy alternatives that treat the mind and body to its core, thus offering optimized healthier living.

Our Values

Healthy Choice Wellness Centers are committed to building a culture of well-being. Our goal is to optimize wellness, both for today and all of our tomorrows.

7

Healthy Choice Wellness Centers view the communities we serve as being comprised of whole and dynamic individuals. We are sensitive to the communal stresses of life that impact our health, wellness, and overall well-being. We promote and encourage personal responsibility and accountability in one’s pursuit of achieving and maintaining their health and wellness. Our Healthy Choice Wellness team not only participates in the facilitation of services in the process of achieving one’s wellness, but also are present to provide information, care, and knowledge to maintain course and maximize one’s well-being according to their individual health goals, wants, and needs.

Healthy Choice Wellness Center also realizes that the whole is only as strong as its parts when it comes to those communities we serve. Thus, we put forth effort to strengthen the environments in which we live and work as they directly impact our well-being. This effort to support wellness for the individuals (the parts) must include working to create a healthy community at large (the whole) that supports the well-being of its members at large.

Our Growth Strategy

We seek to operate and expand our Healthy Choice Wellness centers by approaching growth via three (3) different pathways:

1)Corporately owned and operated wellness centers

2)Wellness Centers implementing the services of Healthy Choice Wellness Centers by way of licensing agreements

3)Expansion by way of franchised locations

Our Products & Services

Healthy Choice Wellness Centers specialize primarily in IV Nutrient Drip Infusion and Intramuscular (IM) Injection treatments, however we seek to expand these offerings (both in the number of IV and IM options offered, but also by adding additional whole-person centered services for optimizing overall general health).

IV Nutrient Drip Infusion Treatments: Healthy Choice Wellness Center’s IV Nutrient Drip Infusions are used to deliver vitamins and minerals directly into the bloodstream, offering superior absorption over oral supplements. We offer server pre-formulated customized solutions to address a variety of issues including:

Immune System Strengthening
Anti-Aging
Optimal Athletic Performance & Recovery
Metabolism
Hangover & Headache Relief
Cold & Flu Symptoms
Chronic Fatigue
Brain Fog

Currently, we offer eleven IV Nutrient Treatment Options: Quench, Get-Up-And-Go, Recovery & Performance, Immunity, Alleviate, Inner Beauty, Myers’ Cocktail, Nad+ (Premium Drip), Reboot, Glutathion, and Brainstorm.

Intramuscular (IM) Injection Treatments: Healthy Choice Wellness Center’s Intramuscular (IM) Injection treatments deliver vitamins and minerals directly into the bloodstream, offering superior absorption over oral supplements. We offer server pre-formulated customized solutions to address a variety of issues including:

Immune Functioning
General Health
Fight Illness
Boost Metabolism
Improve Mood
Increase Energy
Appetite Suppression
Burning Fat

Currently we offer four Injection Treatment Options: Vitamin B-12, Vitamin D-3, Glutathione, and our Skinny Shot.

8

Our Employees

Each Healthy Choice Wellness Center is led by licensed and accredited medical professionals and practitioners who share a like-minded philosophy with that of the Wellness Centers, as does all our support staff – we do not just practice healthy choices, we live it! We encourage and support all of our professionals and practitioners to continue the powerful pursuit of knowledge and education, to better provide consult to our clients for them to best maximize their overall wellness and well-being.

Our Customers

The client base for our wellness centers is not bound by age groups or genders. Our clients consist of a broad range of individuals all seeking a common universal goal of seeking to improve their overall wellness. These individuals tend to be those who consciously live a healthy lifestyle, and are includedseeking treatments to maximize and optimize their overall well-being. This includes athletes seeking treatments to help recover quicker from injury and/or rehydrate, middle aged men and women seeking treatments to maximize their cognitive fortitude, those wanting to help alleviate indigestion or stomach pains, and a slew of other individual reasons all ending with the drive for healthier living.

ONLINE SALES

HCMC is your online source for the leading products in other assets as payment has not been received.the all-natural vitamin and supplement, and health, beauty, and personal care categories of Healthier Living.

Backed by 30+ years of combined experience in the health and nutrition industry, we provide our customers with only the best products on the market — Try our exclusive offering of Ada’s Naturals brand products or any of the top products from the most recognized national natural health brands in the industry.

VITAMINS & SUPPLEMENTS:

Product categories include, but are not limited to: Vitamins, Minerals & Herbals, Immunity, Multivitamins, Sports Nutrition, Protein Powders, Collagen, Stress & Anxiety, Sleep & Relax, Brain Health, Pain & Inflammation, Probiotics, Energy & Stamina, Joint & Bone Support, Digestion, Fish Oils, Just for Men, Kids/Children/Teens, and more.

Product varieties include, but are not limited to: Apple Cider Vinegar, BCAA, Biotin, Calcium, Chlorophyll, CLA, Collagen Peptides, Creatine, Elderberry, Omega-3’s, Garlin, Glucosamine, Iron, Magnesium, Melatonin, Potassium, Prenatals, Probiotics, Protein Powders (Plant and Whey), Ashwaghanda Turmeric, Ginseng, Vitamin B,C,D,E,K+, Zinc, and more.

Product brands include, but are not limited to: Ada’s Naturals, Enzymedica, Garden of Life, Natural Vitality, New Chapter, Renew Life, Solgar, and more.

HEALTH, BEAUTY, AND PERSONAL CARE:

Product categories include, but are not limited to: Oral Care, Hair Care, Body Wash, Skin & Face, Deodorant, Suncare, Soaps, Shaving, Feminine Hygiene, Lip Balms, Ear Candles, Lotions, Hand Sanitizers, Essential Oils, and more.

Product varieties include, but are not limited to: Body Wash, Deodorant, Ear Candles, Shampoos, Conditioners, Toothpaste, Mouthwashes, Shaving, Bar Soaps, Liquid Soaps, Suncare, and more.

Product brands include, but are not limited to: Ada’s Naturals, Alba Botanica, Aura Cacia, Derma-E, Desert Essence, Dr. Bronners, Every Man Jack, Heritage Store, Himalaya Botanique, Life-Flo, Lily of the Desert, Natracare, Naturally Fresh, Oral Essentials, South of France, Tea Tree Therapy, Thai Deodorant Stone, Thayers, and more.

9

 

VAPORIZER AND E-LIQUID BUSINESS

 

Retail Stores

While evaluatingThrough its wholly owned subsidiary HCMC Intellectual Property Holdings, LLC, HCMC manages, and intends to expand, its intellectual property portfolio. Additionally, HCMC markets its patented Q-Unit™ and Q-Cup® technology through its wholly owned subsidiary The Vape Store, Inc.. Information on these products and the technology is available on the Company’s website at www.theQcup.com. During 2022, the Company evaluated its retail store operations in 2016,and management decided to close three ofall retail stores and shift its Atlanta area vape stores on February 15, 2016,brick and December 31, 2016. Additionally, six of its Florida vape stores were closed between May 31, 2016mortar sales focus towards building a wholesale and December 31, 2016.online channel business.

Vaporizers

“Vaporizers” are battery-powered products that enable users to inhale nicotine vapor without smoke, tar, ash, or carbon monoxide. Regardless of their construction, they are comprised of three functional components:

a mouthpiece, which is a small plastic cartridge that contains a liquid nicotine solution;

the heating element that vaporizes the liquid nicotine so that it can be inhaled; and

the electronic devices which include: a lithium-ion battery, an airflow sensor, a microchip controller and an LED, which illuminates to indicate use.

When a user draws air through the vaporizer, the air flow is detected by a sensor, which activates a heating element that vaporizes the solution stored in the mouthpiece/cartridge, the solution is then vaporized and it is this vapor that is inhaled by the user. The cartridge contains either a nicotine solution or a nicotine free solution, either of which may be flavored.

Vaporizers feature a tank or chamber, a heating element and a battery. The vaporizer user fills the tank with e-liquid or the chamber with dry herb or leaf. The vaporizer battery can be recharged and the tank and chamber can be refilled.

Our Brands

We sell a wide variety of our e-liquid under the Vape Store brand. Our in-house engineering and graphic design teams work to provide aesthetically pleasing, technologically advanced and affordable vaporizer and e-liquid flavor options. We are in the process of preparing to commercialize additional brands which we intend to market to new customers and demographics.

Our Improvements and Product Development on Intellectual Property

We have developed, trademarked and are preparing to commercialize additional products. We include product development expenses as part of our operating expenses. WhileIn October 2018, we currently own noannounced the granting of three US patents which are materialrelated to our business, we were recently issued a utility patent covering a vaporizerQ-Cup™ technology. This Q-Cup™ technology provides microdosing potentially more efficiency depending on the vaping method and an “on the go” solution for consumers who prefer to vape concentrates either medicinally or electronic cigarette device. This patented improvement is intended to prevent the release and ingestion of metal particles from the heating element from entering the lungs of the user of the vaporizer or electronic cigarette. Additionally,recreationally. In addition, we have a suite of patent applications pending in the United States. There is no assurance that we will be awarded patents for of any of these pending patent applications. From 2019 through December 31, 2023, the Company was granted 9 new patents related to electronic vaporizers.

3

Vaporizer Biometric Fingerprint Lock Sensor Patent

We have a patent pending for a biometric fingerprint lock sensor that can be used in vaporizers. The biometric fingerprint lock sensor will allow the owner of the vaporizer to keep the device locked and turned off unless the authorized user unlocks the device via fingerprint scan, protecting the device from use by another individual. This technology may be used to protect against minors being able to turn on the device and will also deem the devices unusable in the event the device is lost or stolen. There is no assurance that we will be awarded a patent for this technology.

Flavor Profiles

We are developing new flavor profiles that are distinct to our brands. We believe that as the vaporizer industry matures, users of vaporizers and e-liquids will continue to develop preferences for the product based not only on their quality, ability to successfully deliver nicotine, battery capacity, and vapor volume they generate, but on taste and flavor, like smokers do with their preferred brand of conventional tobacco cigarettes.

Our Kits and Accessories

Our vaporizers are available in kits that contain everything a user needs to begin enjoying their “vaping” experience. In addition to kits, we sell replacement parts including batteries, coils, refill cartridges or cartomizers that contain the liquid solution, atomizers, tanks and e-liquids. Our refill cartridges and e-liquids are available in various assorted flavors and nicotine levels (including 0.0% nicotine). In addition to our vaporizer products, we sell an assortment of accessories, including various types of chargers (including USB chargers), carrying cases and lanyards.

The Market for Vaporizers

We market our vaporizers as an alternative to traditional tobacco cigarettes and cigars. We offer our products in multiple nicotine strengths and flavors. Because vaporizers and electronic cigarettes offer a “smoking” experience without the burning of tobacco leaf, vaporizers and electronic cigarettes offer users the ability to satisfy their nicotine cravings without smoke, tar, ash or carbon monoxide. In many cases vaporizers may be used where tobacco-burning cigarettes may not. Vaporizers may be used in some instances where for regulatory or safety reasons tobacco burning cigarettes may not be used. However, certain states, cities, businesses, providers of transportation and public venues in the U.S. have banned the use of vaporizers, where traditional cigarettes may not be smoked, while others are considering banning the use of vaporizers. We cannot provide any assurances that the use of vaporizers will be permitted in places where traditional tobacco burning cigarette use is banned. See “Risk Factors” for further discussion.

Advertising

Currently, we advertise our products primarily through point of sale materials and displays at retail locations. We also attempt to build brand awareness through social media marketing activities, price promotions, in-store and on-premise promotions, public relations and radio advertising. We intend to continue to strategically manage our advertising activities in 2018 to gain editorial coverage for our brands. Some of our competitors promote their brands through print media and television commercials, and through celebrity endorsements, and have substantial resources to devote to such efforts. We believe that our and our competitors’ efforts have helped increase our sales, our product acceptance and general industry awareness.

Distribution and Sales

The Company sells directly to consumers through thirteen company owned retail vape stores. Our management believes that consumers are shifting towards vape stores for an enhanced experience. This enhanced experienced is derived from the greater variety of products at the stores, the knowledgeable staff and the social atmosphere. The Company anticipates a significant portion of future revenue will continue to come from its retail stores.

Business Strategy

We believe and are seeing in our current stores that there is a large consumer demand centered on the vaporizer products and the “atmosphere” created by the vape stores. We believe that our reputation and our experience in the vaporizer industry, from a development, customer service and production perspective, give us an advantage in attracting customers.

4

Moreover, we believe that our history with our suppliers, including the volume of products we source, gives us an advantage over other market participants as it relates to favorable pricing, priority as to inventory supply and delivery and first access to new products, including first access to next generation products and technology. Management has shifted its retail sales focus to wholesale and online channel.

Our goal is to achieve a position of sustainable leadershipWe believe that our experience in the vaporizer industry. Our strategy consists of the following key elements:industry, from a development, customer service and production perspective, give us an advantage in attracting wholesale customers and develop an online customer base.

develop new product offerings with new technology and performance advancements;

continue our product focus on vaporizers and e-liquids;

invest in and leverage our existing brand through marketing and advertising;

expanding into new potential markets;

align our product offerings and cost with market demand; and

consider diversifying our line of business

 

Competition

Competition in the vaporizer and e-liquid industry is intense. We compete with other sellers, of vaporizes, most notably Altria Group, Inc., JT International, Imperial Tobacco, and Reynolds American, Inc., which are big tobacco companies that have vaporizer and electronic cigarette business segments.businesses that compete in the segment. The nature of our competitors is varied as the market is highly fragmented and the barriers to entry into the business are low. Our direct competitors sell products that are substantially similar to ours. As a general matter, we have access to market and sell the similar vaporizers as our competitors and we sell our products at substantially similar prices as our competitors; accordingly, the key competitive factors for our success is the quality of service we offer our customers, the scope and effectiveness of our marketing efforts, including media advertising campaigns and, increasingly, the ability to identify and develop new sources of customers.

As discussed above, we compete against “big tobacco”, U.S. cigarette manufacturers of both conventional tobacco cigarettes and electronic cigarettes like Altria Group, Inc., JT International, Imperial Tobacco, and Reynolds American, Inc. We compete against “big tobacco” who offers not only conventional tobacco cigarettes and electronic cigarettes and vaporizers, but also smokeless tobacco products such as “snus” (a form of moist ground smokeless tobacco that is usually sold in sachet form that resembles small tea bags), chewing tobacco and snuff. “Big tobacco” has nearly limitless resources, global distribution networks in place and a customer base that is fiercely loyal to their brands. Furthermore, we believe that “big tobacco” is devoting more attention and resources to developing, acquiring technology patents, and offering electronic cigarettes, vaporizers and e-liquids as these markets grow. Because of their well-established sales and distribution channels, marketing expertise and significant resources, “big tobacco” is better positioned than small competitors like us to capture a larger share of the electronic cigarette market. We also compete against numerous other smaller manufacturers or importers of cigarettes.importers. There can be no assurance that we will be able to compete successfully against any of our competitors, some of whom have far greater resources, capital, experience, market penetration, sales and distribution channels than us. If our major competitors were, for example, to significantly increase the level of price discounts offered to consumers, we could respond by offering price discounts, which could have a materially adverse effect on our business, results of operations and financial condition.

10

 

Manufacturing

We have no manufacturing capabilities and do not intend to develop any manufacturing capabilities. Third party manufacturers make our products to meet our design specifications. We depend on third party manufacturers for our vaporizer e-liquid and accessories. Our customers associate certain characteristics of our products including the weight, feel, draw, unique flavor, packaging and other attributes of our products to the brands we market, distribute and sell. Any interruption in supply and or consistency of our products may harm our relationships and reputation with customers, and have a material adverse effect on our business, results of operations and financial condition. In order to minimize the risk of supply interruption, we currently utilize several third-party manufacturers to manufacture our products to our specifications.

We currently utilize several manufacturers both domestically and internationally. We contract with our manufacturers on a purchase order basis. We do not have any output or requirements contracts with any of our manufacturers. Our manufacturers provide us with finished products, which we hold in inventory for distribution, sale and use. Certain Chinese factories and the products they export have recently been the source of safety concerns and recalls, which is generally attributed to lax regulatory, quality control and safety standards. Should Chinese factories continue to draw public criticism for exporting unsafe products, whether those products relate to our products or not, we may be adversely affected by the stigma associated with Chinese production, which could have a material adverse effect on our business, results of operations and financial position.

Although we believe that several alternative sources for our products are available, any failure to obtain the components, chemical constituents and manufacturing services necessary for the production of our products would have a material adverse effect on our business, results of operations and financial condition.

5

Source and Availability of Raw Materials

We believe that an adequate supply of product and raw materials will be available to us as needed and from multiple sources and suppliers.

Patent Litigation

Third party patent lawsuits alleging our infringement of patents, trade secrets or other intellectual property rights have and could force us to do one or more of the following:

stop selling products or using technology that contains the allegedly infringing intellectual property;

incur significant legal expenses;

pay substantial damages to the party whose intellectual property rights we may be found to be infringing;

redesign those products that contain the allegedly infringing intellectual property; or

attempt to obtain a license to the relevant intellectual property from third parties, which may not be available to us on reasonable terms or at all.

Future third party lawsuits alleging our infringement of patents, trade secrets or other intellectual property rights could have a material adverse effect on our business, results of operations and financial condition.

We are required to obtain licenses to patents or proprietary rights of others and may be required to obtain more in the future and as the product continues to evolve. We cannot assure you that any future licenses required under any such patents or proprietary rights would be made available on terms acceptable to us or at all. If we do not obtain such licenses, we could encounter delays in product market introductions while we attempt to design around such patents, or could find that the development, manufacture, or sale of products requiring such licenses could be foreclosed. Litigation may be necessary to defend against claims of infringement asserted against us by others, or assert claims of infringement to enforce patents issued to us or exclusively licensed to us, to protect trade secrets or know-how possessed by us, or to determine the scope and validity of the proprietary rights of others. In addition, we may become involved in oppositions in foreign jurisdictions, reexaminationsreexamination declared by the United States Patent and Trademark Office, or interference proceedings declared by the United States Patent and Trademark Office to determine the priority of inventions with respect to our patent applications or those of our licensors. Litigation, opposition, reexamination or interference proceedings could result in substantial costs to and diversion of effort by us, and may have a material adverse impact on us. In addition, we cannot assure you that our efforts to maintain or defend our patents will be successful.

Patent Enforcement

On November 30, 2020, the Company filed a patent infringement lawsuit against Philip Morris USA, Inc. and Philip Morris Products S.A. in the U.S. District Court (“District Court”) for the Northern District of Georgia (the “Complaint”). The lawsuit alleged infringement on HCMC-owned patent(s) by the Philip Morris product known and marketed as “IQOS™.” Philip Morris claims that it is currently approaching 14 million users of its IQOS® product and has reportedly invested over $3 billion in their smokeless tobacco products. On December 3, 2021, the District Court effectively dismissed HCMC’s patent infringement action against Philip Morris USA, Inc. and Philip Morris Products S.A. On December 14, 2021, the Company filed an appeal of the District Court’s dismissal of the Company’s patent infringement action against Philip Morris USA, Inc. and Philip Morris Products S.A.

11

 

On April 12, 2023, the U.S. Court of Appeals for the Federal Circuit ruled in favor of HCMC on two separate appeals it had filed in its patent infringement action against Philip Morris USA, Inc. and Philip Morris Products S.A. pending in the district court for the Northern District of Georgia.

On September 26, 2023, HCMC filed a patent infringement lawsuit against R.J. Reynolds Vapor Company (“RJR”) in the U.S. District Court for the Middle District of North Carolina in connection with HCMC’s assertions that RJR’s Vuse electronic cigarette infringes one of HCMC’s patents.

Regulations

Since a 2010 U.S. Court of Appeals decision, the Food and Drug Administration (“FDA”) is permitted to regulate electronic cigarettes as “tobacco products” under the Family Smoking Prevention and the Tobacco Control Act. Under this decision, the FDA is not permitted to regulate electronic cigarettes as “drugs” or “devices” or a “combination product” under the Federal Food, Drug and Cosmetic Act unless they are marketed for therapeutic purposes. This is contrary to anti-smoking devices like nicotine patches, which undergo more extensive FDA regulation. Because the Company does not market its electronic cigarettes for therapeutic purposes, the Company’s electronic cigarettes are subject to being classified as “tobacco products” under the Tobacco Control Act. The Tobacco Control Act grants the FDA broad authority over the manufacture, sale, marketing and packaging of tobacco products, although the FDA is prohibited from issuing regulations banning all cigarettes or all smokeless tobacco products, or requiring the reduction of nicotine yields of a tobacco product to zero.

On April 24, 2014,September 9, 2020 the FDA released proposedbegan enforcing rules that would extendextended its regulatory authority to electronic cigarettes and certain other tobacco products under the Tobacco Control Act. The proposed rules would requirerequired that electronic cigarette and e-liquid manufacturers (i) register with the FDA and report electronic cigarette productproducts and ingredient listings; (ii) market new electronic cigarette products only after FDA review; (iii) only make direct and implied claims of reduced risk if the FDA confirms that scientific evidence supports the claim and that marketing the electronic cigarette product will benefit public health as a whole; (iv) not distribute free samples; (v) implement minimum age and identification restrictions to prevent sales to individuals under age 18;21; (vi) include a health warning; and (vii) not sell electronic cigarettes in vending machines, unless in a facility that never admits youth. It is not known how long finalizing and implementing this regulatory process to may take. Accordingly, the Company cannot predicthas responded by beginning to take the content of any final rules from the proposed rules or the impact they may have.necessary steps to ensure compliance.

6

In this regard, total compliance and related costs are not possible to predict and depend substantially on the future requirements imposed by the FDA under the Tobacco Control Act. Costs, however, could be substantial and could have a material adverse effect on the Company’s business, results of operations and financial condition. In addition, failure to comply with the Tobacco Control Act and with FDA regulatory requirements could result in significant financial penalties and could have a material adverse effect on the Company’s business, financial condition and results of operations and ability to market and sell the Company’s products. At present, it is difficult to predict whether the Tobacco Control Act will impact the Company to a greater degree than competitors in the industry, thus affecting the Company’s competitive position.

State and local governments currently legislate and regulate tobacco products, including what is considered a tobacco product, how tobacco taxes are calculated and collected, to whom and by whom tobacco products can be sold and where tobacco products may or may not be smoked. State and local regulation of the e-cigarette market and the usage of e-cigarettes is beginning to accelerate.

As local regulations expand, vaporizers and electronic cigarettes may lose their appeal as an alternative to cigarettes, which may have the effect of reducing the demand for the Company’s products and as a result have a material adverse effect on the Company’s business, results of operations and financial condition.

At present, neither the Prevent All Cigarette Trafficking Act (which prohibits the use of the U.S. Postal Service to mail most tobacco products, which would require individuals and businesses that make interstate sales of cigarettes or smokeless tobacco to comply with state tax laws) nor the Federal Cigarette Labeling and Advertising Act (which governs how cigarettes can be advertised and marketed) apply to electronic cigarettes. The application of either or both of these federal laws to vaporizers and electronic cigarettes would have a material adverse effect on the Company’s business, results of operations and financial condition.

On July 1, 2015, the FDA published a document entitled “Advanced notice of proposed rulemaking” or the Advance. Through the Advance, the FDA solicited public comments on whether it should issue rules with respect to nicotine exposure warning and child-resistant packaging for e-liquids containing nicotine. Following public comment, the FDA may issue proposed rules in furtherance of the purposes outlined in the Advance and ultimately pass the rules as proposed or in modified form. We cannot predict whether rules will be passed or if they will have a material adverse effect on our future results of operations and financial conditions.

12

 

The Company expects that the tobacco industry will experience significant regulatory developments over the next few years, driven principally by the World Health Organization’s FCTC. The FCTC is the first international public health treaty on tobacco, and its objective is to establish a global agenda for tobacco regulation with the purpose of reducing initiation of tobacco use and encouraging cessation. Regulatory initiatives that have been proposed, introduced or enacted include:

the levying of substantial and increasing tax and duty charges;

restrictions or bans on advertising, marketing and sponsorship;

the display of larger health warnings, graphic health warnings and other labelling requirements;

restrictions on packaging design, including the use of colors and generic packaging;

restrictions or bans on the display of tobacco product packaging at the point of sale, and restrictions or bans on cigarette vending machines;

requirements regarding testing, disclosure and performance standards for tar, nicotine, carbon monoxide and other smoke constituents’ levels;

requirements regarding testing, disclosure and use of tobacco product ingredients;

increased restrictions on smoking in public and work places and, in some instances, in private places and outdoors;

elimination of duty free allowances for travelers; and

encouraging litigation against tobacco companies.

If Vaporizers,vaporizers, and electronic cigarettes, or e-liquids, are subject to one or more significant regulatory initiates enacted under the FCTC, the Company’s business, results of operations and financial condition could be materially and adversely affected.

7

Healthy Choice Markets

Healthy Choice is a specialty retailer of natural and organic groceries and dietary supplements. We focus on providing high-quality products at affordable prices, exceptional customer service, nutrition education and community outreach. We strive to generate long-term relationships with our customers based on quality and service by:

selling only natural and organic groceries;

offering affordable prices and a shopper-friendly retail environment; and

dine-in options at our Natural Organic Juice Bar and Green Leaf Café.

Our History and Founding Principles

We are committed to maintaining the following founding principles, which have helped foster our growth:

Quality. Every product on our shelves must go through a rigorous screening and approval process. Our mission includes providing the highest quality groceries and supplements, Natural Grocers branded products, European and United States Department of Agriculture (USDA) certified organic and fresh produce at the best prices in the industry.

Community. Ada’s Market has been serving the Ft. Myers community for 40 years.

Employees. Our employees make our company great. We work hard to ensure that our employees are able to live a healthy, balanced lifestyle. We support them with free nutrition education programs, good pay and excellent benefits.

Our Market

We operate within the natural products retail industry, which is a subset of the United States grocery industry and the dietary supplement business. This industry includes conventional supermarkets, natural, gourmet and specialty food markets, mass and discount retailers, warehouse clubs, independent health food stores, dietary supplement retailers, drug stores, farmers’ markets, food co-ops, mail order and online retailers and multi-level marketers. Industry-wide sales of natural and organic foods and dietary supplements have experienced meaningful growth over the past several years, and we believe that growth will continue for the foreseeable future.

We believe the growth in sales of natural and organic foods and dietary supplements continues to be driven by numerous factors, including:

greater consumer focus on high-quality nutritional products;

an increased awareness of the importance of good nutrition to long-term wellness;

an aging Ft. Myer’s community that is seeking healthy lifestyle alternatives;

heightened consumer awareness about the importance of food quality and a desire to avoid pesticide residues, growth hormones, artificial ingredients and genetically engineered ingredients in foods;

growing consumer concerns over the use of harmful chemical additives in body care and household cleaning supplies;

well-established natural and organic brands, which generate additional industry awareness and credibility with consumers; and

the growth in the number of consumers with special dietary requirements as a result of allergies, chemical sensitivities, auto-immune disorders and other conditions.

Our Competitive Strengths

We are well-positioned to capitalize on favorable natural and organic grocery and dietary supplement industry dynamics as a result of the following competitive strengths:

Strict focus on high-quality natural and organic grocery products. We offer high-quality products and brands, including an extensive selection of widely-recognized natural and organic food, dietary supplements, body care products, pet care products and books. We offer our customers approximately 10,000 Stock Keeping Units (SKUs) of natural and organic products. We believe our broad product offering enables our customers to shop our stores for substantially all of their grocery and dietary supplement purchases. In our grocery departments, we primarily sell USDA certified organic produce and do not approve for sale grocery products that are known to contain artificial colors, flavors, preservatives or sweeteners or partially hydrogenated or hydrogenated oils. In addition, we only sell pasture-raised, humanely-raised dairy products. Consistent with this strategy, our product selection does not include items that do not meet our strict quality guidelines. Our store managers enhance our robust product offering by customizing their stores’ selections to address the preferences of local customers.

8

Engaging customer service experience based on education and empowerment. We strive to offer consistently exceptional customer service in a shopper-friendly environment, which we believe creates a differentiated shopping experience, enhances customer loyalty and generates repeat visits from our clientele. A key aspect of our customer service model is to provide free nutrition education to our customers. We believe this focus provides an engaging retail experience while also empowering our customers to make informed decisions about their health. We offer our science-based nutrition education through our trained employees, our newsletter and sales flyer, community out-reach programs, one-on-one nutrition health coaching, nutrition classes and cooking demonstrations.

Our Growth Strategies

We expect to pursue several strategies to continue our profitable growth, including:

Expand our store base. We intend to expand our store base through the acquisition of new stores.

Increase sales from existing customers. In order to increase our average ticket and the number of customer transactions, we plan to continue offering an engaging customer experience by providing science-based nutrition education and a differentiated merchandising strategy that delivers affordable, high-quality natural and organic grocery products and dietary supplements. We also plan to continue to utilize targeted marketing efforts to reach our existing customers, which we anticipate will drive customer transactions and convert occasional, single-category customers into core, multi-category customers.

Grow our customer base.We plan to implement several measures aimed at building our brand awareness and growing our customer base, including: (i) redesigning our website (www.adasmarket.com) to enhance functionality, create a more engaging user experience and increase its reach and effectiveness; (ii) introducing customer appreciation programs at all our stores; and (iii) developing new collateral marketing materials. We believe offering nutrition education has historically been one of our most effective marketing strategies for reaching new customers and increasing the demand for natural and organic groceries and dietary supplements in our markets.

Improve operating margins. We expect to continue to improve our operating margins as we benefit from investments we have made or are making in fixed overhead and information technology. As we add additional stores, we expect to achieve greater economies of scale through sourcing and distribution. To achieve additional operating margin expansion, we intend to further optimize performance, maintain appropriate store labor levels and effectively manage product selection and pricing.

Ada’s Natural Market

Ada’s offers a comprehensive selection of natural and organic groceries and dietary supplements in a smaller-store format that aims to provide a convenient, easily shopped and relaxed environment for our customers. Our store design emphasizes a clutter-free, organized feel, a quiet ambience accented with warm lighting. We believe our core customers consider us a destination stop for their nutritional education and information, natural and organic products and dietary supplements.

Our Store Format. Ada’s has 16,000 selling square feet. Approximately 1,000 of our stores’ selling square footage is dedicated to dietary supplements. Ada’s sells approximately 10,000 SKUs of natural and organic products per store.

Our Products

Product Selection Guidelines. We have a set of strict quality guidelines covering all products we sell. For example:

we do not approve for sale food known to contain artificial colors, flavors, preservatives or sweeteners or partially hydrogenated or hydrogenated oils or phthalates or parabens, regardless of the proportion of its natural or organic ingredients;

we sell USDA certified organic produce;

we sell meats naturally raised without hormones, antibiotics or treatments and that were not fed animal by-products; and

we do not sell any tobacco or tobacco-related products.

9

Our product review team analyzes all new products and approves them for sale based on ingredients, price and uniqueness within the current product set. We actively research new products in the marketplace through our product vendors, private label manufacturers, scientific findings, customer requests and general trends in popular media. Our stores are able to fully merchandise all departments by providing an extensive assortment of natural and organic products. We do not believe we need to sell conventional products to fill our selection, increase our margins or attract more customers.

What We Sell. We operate both a full-service natural and organic grocery store and a dietary supplement store within a single retail location. The following is a breakdown of our product mix:

The products in our stores include:

Grocery.We offer a broad selection of natural and organic grocery products with an emphasis on minimally processed and single ingredient products that are not known to contain artificial colors, flavors, preservatives or sweeteners or partially hydrogenated or hydrogenated oils. Additionally, we carry a wide variety of products associated with special diets such as gluten free, vegetarian and non-dairy. Our grocery products include:

Produce.We sell USDA-certified organic produce and source from local, organic producers whenever feasible. Our selection varies based on seasonal availability, and we offer a variety of organic produce offerings that are not typically found at conventional food retailers.

Bulk Food and Private Label Products.We sell a wide selection of private label repackaged bulk and other products, including nuts, water, pasta, canned seafood, dried fruits, grains, granolas, honey, eggs, herbs, spices and teas.

Dry, Frozen and Canned Groceries.We offer a wide variety of natural and organic dry, frozen and canned groceries, including cereals, soups, baby foods, frozen entrees and snack items. We offer a broad selection of natural chocolate bars, and energy, protein and food bars.

Meats and Seafood.We offer naturally-raised or organic meat products. The meat products we offer come from animals that have never been treated with antibiotics or hormones or fed animal by-products. Additionally, we only buy from companies we believe employ humane animal-raising practices. Our seafood items are generally frozen at the time of processing and sold from our freezer section, thereby ensuring freshness and reducing food spoilage and safety issues.

Dairy Products and Dairy Substitutes.We offer a broad selection of natural and organic dairy products such as milk, eggs, cheeses, yogurts and beverages, as well as non-dairy substitutes made from almonds, coconuts, rice and soy.

Prepared Foods.Our stores have a convenient selection of refrigerated prepared fresh food items, including salads, sandwiches, salsa, humus and wraps. The size of this offering varies by location.

Bread and Baked Goods.We receive regular deliveries of a wide selection of bakery products for our bakery section, which includes an extensive selection of gluten-free items.

Beverages.We offer a wide variety of non-alcoholic and alcoholic beverages containing natural and organic ingredients.

Dietary Supplements. We offer a wide selection of vitamins, supplements and natural remedies. Our staff is well educated and trained on multiple aspects of natural medicine.

Body Care. We offer a full range of cosmetics, skin care, hair care, fragrance and personal care products containing natural and organic ingredients. Our body care offerings range from bargain-priced basics to high-end formulations.

Household and General Merchandise. Our offerings include sustainable, hypo-allergenic and fragrance-free household products, including cleaning supplies, paper products, dish and laundry soap and other common household products, including diapers.

Quality Assurance. We endeavor to ensure the quality of the products we sell. We work with reputable suppliers we believe are compliant with established regulatory and industry guidelines. Our purchasing department requires a complete supplier and product profile as part of the approval process. Our dietary supplement suppliers must follow Food and Drug Administration (FDA) current good manufacturing practices supported by quality assurance testing for both the base ingredients and the finished product. We expect our suppliers to comply with industry best practices for food safety.

10

Many of our suppliers are inspected and certified under the USDA National Organic Program, voluntary industry associations, and other third-party auditing programs with regard to additional ingredients, manufacturing and handling standards. We operate all our stores in compliance with the National Organic Program standards, which restricts the use of certain substances for cleaning and pest control and requires rigorous recordkeeping, among other requirements.

Our Pricing Strategy

We believe our pricing strategy allows our customers to shop our stores on a regular basis for their groceries and dietary supplements.

The key elements of our pricing strategy include:

heavily advertised deals supported by manufacturer participation;

in-store specials generally lasting for 30 days and not advertised outside the store;

managers’ specials, such as clearance, overstock, short-dated or promotional incentives; and

specials on seasonally harvested produce.

As we expand our store base, we believe there are opportunities for increased leverage in fixed costs, such as administrative expenses, as well as increased economies of scale in sourcing products. We strive to keep our product, operating and general and administrative costs low, which allows us to continue to offer attractive pricing for our customers.

Our Store Operations

Store Hours. Our stores are open from 8:00 a.m. to 8:30 p.m., Monday through Saturday, and from 9:00 a.m. to 8:00 p.m. on Sunday.

Store Management and Staffing. Our store staffing includes a manager and assistant manager, with department managers in each of the dietary supplement, grocery, dairy and frozen, produce, body care and receiving departments, as well as several non-management employees. The store manager is responsible for monthly store profit and loss, including labor, merchandising and inventory costs.

To ensure a high level of service, all employees receive training and guidance on customer service skills, product attributes and nutrition education. Employees are carefully trained and evaluated based on a requirement that they present nutrition information in an appropriate and legally compliant educational context while interacting with customers. Additionally, store employees are cross-trained in various functions, including cashier duties, stocking and receiving product.

Inventory.We use a robust merchandise management and perpetual inventory system that values goods at average cost. We manage shelf stock based on weeks-on-hand relative to sales, resupply time and minimum economic order quantity.

Sourcing and Vendors. We source from approximately 250 suppliers, and offer over 4,000 brands. These suppliers range from small independent businesses to multi-national conglomerates. As of December 31, 2017, we purchased approximately 75% of the goods we sell from our top 20 suppliers. For the fiscal year ended December 31, 2017, approximately 40% of our total purchases were from one vendor. We maintain good relations with all our suppliers and believe we have adequate alternative supply methods, including self-distribution.

We have longstanding relationships with our suppliers, and we require disclosure from them regarding quality, freshness, potency and safety data information. Our bulk food private label products are packaged by us in pre-packed sealed bags to help prevent contamination while in transit and in our stores. Unlike most of our competitors, most of our private label nuts, trail mix and flours are refrigerated in our warehouse and stores to maintain freshness.

Our Employees

Commitment to our employees is one of our five founding principles. Employees are eligible for health, long-term disability, vision and dental insurance coverage, as well as Company paid short-term disability and life insurance benefits, after they meet eligibility requirements. Additionally, our employees are offered a 401(k) retirement savings plan with discretionary contribution matching opportunities. This further offers our employees the opportunity to become more familiar with our products, which we believe improves the customer service our employees are able to provide. We believe these and other factors result in higher retention rates and encourage our employees to appreciate our culture, which helps them better promote our brand.

11

Our Customers

The growth in the natural and organic grocery and dietary supplement industries and growing consumer interest in health and nutrition have led to an increase in our core customer base. We believe the demands for affordable, nutritious food and dietary supplements are shared attributes of our core customers, regardless of their socio-economic status. Additionally, we believe our core customers prefer a retail store environment that offers carefully selected natural and organic products and dietary supplements. Our customers tend to be interested in health and nutrition, and expect our store employees to be highly knowledgeable about these topics and related products.

Competition

The grocery and dietary supplement retail business is a large, fragmented and highly competitive industry, with few barriers to entry. Our competition varies by market and includes conventional supermarkets such as Publix and Winn-Dixie, mass or discount retailers such as Wal-Mart and Target, natural and gourmet markets such as Whole Foods and The Fresh Market, specialty food retailers such as Trader Joe’s, independent health food stores, dietary supplement retailers, drug stores, farmers’ markets, food co-ops, mail order and online retailers and multi-level marketers. These businesses compete with us for customers on the basis of price, selection, quality, customer service, shopping experience or any combination of these or other factors. They also compete with us for products and locations. In addition, some of our competitors are expanding to offer a greater range of natural and organic foods. We believe our commitment to carrying only carefully vetted, affordably priced and high-quality natural and organic products and dietary supplements, as well as our focus on providing nutritional education, differentiate us in the industry and provide a competitive advantage.

Seasonality

Our business is active throughout the calendar year and does not experience significant fluctuation caused by seasonal changes in consumer purchasing.

Insurance and Risk Management

We use a combination of insurance and self-insurance to cover workers’ compensation, general liability, product liability, director and officers’ liability, employment practices liability, associate healthcare benefits and other casualty and property risks. Changes in legal trends and interpretations, variability in inflation rates, changes in the nature and method of claims settlement, benefit level changes due to changes in applicable laws, insolvency of insurance carriers and changes in discount rates could all affect ultimate settlements of claims. We evaluate our insurance requirements and providers on an ongoing basis.

Information Technology Systems

We have made significant investments in overhead and information technology infrastructure, including purchasing, receiving, inventory, point of sale, warehousing, distribution, accounting automation, reporting and financial systems.

13

 

Segment Information

We have two reporting segments, natural and organic retail stores (“Grocery”) and vapor products (“Vapor”), through which we conduct all of our business.

The Company has included the results of the Healthy Choice Wellness Centers and Healthy Choice Wellness II, LLC under the grocery segment due to its operations being de minimis.

Going Concern and LiquidityManagement’s Plan

The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”), which contemplate the continuation of the Company as a going concern for the next twelve months from the issuance of this Form 10-K and realization of assets and satisfaction of liabilities in the normal course of business and do not include any adjustments that might result from the outcome of any uncertainties related to our going concern assessment. The carrying amounts of assets and liabilities presented in the consolidated financial statements do not necessarily purport to represent realizable or settlement values.

We had a large numberThe Company currently and historically has reported net losses and cash outflows from operations. As of warrants outstanding with features that made the warrants more debt-like than equity and could possibly result in cash outflows. Additionally, for the year ended December 31, 2017, we reported a net loss of2023, cash totaled approximately $9.9 million$5.1 million. The Company anticipates that its current cash and had a working capital deficit of approximately $2.3 million. These factors raised substantial doubt about our abilitycash generated from operations will not be sufficient to continue as a going concern.

During 2016 and early 2017, we took steps to mitigate these factors by:

1)increasing the number of authorized shares to 750,000,000,000 shares so that there would be sufficient shares available for issuance should all the warrant holders exercise;

2)entering into a Fifth Amended and Restated Series A Warrant Standstill Agreement (the “Fifth Amendment”) with warrant holders effectively eliminating the possibility that warrant holders will exercise for anything other than shares, and

12

The steps above substantially lowered our outstanding liabilities and resulted inmeet the Company having positive equity. As a result, as of the date of the issuance of these financial statements, we believe our plans have alleviated substantial doubt about the Company’s ability to sustain operationsprojected operating expenses for the foreseeable future through a year and a dayat least twelve months from the issuance of these consolidated financial statements. In order to improve the Company’s liquidity position, management’s plans include significantly reducing the use of outside consultants, which would result in over $1,000,000 in general and administrative expenses savings based on the actual spend which occurred during the year ended December 31, 2023. The Company contracted a third party consultant, whose expertise is streamlining operations, to identify areas of improvement and cost savings. The Company will implement the consultant’s recommendation in anticipation of realizing savings and achieving profitability. The Company plans on continuing to expand its Grocery segment via acquisition which will help achieve profitability. Also, the Company is formulating plans to raise capital from outside investors, as it has done in the past, to fund any operating losses and also provide capital for further business acquisitions. The result of the capital raise is to improve the Company’s operating and financial performance. The success of these plans is dependent upon various factors, foremost being the ability to reduce outside consulting expenses and the ability to secure additional capital from outside investors. There can be no assurance that such plans will be successful.

Item 1A. Risk Factors.

Not applicable to smaller reporting companies. Please see the Company’s risk factors contained under Item 7.

Item 1B. Unresolved Staff Comments.

None

Item 1C. Cybersecurity

We believe cybersecurity is critical importance to our success. We are susceptible to a number of significant and persistent cybersecurity threats, including those common to most industries as well as those we face as a retailer, operating in an industry characterized by a high volume of customer transactions and collection of sensitive data. These threats, which are constantly evolving, include data breaches, ransomware, and phishing attacks. We, and our vendors and suppliers, regularly face attempts by malicious actors to breach our security and compromise our information technology systems. A cybersecurity incident impacting us or any vendor or supplier could significantly disrupt our operations and result in damage to our reputation, costly litigation and/or government enforcement action. Accordingly, we are committed to maintaining robust cybersecurity and data protection and continuously evaluate the impact of cybersecurity threats, considering both immediate and potential long-term effects of these threats on our business strategy, operations, and financial condition.

Under the oversight of our Board of Directors, our management has established comprehensive processes for identifying, assessing and managing material risks from cybersecurity threats, and these processes are integrated into our overall enterprise risk management program. Our approach is proactive and adaptive, featuring regular security assessments, third-party audits, team member training, and continuous improvement of our cybersecurity infrastructure. We work to align our practices with industry best practices and regulatory standards. Our processes include detailed response procedures to be followed in the event of a cybersecurity incident, which outline steps to be followed from detection to assessment to notification and recovery, including internal notifications to management, the risk committee and the Board, as appropriate.

14

 

None

Members of management, including our Chief Operating Officer, provide the Board updates on cybersecurity risk matters on a quarterly basis and more frequently if circumstances dictate. In these updates, members of the Board apprised of cybersecurity incidents that are deemed to have had a moderate or higher impact even if immaterial to us. In addition, management regularly discusses with among themselves the risks related to cybersecurity and critical systems in order to provide input on the appropriate level of risk for our company and reviews management’s strategies for adequately mitigating and managing the identified risks. Management regularly update our full Board with respect to cybersecurity matters.

Our Chief Operating Officer is primarily responsible for managing material risks from cybersecurity threats, and is supported by third party cybersecurity specialists. Management participates in periodic training and education on cybersecurity related topics. We engage specialized cybersecurity consultants and leverage third-party expertise to bolster our cybersecurity defenses. Our enterprise risk management program is designed to identify, prioritize and assess a broad range of risks, including risks from cybersecurity threats, that may affect our ability to execute our corporate strategy and fulfill our business objectives.

The following is a list of measures that were implemented as part of our increased focus on cybersecurity:

Complete endpoint protection - All endpoints have been covered by an enhanced endpoint protection agent.
Cloud infrastructure - Critical infrastructure started moving to the cloud and protected by enhanced anti-virus and recurring backup policies.
Email services have been put through a rigorous intelligent phishing and spam filter to prevent attacks

In addition, our third-party vendors and service providers play a role in our cybersecurity. These third parties are integral to our operations but pose cybersecurity challenges due to their access to our data and our reliance for various aspects of our operations, including our supply chain. We conduct due diligence before onboarding new vendors and maintain ongoing evaluations to ensure compliance with our security standards.

As of the date of this report, no cybersecurity incidents have had, either individually or in the aggregate, a material adverse effect on our business, financial condition or results of operations. Notwithstanding the extensive approach we take to cybersecurity, we may not be successful in preventing or mitigating a cybersecurity incident that could have a material adverse effect on us.

Item 2. Properties.

The Company currently has lease agreements for 13operates its business from numerous facilities in Florida, Virginia, New York and New Jersey. These leased facilities include our headquarters location, warehouse and retail vape store locationsstores.

Grocery Segment. As of December 31, 2023, our Grocery segment had 15 retail stores in Florida, New York, New Jersey, and an administrative office. Under these leases, the initial lease terms range from one to five years.Virginia which aggregate approximately 122,000 square feet, 14 stores are leased by our grocery segment. The Company also has a lease agreement for itsowns the property in Saugerties store in New York. The Company believes the properties used by our grocery sales operations. Refer to Note 9segment are in good operating condition and are suitable for the overall lease liability commitment.conduct of its business.

Our headquarters and warehouse are located in Hollywood, Florida which aggregates approximately 10,000 square feet.

Item 3. Legal Proceedings.

No response is required under Item 103 of Regulation S-K. For a description of any other legal proceedings, see Note 9 of the Notes to Consolidated Financial Statements included in Item 8, Financial Statements and Supplementary Data.

Item 4. Mine Safety Disclosures.

None.

1315

 

PART II

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.

Our common stock is currently listed on the OTC Pink marketplace under the symbol “HCMC”. On January 25, 2016, the Units separated into Series A Convertible Preferred Stock and Series A Warrants and public trading of the Units ceased.

Change from NASDAQ to OTCQB to OTC Pink Sheets Stock Listing

On January 22, 2016, the Company received a letter from the Listing Qualifications Staff (the “Staff”) of The NASDAQ Stock Market LLC (“Nasdaq”) indicating that the Staff had determined to delist the Company’s securities based upon its concerns that the Company’s continued listing on Nasdaq, particularly pursuant to a grace period within which to regain compliance with the $1.00 bid price requirement set forth in Nasdaq Listing Rule 5450, is no longer in the public interest as that concept is described in Nasdaq Listing Rule 5110. Specifically, the Staff indicated that, given the potential for dilution of the Company’s stockholders that may be caused by the cashless exercise provision of the Company’s Series A warrants, the Staff believes that the grace period provided to the Company to regain compliance with the $1.00 bid price requirement is no longer warranted. Previously on September 14, 2015, the Staff had notified the Company that, based upon its non-compliance with the minimum $1.00 bid price requirement for the prior 30 consecutive business days, the Company – in accordance with the Nasdaq Listing Rules – had been provided a grace period, through March 14, 2016, to regain compliance with the minimum bid price requirement. On the afternoon of February 11, 2016, the Company was notified by Nasdaq that trading of the Company’s common stock would be halted.

On February 16, 2016, the Company notified the Staff of Nasdaq that it was withdrawing its request to the Nasdaq Listing Qualifications Panel (the “Panel”) for an appeal of the delisting determination made by the Staff on January 22, 2016. As a result, the Company’s shares of common stock were suspended from The Nasdaq Capital Market at the opening of business on Wednesday, February 17, 2016. Nasdaq filed a Form 25 Notification of Delisting with the Securities and Exchange Commission relating to the delisting of the Company’s common stock. The official delisting of the Company’s common stock became effective ten days thereafter. Upon the delisting from Nasdaq, the Company no longer met the “Equity Conditions” required to issue the Company’s common stock to fulfill a cashless exercise pursuant to Section 1(d) of its Series A Warrants. The Company began trading on the OTCQB Market at the opening of the markets on March 16, 2016 under its temporary symbol, VPCOD and thereby met the “Equity Conditions” required to issue the Company’s common stock to fulfill a cashless exercise pursuant to Section 1(d) of its Series A Warrants.

On October 31, 2016, the Company received notice from OTC Markets Group that the Company’s common stock would be moved from the OTCQB to the OTC Pink Sheets on November 1, 2016, as a result of the Company’s failure to cure its bid price deficiency. On November 1, 2016, the date of the delisting from OTCQB, the Company no longer meets the “Equity Conditions” required to allow the Company to elect to issue common stock to fulfill a cashless exercise pursuant to Section 1(d) of its Series A Warrants. Holders of the Series A Warrants may still undertake a cashless exercise of their warrants and agree to permit the Company to issue common stock to fulfill such exercise.

14

On February 1, 2016, the Company’s stockholders approved an amendment to the Company’s Amended and Restated Certificate of Incorporation to (i) effect a reverse stock split of the Common Stock at a ratio between 1-for-10 and 1-for-70, such ratio to be determined by the Board, (ii) reduce the par value of the Common Stock from $0.001 to $0.0001 and (iii) increase the number of authorized shares of the Common Stock from 500,000,000 shares to 5,000,000,000 shares. Each share entitles the holder to one vote. On March 8, 2016, the Board effected a reverse stock split of the Common Stock at a ratio of 1-for-70. On March 21, 2016, the Company’s stockholders approved an amendment to the Company’s Amended and Restated Certificate of Incorporation to effect a reverse stock split of the Common Stock at a ratio between 1-for-10,000 and 1-for-20,000, such ratio to be determined by the Board. On June 1, 2016, the Board effected a reverse stock split of the Common Stock at a ratio of 1-for-20,000.

The following table contains, for the periods indicated, the intraday high and low sale prices per share of our common stock and Units.1

  Common Stock1 
  High  Low 
  $  $ 
Fiscal 2016  1.00   0.0005 
First Quarter  0.25   0.0071 
Second Quarter  1.00   0.0001 
Third Quarter  0.0002   0.0001 
Fourth Quarter  0.0001   0.0005 
Fiscal 2017  0.0001   0.0001 
First Quarter  0.0001   0.0001 
Second Quarter  0.0002   0.0001 
Third Quarter  0.0001   0.0001 
Fourth Quarter  0.0001   0.0001 

1The Company effected a 1-for-70 reverse stock split on March 9, 2016 and a 1-for-20,000 reverse stock split on May 27, 2016. Common stock per share information gives effect to the aforementioned reverse splits of the Company’s common stock.

As of March 13, 2018,27, 2024, there were approximately 29,348,867,1081,400 stockholders of record for our common stock. A substantially greater number of stockholders may be “street name” or beneficial holders, whose shares are held of record by banks, brokers and other financial institutions.

As of March 13, 201827, 2024, the last reported sale price of our common stock on the OTC Pink Marketplace was $0.0001 per share.

We have never declared or paid, and do not anticipate declaring or paying, any cash dividends on any of our capital stock. We currently intend to retain all available funds and any future earnings for use in the operation of our business and do not anticipate paying any dividends in the foreseeable future. Future determination as to the declaration and payment of dividends, if any, will be at the discretion of our Board and will depend on then existing conditions, including our operating results, financial conditions, contractual restrictions, capital requirements, business prospects and other factors our Board may deem relevant.

Tender Offer for the Repurchase of Outstanding Series A Warrants

On December 7, 2016,August 18, 2022, the Company commencedentered into a tender offerSecurities Purchase Agreement pursuant to repurchasewhich the Company sold and issued 14,722 shares of its outstanding Series A Warrants,E Redeemable Convertible Preferred Stock to institutional investors for $1,000 per share or an aggregate subscription of $13.25 million. The number of shares issued to each participant is based on subscription amount multiplied by conversion rate of 1.1111. The Company also incurred offering costs of approximately $410,000, which offer expired on January 17, 2017 with a totalcovers legal and consulting fees. As of 10,073,884 Series A Warrants being tendered at a cost of $2,216,255 to the Company.

Other Repurchases of Outstanding Series A Warrants

Other repurchasesMarch 27, 2024, 12,026 shares of Series A Warrants during 2017 are set forth in the table below.E Redeemable Convertible Preferred Stock were redeemed, and 1,585 shares were converted into common stock.

Period Total Number of
Series A Warrants
Purchased
  Average Price Paid
per Series A
Warrant
 
April 1, 2016 – June 30, 2016  3,706,793.000   0.39 
July 1, 2016 – September 30, 2016  1,817,501.000   0.25 
January 1, 2017 – September 30, 2017  10,601,412   0.23 

15

Item 6. Selected Financial Data.

Not required for smaller reporting companies.

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

You should read the following discussion in conjunction with our audited historical consolidated financial statements, which are included elsewhere in this report. “Management’s Discussion and Analysis of Financial Condition” and “Results of Operations” contains forward-looking statements that reflect our plans, estimates, and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements.

Cautionary Note Regarding Forward Looking Statements

This report includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained in this report, including statements regarding our future financial position, liquidity, business strategy, plans and objectives of management for future operations, are forward-looking statements.

Forward-looking statements contained in this report include:

Our liquidity;

Increase demand for vaporizers and related products;

Opportunities for our business; and

Growth of our business.

16

The words “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” “expect,” and similar expressions, as they relate to us, are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs.

The results anticipated by any or all of these forward-looking statements might not occur. Important factors, uncertainties and risks that may cause actual results to differ materially from these forward-looking statements are contained in the Risk Factors contained herein. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise. For more information regarding some of the ongoing risks and uncertainties of our business, see the Risk Factors below.

Factors Affecting Our Performance

We believe the following factors affect our performance:

Retail: We believe the operating performance of our retail stores will affect our revenue and financial performance. The Company has a total of thirteenfour natural and organic groceries and dietary supplement stores located in Florida, as well as ten located in New York and New Jersey. The Company closed its last 4 remaining retail vape stores which are located in Florida, Georgiaduring the calendar year ended December 31, 2022, as management had shifted its retail sales focus to the wholesale and Alabama.online channel. The Company has ceased plans to increase the number of retail vape stores due to adverse industry trends and increasing federal and state regulations that, if implemented, may negatively impact future retail revenues.wholesale and online operations in vapor segment.

Inventory Management: Our revenue trends are affected by an evolving product acceptance and consumer demand. We are creating and offering new products to our retail customers. Evolving product development and technology impacts our licensing and intellectual properties spending. We expect the transition to vaporizer and advanced technology and enhanced performance products to continue and will impact our operating results in the future.

Increased Competition: Food retail is a large and competitive industry. Our competition varies and includes national, regional, and local conventional supermarkets, national superstores, alternative food retailers, natural foods stores, smaller specialty stores, and farmers’ markets. In addition, we compete with restaurants and other dining options in the food-at-home and food-away-from-home markets. The Launch by national competitorsopening and closing of branded vaporizercompetitive stores, as well as restaurants and e-cigarette products have made it more difficultother dining options, in regions where we operate will affect our results. In addition, changing consumer preferences with respect to compete on pricesfood choices and to secure business.dining out or at home can impact us. We also expect increased vaporizer product supply and downward pressure on prices to continue and impact our operating results in the future. We market and sell the similar vaporizers and e-liquids as our competitors and we sell our products at substantially similar prices as our competitors; accordingly, the key competitive factors for our success is maintain the quality of service we offer our customers and effective marketing efforts.

16

Results of Operations

The following table sets forth our Consolidated Statements of Operations for the years ended December 31, 20172023 and 2016 that2022 which is used in the following discussions of our results of operations:

  For the Year Ended December 31,  2023 to 2022 
  2023  2022  Change $ 
SALES:         
Vapor sales, net $617  $257,363  $(256,746)
Grocery sales, net  55,689,793   29,009,640   26,680,153 
Total Sales  55,690,410   29,267,003   26,423,407 
Cost of sales vapor  787   112,880   (112,093)
Cost of sales grocery  35,341,569   18,929,905   16,411,664 
GROSS PROFIT  20,348,054   10,224,218   10,123,836 
             
OPERATING EXPENSES            
Selling, general and administrative  32,219,733   18,877,302   13,342,431 
Impairment of goodwill  6,104,000   -   6,104,000 
TOTAL OPERATING EXPENSES  38,323,733   18,877,302   19,446,431 
             
LOSS FROM OPERATIONS  (17,975,679)  (8,653,084)  (9,322,595)
             
OTHER INCOME (EXPENSES):            
Change in contingent consideration  774,900   333,100   441,800 
Other (expenses) income, net  (1,485,612)  913,092   (2,398,704)
Interest income (expense), net  211,996   202,653   9,343 
Loss on investment  (8,485)  (13,372)  4,887 
Total other income (expense), net  (507,201)  1,435,473   (1,942,674)
             
NET LOSS $(18,482,880) $(7,217,611) $(11,265,269)

17

 

  For the Year Ended
December 31,
  2017 to 2016 
  2017  2016  Change $ 
SALES:         
Vapor sales, net $5,867,202  $6,722,052  $(854,850)
Grocery sales, net  7,093,893   3,843,111   3,250,782 
Total Sales  12,961,095   10,565,163   2,395,932 
Cost of sales vapor  2,567,400   2,979,609   (412,209)
Cost of sales grocery  4,114,914   2,352,201   1,762,713 
GROSS PROFIT  6,278,781   5,233,353   1,045,428 
             
EXPENSES:            
Advertising  110,694   92,124   18,570 
Selling, general and administrative  16,444,944   9,700,479   6,744,465 
Impairment of goodwill and intangible assets  -   3,955,362   (3,955,362)
Retail store and kiosk closing costs  -   347,656   (347,656)
Total operating expenses  16,555,638   14,095,621   2,460,017 
Operating loss  (10,276,857)  (8,862,268)  (1,414,589)
             
OTHER INCOME (EXPENSES):            
Amortization of debt discounts  -   21,599   (21,599)
Gain (loss) on warrant repurchases  (94,955)  5,189,484   (5,284,439)
Non-cash change in fair value of derivative liabilities  -   15,255,143   (15,255,143)
Other income  200,129   640,000   (439,871)
Interest income  33,774   45,723   (11,949)
Other expense  (1,780)  -   (1,780)
Interest expense  (3,722)  (15,386)  11,664 
Total other income  133,446   21,136,563   (21,003,117)
             
Net income (loss) from continuing operations  (10,143,411)  12,274,295   (22,417,706)
Net income (loss) from discontinued operations  281,483   (1,589,803)  1,871,286 
NET INCOME (LOSS) $(9,861,928) $10,684,492  $(20,546,420)

Net vapor sales decreased $854,850$0.3 million to $5,867,202$0.6 thousand for the twelve monthsyear ended December 31, 20172023 as compared to $6,722,052$0.3 million for the same period in 2016.2022. The decrease in sales iswas primarily due to closing all our retail vape stores throughout 2022, as management shifted its retail sales focus to the decreased numberwholesale and online channel. The sales for 2023 were significantly impacted by technical issues associated with the processing of stores open during 2017 of thirteen, comparedcredit card payments on the Q-Cup.com website and the inability to twenty retail stores in 2016. 

bring new products to market via distribution. Net grocery sales increased $3,250,782$26.6 million to $7,093,893$55.7 million for the twelve monthsyear ended December 31, 20172023 as compared to $3,843,111$29.0 million for the same period in 2016.2022. The $27.6 million increase in grocery sales was primarily due to Ada’s Natural Market beinga result of a full year operations for the year ended December 31, 2023 of Mother Earth’s Storehouse acquired in June 1, 2016, which represents twelve monthsFebruary 2022, Green’s Natural Foods acquired in October 2022 and the acquisition of Ellwood Thompson’s in October 2023, offset by a decrease in same-store sales in 2017 compared to seven months of sales in 2016.$1.0 million.

Vapor cost of goods sold for the twelve monthsyear ended December 31, 20172023 and 20162022 were $2,567,400$0.01 million and $2,979,609,$0.1 million, respectively, a decrease of $412,209.$0.1 million. The decrease in cost of goods sold iswas primarily due to closing all of our retail vape stores throughout 2022, as management shifted its retail sales focus to build the decreased number of stores open during 2017 of thirteen, compared to twenty retail stores 2016. Gross profit from vapor decreased by $442,641 to $3,299,802 for the twelve months ended December 31, 2017 as compared to $3,742,443 for the twelve months ended December 31, 2016.

wholesale and online channel. Grocery store cost of goods sold for the twelve monthsyear ended December 31, 20172023 and 20162022 were $4,114,914$35.3 million and $2,352,201,$18.9 million, respectively, an increase of $1,762,713.$17.5 million was primarily a result of full year operations in 2023 of Mother Earth’s Storehouse acquired in February 2022, Green’s Natural Foods acquired in October 2022 and the acquisition of Ellwood Thompson’s in October 2023, offset by a decrease in same-store cost of goods sold of $1.1 million.

Total selling, general and administrative expenses increased $13.3 million from $18.9 million for the year ended December 31, 2022 to $32.2 million for the year ended December 31, 2023. The increase of $11.3 million was a result of full year operations for the year ended December 31, 2023 of Mother Earth’s Storehouse acquired in February 2022, Green’s Natural Foods acquired in October 2022 as well as the acquisition of Ellwood Thompson’s in October 2023. The remaining increase was primarily due to Ada’s Natural Market being acquiredan increase in June 1, 2016, which represents twelve monthsstock compensation of cost$3.4 million, offset by $0.8 million decrease in professional fees, coupled with a decrease in headquarter payroll and payroll benefits of goods sold in 2017 compared to seven months$0.6 million.

The Company had an impairment of cost of goods sold in 2016. Gross profit from grocery increased by $1,488,069 to $2,978,979$6.1 million for the twelve monthsyear ended December 31, 2017 as compared2023. The Company experienced recurring losses coupled with the reduction in same store revenue, a highly competitive industry and certain operational costs that have impacted our expectations such that future growth and profitability is lower than previous estimates. Furthermore, during the fourth quarter of 2023, the Company operated with negative working capital which, although not a determinant on its own, when combined with the other factors indicated that the Company’s goodwill of $6.1 million was determined to $1,490,910be impaired for the twelve monthsyear ended December 31, 2016.2023.

Total operating expenses increased $2,460,017 to $16,555,638other (expenses) income, net of $0.5 million for the twelve monthsyear ended December 31, 2017 compared to $14,095,621 for the same period in 2016. The increase is primarily attributable to an increase in the following expenses in 2017 compared to 2016 of $7,421,419 of stock compensation, $353,845 of payroll and benefits, and $48,393 of insurance offset by a decrease of the following expenses in 2017 compared to 2016 of $3,955,362 of impairment of goodwill and intangible assets, $1,054,912 of professional fees, $347,656 of retail store and kiosk closing costs.

17

The Company concluded that goodwill was impaired and recorded an impairment charges of $3,955,362 for the twelve months ended December 31, 2016. The Company determined that the carrying value of intangible assets in connection with the Vaporin merger exceeded their potential cash flow from disposition. The Company did not have an impairment charge for 2017.

Net other income of $133,446 for the twelve months ended December 31, 20172023 includes $94,955 loss on repurchase of Series A warrants, $200,129$0.8 million of other income $1,780 of other expense, $33,774 of interest income and $3,722 of interest expense. Net other income of $21,136,563 for the twelve months ended December 31, 2016 includes a $21,599 amortization of debt discounts from notes receivable related to the sale of the wholesale business, $5,189,484 gain on repurchase of Series A warrants, $15,255,143 non-cash change in fair value of Series A warrants, $640,000the contingent consideration with Green’s Natural Foods seller’s earn-out, interest income of $0.2 million, offset by $0.01 million loss on investment, and $1.5 million provision for probable and estimable legal matter issue. Net other income $45,723of $1.5 million for the year ended December 31, 2022 includes a gain on employee retention tax credit of $0.9 million, change in fair value of the contingent consideration with Green’s Natural Foods seller’s earn-out of $0.3 million, and interest income and $15,386 of interest expense.$0.2 million, offset by $0.01 million loss on investment.

The Series A warrants contain a cashless exercise feature that provides for the issuance of a number of shares of our common stock that increases as the trading market price of our common stock decreases. Series A warrants are exercised pursuant to a cashless exercise based on the closing bid price of our common stock as of the two trading days prior to the time of such exercise and the Black Scholes Value. The potential for such highly dilutive exercise of the Series A Warrants may depress the price of our common stock regardless of the Company’s business performance, and could encourage short selling by market participants, especially if the trading price of our common stock begins to decrease. In any such event, investors may be adversely affected.

Liquidity and Capital Resources

  For the year ended December 31, 
  2023  2022 
Net cash (used in) provided by:      
Operating activities $(4,739,136) $(3,866,082)
Investing activities  (768,555)  (10,726,409)
Financing activities  (13,548,115)  12,786,211 
  $(19,055,806) $(1,806,280)

18

  For the year ended
December 31,
 
  2017  2016 
       
Net cash used in operating activities $(2,823,445) $(7,315,987)
Net cash used in investing activities  (192,885)  (3,187,516)
Net cash used in financing activities  (2,466,751)  (3,345,216)
  $(5,483,081) $(13,848,719 

Our net cash used in operating activities of $4.7 million for the year ended December 31, 2023 resulted from our net loss of $18.5 million and a net cash usage of $1.9 million from changes in operating assets and liabilities, offset by a non-cash adjustments of $15.6 million. Our net cash used in continuing operating activities of $2,602,021$3.8 million for the twelve monthsyear ended December 31, 20172022 resulted from our net loss from continuing operations of $10,143,411,$7.2 million and a net cash usage of $789,218$0.2 million from changes in operating assets and liabilities, offset by a non-cash adjustments of $8,330,608. Our net cash used in discontinued operations of $221,424 for the twelve months ended December 31, 2017 resulted from our net income from discontinued operations of $281,483 offset by non-cash adjustments of $502,907. Our net cash used in continuing operating activities of $3,576,816 for the twelve months ended December 31, 2016 resulted from our net income from continuing operations of $12,274,295, a net cash usage of $846,858 from changes in operating assets and liabilities offset by non-cash adjustments of $15,004,253. Our net cash used in discontinued operations of $3,739,171 for the twelve months ended December 31, 2016 resulted from our net loss from discontinued operations of $1,589,803 a net cash usage of $2,466,269 from changes in assets and liabilities from discontinued operations offset by noncash adjustments of $316,901.$3.5 million.

The net cash used in investing activities of $192,885$0.8 million for the twelve monthsyear ended December 31, 20172023 resulted from patentthe acquisition of Ellwood Thompson’s, the collection of a note receivable, and purchases of $50,000a patent and property and equipment of $142,885.

equipment. The net cash used in investing activities of $3,187,516$10.7 million for the twelve monthsyear ended December 31, 20162022 resulted from the collection of a note receivable, the acquisition of grocery store business assets for $2,910,612,new businesses and purchases of $25,299 ofa patent and property and equipment, purchases of tradename of $25,000, issuance of note receivable to related party in conjunction with sale of wholesale business of $500,000 offset by proceeds received from sale of tradename of $100,000 and collection of note receivable of $173,395.equipment.

The net cash used in financing activities of $2,466,751$13.5 million for the twelve monthsyear ended December 31, 20172023 is due to repurchases of Series A warrants totaling $2,427,267, principal payments on capital lease obligations of $53,054,E Preferred Stock redemptions and principal paymentsexercises, payment for deferred offering cost related with the spin off, and principle payment on loan payable of $1,407 offset by proceeds from loan payable of $13,977 and proceeds from exercise of stock options of $1,000.payable. The net cash used inprovided by financing activities of $3,345,216$12.8 million for the twelve monthsyear ended December 31, 20162022 is due to repurchasesproceeds received from Securities Purchase Agreement of Series A warrants totaling $3,278,827 and$12.8 million, partially offset by a principal payment of $66,389 of capital lease obligation.$0.09 million on promissory note.

At December 31, 20172023 and December 31, 2016,2022, we dodid not have any material financial guarantees or other contractual commitments with thesetrade vendors that are reasonably likely to have an adverse effect on liquidity.

18

Our cash balances are kept liquid to support our growing acquisition and infrastructure needs for operational expansion. The majority of our cash and cash equivalents are concentrated in one large financial institution which isand are generally in excess of the Federal Deposit Insurance Corporation (FDIC) coverage.insurance limit. The Company has not experienced any losses on its cash and cash equivalents. The following table presents the Company'sCompany’s cash position as of December 31, 20172023 and December 31, 2016.2022.

 December 31, 2017 December 31, 2016  

December 31,

2023

  

December 31,

2022

 
          
Cash $7,883,191  $13,366,272  $5,081,086  $22,911,892 
Total assets $11,701,405  $17,234,751  $30,969,579  $55,255,030 
Percentage of total assets  67.4%  77.6%  16.41%  41.5%

The Company reported net loss allocable to common stockholdersAs of approximately $9.9 million for the year ended December 31, 2017. The2023, the Company had a deficit incash of $5.1 million and negative working capital of approximately $2.3 million$0.5 million. The Company has incurred recurring net losses and operations have not provided cash flows. The Company expects to continue incurring losses for the foreseeable future and may need to raise additional capital to satisfy business obligations, and to continue as of December 31, 2017, As of March 13, 2018,a going concern. We believe that current cash on hand and cash flow from operations will not be sufficient to fund our working capital and other cash requirements over the Company had approximately $7.6 million of cash. The decrease in cash from December 31, 2016 is primarily attributable to repurchases of Series A warrants and operating expenses.next twelve months.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements other than operating leases for retail locations, equipment, and vehicles.

Seasonality

We do not consider our business to be seasonal.

19

Critical Accounting Policies and Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States (U.S. GAAP) requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The financial statements include estimates based on currently available information and our judgment as to the outcome of future conditions and circumstances. These estimates and assumptions include useful lives and impairment of long-lived assets, goodwill, deferred taxes and related valuation allowances, and the valuation of the assets and liabilities acquired in business combinations. Changes in the status of certain facts or circumstances could result in material changes to the estimates used in the preparation of the financial statements and actual results could differ from the estimates and assumptions.

Revenue Recognition

The Company recognizes revenue in accordance with ASC 606, Revenue from Contracts with Customers (“ASC 606”), the core principle of which is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to receive in exchange for those goods or services. To achieve this core principle, five basic criteria must be met before revenue can be recognized:

Identification of the contract, or contracts, with a customer;

Identification of the performance obligations in the contract;

Determination of the transaction price;

Allocation of the transaction price to the performance obligations in the contract; and

Recognition of revenue when, or as, the Company satisfies a performance obligation.

Impairment of Long-Lived Assets

We review long-lived assets for impairment including intangible assets with determinable useful lives whenever events or changes in circumstances indicate that the carrying value of the corresponding asset group may not be realizable. The Company estimated future undiscounted cash flows associated with the asset group are compared to the asset group’s carrying amount to determine if an impairment of such asset is necessary. This requires us to make long-term forecasts of the future revenues and costs related to the assets groups subject to review. Forecasts require assumptions about demand for our products and future market conditions. Estimating future cash flows requires significant judgment, and our projections may vary from cash flows eventually realized. Future events and unanticipated changes to assumptions could require a provision for impairment in a future period. The effect of any impairment would be reflected in operating income in the Consolidated Statements of Operations. In addition, we estimate the useful lives of our long-lived assets and other intangibles and periodically review these estimates to determine whether these lives are appropriate.

20

Goodwill

 

Non-GAAP – Financial MeasureGoodwill is the excess of consideration paid for an acquired entity over the fair value of the amounts assigned to assets acquired, including other identifiable intangible assets, and liabilities assumed in a business combination. To determine the amount of goodwill resulting from a business combination, the company hires third party valuation firm to perform valuation and assessment to determine the acquisition date fair value of the acquired company’s tangible and identifiable intangible assets and liabilities.

 

Goodwill is required to be evaluated for impairment on an annual basis or whenever events or changes in circumstances indicate the asset may be impaired. An entity has the option to first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. These qualitative factors include: macroeconomic and industry conditions, cost factors, overall financial performance and other relevant entity-specific events. If the entity determines that this threshold is met, then the company may apply a one-step quantitative test and record the amount of goodwill impairment as the excess of a reporting unit’s carrying amount over its fair value, not to exceed the total amount of goodwill allocated to the reporting unit. The company determines fair value through multiple valuation techniques and weights the results accordingly. The company is required to make certain subjective and complex judgments in assessing whether an event of impairment of goodwill has occurred, including assumptions and estimates used to determine the fair value of its reporting units. The company has elected to perform its annual goodwill impairment review on September 30 of each year or more often if deemed necessary.

Business Combinations

The Company applies the provisions of ASC Topic 805, Business Combinations (“ASC 805”) in the accounting for acquisitions of businesses. ASC 805 requires the Company to use the acquisition method of accounting by recognizing the identifiable tangible and intangible assets acquired and liabilities assumed, measured at their acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the aforementioned amounts. Acquisition costs are expensed as incurred and recorded in selling, general and administrative expenses in the consolidated statements of operations.

Deferred Taxes and Valuation Allowance

We account for income taxes pursuant to the asset and liability method of accounting for income taxes pursuant to FASB ASC740, “Income Taxes.” Deferred tax assets and liabilities are recognized for taxable temporary differences and operating loss carry forwards. Temporary differences are the differences between the reported amount of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.

Non-GAAP Financial Measures

The following discussion and analysis contains a non-GAAP financial measure. Generally, a non-GAAP financial measure is a numerical measure of a company’s performance, financial position or cash flows that either excludes or includes amounts that are not normally included or excluded in the most directly comparable measure calculated and presented in accordance with generally accepted accounting principles (GAAP). Non-GAAP financial measures should be viewed as supplemental to, and should not be considered as alternative to, net income, operating income, and cash flow from operating activities, liquidity or any other financial measures. Non-GAAP financial measures may not be indicative of the historical operating results of the Company nor are they intended to be predictive of potential future financial results. Investors should not consider non-GAAP financial measures in isolation or as substitutes for performance measures calculated in accordance with GAAP.

Management believes stockholders benefit from referring to the Adjusted EBITDA in planning, forecasting, and analyzing future periods. Management uses this non-GAAP financial measure in evaluating its financial and operational decision making and as a means of evaluating period to period comparison.

We define Adjusted EBITDA, as net loss from operations adjusted for non-cash charges foror earnings before interest, taxes, depreciation, and amortization, and stock compensation.is an alternate measure of profitability to net income. Management believes Adjusted EBITDA is an important measure of our operating performance because it allows management, investors and analysts to evaluate and assess our core operating results from period to period after removing the impact of significant non-cash and non-recurring charges that effect comparability between reporting periods. We define Adjusted EBITDA as net loss adjusted for non-cash charges for depreciation and amortization, impairment of goodwill, stock compensation, change in contingent consideration, also adjusted for non-recurring other expense (income), net, loss on investment, and interest income. Our management recognizes that Adjusted EBITDA has inherent limitations because of the excluded items.

We have included a reconciliation of our non-GAAP financial measure to net loss from operations as calculated in accordance with GAAP. We believe that providing the non-GAAP financial measure, together with the reconciliation to GAAP, helps investors make comparisons between the Company and other companies. In making any comparisons to other companies, investors need to be aware that companies use different non-GAAP measures to evaluate their financial performance. Investors should pay close attention to specific definitions being used and to the reconciliation between such measures and the corresponding GAAP measures provided by each company under applicable rules of the Securities and Exchange Commission.

 2017 2016  2023  2022 
     
Reconciliation of Adjusted EBITDA to net loss allocable to common stockholders:     
Reconciliation from net loss to adjusted EBITDA:     
Operating loss $(10,276,857) $(8,862,268) $(18,482,880) $(7,217,611)
Interest expense  205,449   35,730 
Depreciation and amortization  350,647   374,388   1,492,261   1,061,615 
EBITDA  (16,785,170)  (6,120,266)
Stock-based compensation expense  7,496,849   75,430   3,430,250   72,222 
Impairment of goodwill  6,104,000   - 
Change in contingent consideration  (774,900)  (333,100)
Loss on investment  8,485   13,372 
Other expense (income), net  1,485,612   (913,092)
Interest income  (417,445)  (238,383)
Adjusted EBITDA $(2,429,361) $(8,412,450) $(6,949,168) $(7,519,247)

Item 7A. Quantitative and Qualitative Disclosures About Market Risk.

Not applicable to smaller reporting companies.

19

Item 8. Financial Statements and Supplementary Data.

See pages F-1 through F-27.F-23.

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.

The Audit Committee of the Company completed a competitive process to determine what firm would serve as the Company’s independent registered public accounting firm for the year ended December 31, 2017. On April 20, 2017, the Audit Committee determined to dismiss Morrison, Brown, Argiz & Farra, LLC as the Company’s independent registered public accounting firm effective immediately.None.

During the years ended December 31, 2016 and 2017, there were no (a) disagreements with auditors on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to satisfaction, would have caused our auditors to make reference to the subject matter thereof in connection with its reports for such years; or (b) reportable events, as described under Item 304(a)(1)(v) of Regulation S-K.

Item 9A. Controls and Procedures.

We are required to report under Section 404(a) of Sarbanes-Oxley regarding the effectiveness of our internal control over financial reporting. If we determine that we have material weaknesses, it may be necessary to make restatements of our consolidated financial statements and investors will not be able to rely on the completeness and accuracy of the financial information contained in our filings with the SEC and this could potentially subject us to sanctions or investigations by the SEC or other regulatory authorities or stockholder litigation.

Evaluation of Disclosure Controls and Procedures. Our management, including our Principal Executive Officer and Principal Financial Officer, did not carry out an evaluation on internal controls during the year ended December 31, 20172023 in regard to the effectiveness of our disclosure controls and procedures as defined in Rule 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, or the Exchange Act. As an evaluation was not carried out, our Principal Executive Officer and Principal Financial Officer concluded that our disclosure controls and procedures were ineffective as of the end of the period covered by this report.

21

 

Inherent Limitations of Internal Controls over Financial Reporting. The Company’s internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. The Company’s internal control over financial reporting includes those policies and procedures that: (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the Company’s assets; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that the Company’s receipts and expenditures are being made only in accordance with authorizations of the Company’s management and directors; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company’s assets that could have a material effect on the Company’s financial statements.

Changes in Internal Control Over Financial Reporting. There were no changes in the Company’s internal control over financial reporting that occurred during the quarter ending December 31, 2023 that have materially affected, or are reasonably likely to materially affect, its internal control over financial reporting.

Management’s Annual Report on Internal Control over Financial Reporting. OurThe Company’s management is responsible for establishing and maintaining adequate internal controlscontrol over financial reporting. Under the supervision and with the participation of the Company’s management, including the Chief Executive Officer and Chief Financial Officer, the Company evaluated the effectiveness of the design and operation of its internal control over financial reporting as such term is definedbased on the framework established in Rule 13a-15(f)Internal Control - Integrated Framework issued by the Committee of Sponsoring Organizations of the Securities Exchange Act of 1934. Our management, including our PrincipalTreadway Commission (2013 framework). Based on that evaluation, the Company’s Chief Executive Officer and PrincipalChief Financial Officer did not conduct an evaluation ofconcluded that the effectiveness of ourCompany’s internal controlscontrol over financial reporting was ineffective as of December 31, 2017.

In planning2023 and performing its audit of our financial statements fornoted the year ended December 31, 2017 in accordance with standards of the Public Company Accounting Oversight Board, our independent registered public accounting firm noted material weaknesses in internal control over financial reporting. A list of our material weaknesses are as follows:

Failure to have properly documented and designed disclosure controls and procedures and testing of the operating effectiveness of our internal control over financial reporting
reporting.

Failure to perform periodic and year-end inventory observations in a timely manner and adequate controls to sufficiently perform required rollback procedures of inventory counts to the year-end.

Weakness around our purchase orders and inventory procedures, inclusive of year-end physical inventory observation procedures as well as physical count procedures
procedures.

Segregation of duties due to lack of personnelpersonnel.
Failure to follow accounts payable policies and procedures for vendor information updates.

The Company had ineffective design, implementation and, operation of controls over logical access, program change management, and vendor management controls. The Company controls on IT should have included the following:

appropriate restrictions that would adequately prevent users from gaining inappropriate access to the financially relevant systems.
IT program and data changes affecting the Company’s financial IT applications and underlying accounting records, should be identified, tested, authorized and implemented appropriately to validate that data produced by its relevant IT system(s) were complete and accurate.
Obtaining and reviewing key third party service provider SOC reports.

Our management concluded that considering internal control deficiencies, that, in the aggregate, rise to the level of material weaknesses, we did not maintain effective internal control over financial reporting as of December 31, 20172023 based on the criteria set forth in Internal Control-Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”).

Remediation Efforts

Following this assessment and during the first and second quarters of fiscal year 2017,twelve months ended December 31, 2023, we have undertaken an action plan to strengthen internal controls and procedures:

We continueContinuing to build out our accounting team by filling our Chief Financial Officer, Controllerincrease headcount across the Company, with a particular focus on hiring individuals with strong internal control backgrounds and Accounting Manager positions with personnel possessing extensive experience working at large, publicly-traded companies with exposure to SEC reporting and numerous areas of technical accounting. We also established relationships with financial reporting consultants to assist with technical accounting as deemed necessary.inventory expertise.

Our SEC reporting was brought in-house as the function was previously accomplished using outside consultants; providing for a more efficient reporting process than that experienced in 2016.
Our management has increasedIncreasing its focus on the Company’s month-end account reconciliationpurchase order process in order to provide forbetter manage inventory thereby improving cash management and ultimately leading to more reliable and precise financial statements.reporting. The Company implemented an open to buy program by comparing purchases with sales to better control overall inventory purchases.

Establishing policies and procedures in the IT area to mitigate data breach, unauthorized access and address segregation of duties, as well as review key third party service provider SOC reports.

Using business intelligence to combine business analytics, data tools and infrastructure to help the Company quickly identify the issues in POS system and facilitate internal control over financial reporting. Developing dashboards for operation to monitor the margin at store level, department level and sku level.
Providing sufficient training to accounts payable associates and enforcing accounts payable policies and procedures.

Our management continuesWe are currently working to review waysimprove and simplify our internal processes and implement enhanced controls, as discussed above, to address the material weaknesses in which we can make improvements inour internal control over financial reporting.reporting and to remedy the ineffectiveness of our disclosure controls and procedures. These material weaknesses will not be considered to be remediated until the applicable remediated controls are operating for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively.

20

Item 9B. Other Information.

None.

22

 

None.

PART III

Item 10. Directors, Executive Officers and Corporate Governance

Directors and Executive Officers

The following table sets forth information regarding our executive officers and directors as of March 13, 2018:December 31, 2023:

NameAgePosition
Executive Officers:
Jeffrey Holman5156Chief Executive Officer, Chairman and Director
John A. Ollet5561Chief Financial Officer
Christopher Santi4753President and Chief Operating Officer
Non-Employee Directors:
Clifford J. Friedman5662Director
Dr. Anthony Panariello5864Director

Executive Officers

Jeffrey Holman has been our Chairman of the Board and Chief Executive Officer since April 2014. From February 2013 until March 4, 2015, Mr. Holman serviced as our President. Mr. Holman has been a member of our Board since May 2013 and has served as a member of the Board of Directors of our subsidiary Smoke Anywhere, USA since its inception on March 24, 2008. Since 1998, Mr. Holman has been the President of Jeffrey E. Holman & Associates, P.A., a South Florida based law firm. He has also been a Partner in the law firm of Holman, Cohen & Valencia since 2000. Mr. Holman was selected as a director for his business and legal experience. In addition, as one of the founders of Smoke Anywhere, Mr. Holman possesses an in-depth understanding of the challenges, risks and characteristics unique to our industry.

Christopher Santi has been our Chief Operating Officer since December 12, 2012 and has also served as the President and Chief Operating Officer since April 11, 2016. Prior to thatPreviously, Mr. Santi served as Director of Operations of the Company beginning in October 2011. Mr. Santi served as the National Sales Manager of Collages.net from November 2007 to October 2011.

John A. Ollet has been our Chief Financial Officer since December 12, 2016. Mr. Ollet previously served as Executive Vice President-Finance for Systemax, Inc. (NYSE:SYX) from 2006 to 2016. His prior chief financial officer experience also includes serving as Vice President and Chief Financial Officer of Arrow Cargo Holdings, Inc., an airline logistics company, and VP Finance /CFO - The Americas - Cargo Division, KLM Royal Dutch Airlines, an airline company. He also previously served as Vice President Finance/Administration at Sterling-Starr Maritime Group, Inc. and served on the audit staff of Arthur Andersen & Co. Mr. Ollet received a bachelor’s degree in Finance/Economics and a master’s degree in business administration from Florida International University. Mr. Ollet is a Certified Public Accountant.

Non-Employee Directors

Anthony Panariello, M.D. has been a director since April 15, 2016. Dr. Panariello is a Board CertifedCertified in Pulmonology and Internal Medicine in Florida and has been in private practice since 1996, serving as an attending physician at a number of hospitals. Dr. Panariello is a member of the College of Physicians and the American College of Chest Physicians. Additionally, Dr. Panariello currently serves as a Lieutenant Commander in the Medical Corps of the United States Navy Reserve. Dr. Panariello received his Bachelor of Science from the State University of New York at Stony Brook and his medical degree from the Autonomous University of Guadalajara.

Clifford J. Friedman has been a director since April 15, 2016. Mr. Friedman is a certified public accountant in Coral Springs, Florida and managedmanages his own public accounting, tax and consulting practice since 2001. From 1992 to 2000, Mr. Friedman was Vice President-Finance ofPresident - Finance and Administration of the Box Worldwide, Inc., a Viacom company. He received an M.B.A. from Nova Southeastern University and his B.B.A. from Pace University.

2123

 

Corporate Governance

 

Board Responsibilities

The Board oversees, counsels, and directs management in the long-term interest of the Company and its stockholders. The Board’s responsibilities include establishing broad corporate policies and reviewing the overall performance of the Company. The Board is not, however, involved in the operating details on a day-to-day basis.

Board Committees and Charters

The Board and its Committees meet throughout the year and act by written consent from time-to-time as appropriate. The Board delegates various responsibilities and authority to different Board Committees. Committees regularly report on their activities and actions to the Board.

The Board currently has and appoints the members of: The Audit Committee, the Compensation Committee and the Nominating and Corporate Governance Committee. Each of these committees have a written charter which can be found on our corporate website atwww.healthiercmc.com/committee-charters/.

The following table identifies the independent and non-independent current Board and committee members:

NameIndependentIndependentAuditCompensationAuditCompensationNominating
And Corporate
Governance
Jeffrey Holman
Dr. Anthony PanarielloXXXXXXX
Clifford J. FriedmanXXXXXXX

Director Independence

Our Board has determined that Clifford J. Friedman and Dr. Anthony Panariello are independent in accordance with standards under the OTC Pink Marketplace. Our Board determined that as a result of being an executive officer, Messrs. Jeffrey Holman is not independent under the OTC Pink Marketplace Bulletin Boards. Our Board has also determined that Clifford J. Friedman and Dr. Anthony Panariello are independent under the OTC Pink Marketplace independence standards for Audit and Compensation Committee members.

Committees of the Board

Audit Committee

The Audit Committee, which currently consists of Clifford J. Friedman (chair) and Dr. Anthony Panariello, reviews the Company’s financial reporting process on behalf of the Board and administers our engagement of the independent registered public accounting firm. The Audit Committee approves all audit and non-audit services, and reviews the independence of our independent registered public accounting firm.

Audit Committee Financial Expert

Our Board has determined that Clifford J. Friedman is qualified as an Audit Committee Financial Expert, as that term is defined by the rules of the SEC and in compliance with the Sarbanes-Oxley Act of 2002.

Compensation Committee

The function of the Compensation Committee is to determine the compensation of our executive officers. The Compensation Committee has the power to set performance targets for determining periodic bonuses payable to executive officers and may review and make recommendations with respect to stockholder proposals related to compensation matters. Additionally, the Compensation Committee is responsible for administering the Company’s equity compensation plans including the Plan.Company’s 2015 Equity Incentive Plan, as amended.

The members of the Compensation Committee are all independent directors within the meaning of applicable Nasdaq Listing Rules and all of the members are “non-employee directors” within the meaning of Rule 16b-3 under the Exchange Act.

2224

 

 

Nominating and Corporate Governance Committee

The responsibilities of the Nominating and Corporate Governance Committee include the identification of individuals qualified to become Board members, the selection of nominees to stand for election as directors, the oversight of the selection and composition of committees of the Board, establish procedures for the nomination process including procedures and the oversight of the evaluations of the Board and management. The Nominating and Corporate Governance Committee has not established a policy with regard to the consideration of any candidates recommended by stockholders since no stockholders have made any recommendations. If we receive any stockholder recommended nominations, the Nominating Committee will carefully review the recommendation(s) and consider such recommendation(s) in good faith.

Compensation Committee Interlocks and Insider Participation

None of the members of our compensation committee has ever been an officer or employee of the Company. None of our executive officers serve, or have served during the last fiscal year, as a member of our compensation committee or other Board committee performing equivalent functions of any entity that has one or more executive officers serving on our Board or on our compensation committee.

Board Assessment of Risk

The Board is actively involved in the oversight of risks that could affect the Company. This oversight is conducted primarily through the Audit Committee, but the full Board has retained responsibility for general oversight of risks. The Audit Committee considers and reviews with our independent public accounting firm and management the adequacy of our internal controls, including the processes for identifying significant risks and exposures, and elicits recommendations for the improvements of such procedures where desirable. In addition to the Audit Committee’s role, the full Board is involved in oversight and administration of risk and risk management practices. Members of our senior management have day-to-day responsibility for risk management and establishing risk management practices, and members of management are expected to report matters relating specifically to the Audit Committee directly thereto, and to report all other matters directly to the Board as a whole. Members of our senior management have an open line of communication to the Board and have the discretion to raise issues from time-to-time in any manner they deem appropriate, and management’s reporting on issues relating to risk management typically occurs through direct communication with directors or committee members as matters requiring attention arise. Members of our senior management regularly attend portions of the Board’s meetings, and often discuss the risks related to our business.

Presently, the largest risks affecting the Company are the Company’s ability to manage and satisfy the Series A Warrant obligations and evaluation of potential adverse impact of the FDA’s final regulations on vaporizers and e-liquids on the retail business operations. The Board actively interfaces with management on seeking solutions.

Code of Ethics

The Company has a code of ethics, “Business Conduct: “Code of Conduct and Policy,” that applies to all of the Company’s employees, including its principal executive officer, principal financial officer and principal accounting officer, and the Board. A copy of this code is available on the Company’s website at http://www.healthiercmc.com/code-of-conduct. The Company intends to disclose any changes in or waivers from its code of ethics by posting such information on its website or by filing a Current Report on Form 8-K.

Stockholder Communications

Although we do not have a formal policy regarding communications with our Board, stockholders may communicate with the Board by writing to us at Healthier Choices Management Corp., 3800 N 28th Way, Hollywood, FL 33020, Attention: Corporate Secretary, or by facsimile (954) 272-7773.(305) 600-5004. Stockholders who would like their submission directed to a member of the Board may so specify, and the communication will be forwarded, as appropriate.

25

 

Section 16(a) Beneficial Ownership Reporting Compliance

Section 16(a) of the Exchange Act requires our officers and directors, and persons who own more than 10% of a registered class of our equity securities, to file with the SEC initial reports of ownership and reports of changes in ownership of common stock and the other equity securities. Officers, directors and greater than ten percent stockholders are required by SEC rules to furnish us with copies of all Section 16(a) reports they file.

Based solely on a review of the reports furnished to us, or written representations from reporting persons that all reportable transactions were reported and that no Form 5s were required, we believe that during 20162023 our officers, directors and greater than 10% owners timely filed all reports they were required to file under Section 16(a).

23

ITEM 11. Executive Compensation

The following information is related to the compensation paid, distributed or accrued by us for fiscal 2017 and 20162023 to all Chief Executive Officers (principal executive officers) serving during the last fiscal year and the two other most highly compensated executive officers serving at the end of the last fiscal year whose compensation exceeded $100,000. We refer to these individuals as our “named executive officers.”

Summary Compensation Table

Name and Principal Position Year Salary
($)
  Bonus
($)
  

Option
Awards

(1)

  All
Other
Compensation
($)
  Total  Year  Salary ($)  Bonus ($)  Restricted Stock/ (Forfeited) (1)$  Restricted Stock Awards(1) $  All Other Compensation ($)  Total 
                            
Jeffrey Holman 2017  346,368   100,000   4,999,998   9,900   5,456,266  2023   688,149   -   -   5,000,000   -   5,688,149 
Chief Executive Officer 2016  312,346   100,000   -   -   412,346  2022   598,379   350,000   -   -   -   948,379 
                                                
Christopher Santi 2017  225,410   25,000   2,499,999   601   2,751,010  2023   405,321   -   -   2,500,000   -   2,905,321 
President & Chief Operating Officer 2016  209,117   50,000   -   -   259,117 
President and Chief Operating Officer 2022   394,832   200,000   -   -   -   594,832 
                                                
John Ollet 2017  185,931   -   500,000   510   686,441  2023   304,616   -   -   1,800,000   -   2,104,616 
Chief Financial Officer 2016  8,307   -   -   -   8,307  2022   260,616   125,000   -   -   -   385,616 
                      
Gina Hicks 2017  38,462   -   -   -   38,462 
Former Chief Financial Officer 2016  197,117   -   -   45,113   242,250 

(1) Amounts reflect the aggregate grant date fair value, without regard to forfeitures, computed in accordance with ASC 718. These amounts represent options and restricted stock of the Company’s common stock and do not reflect the actual amounts that may be realized by the Named Executive Officers. Our assumptions with respect to the calculation of the stock options and restricted stock value are set forth in Note 2 to the consolidated financial statements contained herein.

Named Executive Officer Employment Agreements

On August 10, 2015,13, 2018, the Company entered into three-year Employment Agreementsamended and restated its existing employment agreement with Jeffrey Holman, the Company’s Chief Executive Officer and Gregory Brauser, the Company’s President. Each of the(the “Holman Employment Agreements provideAgreement”). The Holman Employment Agreement provides for an annual base salary of $300,000$450,000 and a target bonus only in an amount ranging from 20% to 200% of theirhis base salaries subject to the Company meeting certain adjusted earnings before interest, taxes depreciation and amortization (“Adjusted EBITDA”) performance milestones. Adjusted EBITDAThe Holman Employment Agreement automatically renews each year unless terminated by either party on 30 days’ prior notice. Mr. Holman is defined in the Employment Agreements as earnings (loss) from continuing operations before interest expense, income taxes, collateral valuation adjustment, bad debt expense, one-time expenses, depreciation and amortization and amortization of stock compensation or Adjusted EBITDA defined in any filing of the Company with the SEC subsequent to the date of the Employment Agreements. Messrs. Holman and Brauser are also entitled to receive severance payments, including two years of theirhis then base salary and other benefits in the event of a change of control, termination by the Company without cause, termination for good reason by the executive or non-renewal by the Company. Mr. Holman was also granted 11 billion shares of restricted common stock pursuant to the Holman Employment Agreement Amendment on the condition that 11 billion of his options to purchase Company common stock are forfeited. This restricted stock will vest one year following the date of issuance provided that the grantee remains an employee of the Company through each applicable vesting date. On August 12, 2019, the Company agreed to extend the expiration date of the vesting period for the restricted stock by six months to February 13, 2020. On August 12, 2020, the Company agreed to extend for a second time the expiration date of the vesting period for the restricted stock by six months to February 13, 2021. The Term shall be automatically renewed for successive one-year terms unless notice of non-renewal is given by either party at least 30 days before the end of the Term. The above description of the terms of the Holman Employment Agreement is not complete and is qualified by reference to the complete document.

26

 

Effective December 12, 2012,

On February 26, 2021, the Company entered into a three-yearan amended and restated employment agreement (the “Santi Employment Agreement”) with Christopher Santi, the Company’s President and Chief Operating Officer. The employment agreement paid a beginning base salary of $156,000 which increasedOfficer, Christopher Santi. Pursuant to $170,000 beginning in December 2016. In accordance with this employment agreement,the Employment Agreement Amendment. Mr. Santi received a 10-year option to purchase up to 57 sharesbase salary of $0.4 million for 2021 and his salary has increased 10% in each subsequent year. The term shall be automatically renewed for successive one-year terms unless notice of non-renewal is given by either party at least 30 days before the end of the Company’s common stock at an exercise price of $437.50, vesting monthly at the rate of approximately 2 shares per month. AsTerm. The above description of the dateterms of this report, the options are fully vested. Santi Employment Agreement is not complete and is qualified by reference to the complete document.

On January 30, 2017,February 2, 2022, the Company entered into a newsecond amended and restated employment agreement (the “Ollet Employment Agreement”) with Mr. Santi for a three-year term beginning January 30, 2017.the Company’s Chief Financial Officer, John Ollet. Pursuant to the new employment agreement,Employment Agreement Amendment, Mr. SantiOllet will receivecontinue to be employed as the Company’s Chief Financial Officer through February 14, 2025. Mr. Ollet received a base salary of $225,000, increasing to $250,000$300,000 for 2022 and $275,000, respectively,his salary will increase 10% in each subsequent calendar year. The term shall be automatically renewed for successive one-year terms unless notice of non-renewal is given by either party at least 30 days before the second and third yearsend of the employment agreement. Mr. Santi is also eligible to earn an annual bonus at the discretionTerm. The above description of the Company’s Boardterms of Directors.the Ollet Employment Agreement is not complete and is qualified by reference to the complete document.

24

Termination Provisions

The table below describes the severance payments that our Named Executive Officers are entitled to in connection with a termination of their employment upon death, disability, dismissal without cause, Change of Control or for Good Reason. All of the termination provisions are intended to comply with Section 409A of the Internal Revenue Code of 1986 and the Regulations thereunder.

HolmanSantiSanti/Ollet
Death or Total DisabilityAny amounts due at time of termination plus full vesting of equity awardsAny amounts due at time of termination
Dismissal Without Cause or Termination by Executive for Good Reason or upon a Change of Control (1)Two years of Base Salary, full vesting of equity awards, benefit continuation for eighteen months plus pro-rated bonus if, any, that would have been earned for the fiscal year in which the termination occursFifteen months of Base Salary plus one additional month for every additional four months of service, up to eighteen months’ maximum
Termination upon a Change of Control (2)Two years of Base Salary, full vesting of equity awards, benefit continuation for eighteen months plus pro-rated bonus if, any, that would have been earned for the fiscal year in which the termination occursEighteen months of Base Salary

(1) Good reason is generally (with certain exceptions) defined, in the case of Holman, as (i) a material diminution in their authority, duties or responsibilities, (y) the Company failing to maintain an office in the stated area or (ii) any other action or inaction that constitutes a material breach by the Company of the Employment Agreement. Mr.Messrs. Ollet and Santi’s employment agreement doesdo not include the concept of good reason.

(2) Change of Control is generally defined (i) in the case of Holman, as any Change of Control Event as defined in Treasury Regulation Section 1.409A-3(i)(5); and (ii) in the case of Santi, as (w) a sale of substantially all of the Company, (x) any “person” (as such term is defined under the Exchange Act) becomes the beneficial owners of over 50% of the Company’s voting power, (y) a change in the majority of the composition of the Board or (z) a transaction that results in over 50% of the Company’s voting power ceasing to hold a majority of the voting power post-transaction.

27

 

Risk Assessment Regarding Compensation Policies and Practices as they Relate to Risk Management

Our compensation program for employees does not create incentives for excessive risk taking by our employees or involve risks that are reasonably likely to have a material adverse effect on us. Our compensation has the following risk-limiting characteristics:

Our base pay programs consist of competitive salary rates that represent a reasonable portion of total compensation and provide a reliable level of income on a regular basis, which decreases incentive on the part of our executives to take unnecessary or imprudent risks; and

Cash bonus awards are not tied to formulas that could focus executives on specific short-term outcomes.

Outstanding Awards at Fiscal Year End

Listed below is information with respect to unexercised options that have not vested, and equity incentive plan awards for each named executive officer outstanding as of December 31, 2017:2023:

Outstanding Equity Awards at 20172023 Fiscal Year-End

Name 

Number of Shares Issued

Under Stock Options

 

Stock Options Exercise
Price ($) Per

Share of Stock

 

Stock Option

Expiration Date

 

Number of Shares

That

Have Not Vested (#)

 

Market Value of
Shares That Have

Not Vested ($)

 
 Number of Shares Issued Under Stock Options  Number of Shares Issued Under Restricted Stock  Stock Options and Restricted Stock Exercise Price ($) Per Share of Stock  Expiration Date Number of Shares That Have Not Vested (#)  Market Value of Shares That Name Have Not Vested ($) 
Jeffrey Holman  -   59,075,000,000   0.0001  8/13/2028  50,000,000,000   5,000,000 
Jeffrey Holman  50,000,000,000   0.0001   2/1/2027   -   -   39,000,000,000   -   0.0001  2/1/2027  -   - 
Christopher Santi  1   0.02   3/29/22   -   -   -   31,600,000,000   0.0001  8/13/2028  25,000,000,000   2,500,000 
Christopher Santi  25,000,000,000   0.0001   2/1/2027   -   -   17,000,000,000   -   0.0001  2/1/2027  -   - 
John Ollet  1,000,000,000   0.0001   12/9/2026   500,000,000   50,000   -   20,475,000,000   0.0001  8/13/2028  18,000,000,000   1,800,000 
John Ollet  4,000,000,000   0.0001   8/30/2027   1,000,0000,000   100,000   1,000,000,000   -   0.0001  12/9/2026  -   - 
John Ollet  4,000,000,000   -   0.0001  8/30/2027  -   - 

Director Compensation

Non-employee directors are paid an annual fee of $10,000 or $15,000, plus a monthly fee of $1,000 per month and $1,000$1,500 for each meeting attended. On December 14, 2022, the Company granted 2,000,000,000 shares of Restricted Stock (the “Award”) to each non-employee director. Commencing on the first anniversary of the date of Grant, the Award will vest in 12.5% increments on the last day of each quarter thereafter. Because we do not pay any compensation to employee directors, Mr. Holman is omitted from the following table. Non-employee members of our Board of Directors were compensated for as follows:

Fiscal 2023 Director Compensation

Name 

Fees Earned or

Paid in Cash ($)

 
    
Dr. Anthony Panariello $40,000 
Clifford J. Friedman $45,000 

2528

 

Fiscal 2017 Director Compensation

Name Fees
Earned or
Paid in Cash
($)
 
    
Dr. Anthony Panariello $36,000 
Clifford J. Friedman $37,000 

Equity Compensation Plan Information

The 2015 Equity Incentive Plan (the “Plan”) was approved by the Company’s stockholders at the June 26, 2015 stockholders meeting. On November 21, 2016, the Company’s Board of Directors increased the number of shares of common stock available for issuance pursuant to the Plan to 100,000,000,000. On April 23, 2023, the Board of Directors (the “Board”) of HCMC approved the Second Amendment to the 2015 Equity Incentive Plan (the “Amended Plan”). The Amended Plan increased the number of shares of HCMC common stock authorized for issuance under the Amended Plan to 225,000,000,000 shares. The Plan is a broad-based plan in which all employees, consultants, officers, and directors of the Company are eligible to participate. The purpose of the Plan is to further the growth and development of the Company by providing, through ownership of stock of the Company and other equity-based awards, an incentive to its officers and other key employees and consultants who are in a position to contribute materially to the prosperity of the Company, to increase such persons’ interests in the Company’s welfare, by encouraging them to continue their services to the Company, and by enabling the Company to attract individuals of outstanding ability to become employees, consultants, officers and directors of the Company.

The following chart reflects the number of awards granted under equity compensation plans approved and not approved by stockholders and the weighted average exercise price for such plans as of December 31, 2017.2023.

Name of Plan Number of
securities
to be issued
upon exercise of
outstanding
options,
warrants and
rights
(a)
  Weighted
average
exercise price
of outstanding
options,
warrants and
rights
(b)
  Number of
securities
remaining
available for
future issuance
under equity
compensation
plans
(excluding
securities
reflected in
column (a))
(c)
  Number of securities to be issued upon exercise of outstanding options, warrants and rights  Weighted average exercise price of outstanding options, warrants and rights  Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column 
Equity compensation plans approved by security holders              
2009 Equity Incentive Plan  0.011  $20,506,610   - 
2015 Equity Incentive Plan  87,894,750,004   0.0001   12,105,249,996   199,824,722,200   0.0001   25,175,277,800 
Total  87,894,750,004   -   12,105,249,996   199,824,722,200   -   25,175,277,800 

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholders Matters.

The following table sets forth the number of shares of our common stock beneficially owned as of March 13, 2018,27, 2024, by (i) those persons known by us to be owners of more than 5% of our common stock, (ii) each director, (iii) our Named Executive Officers and (iv) all of our executive officers and directors of as a group. Unless otherwise specified in the notes to this table, the address for each person is: c/o Healthier Choices Management Corp., 3800 North 28th Way, Hollywood, Florida 33020.

Title of Class Beneficial Owner Amount and
Nature of Beneficial
Owner(1)
  

Percent of
Class(1)

  Beneficial Owner Amount and Nature of Beneficial Owner (1)  Percent of Class (1) 
Directors and Executive Officers:          
Common Stock Jeffrey E. Holman (2)  4,711,732,180   19.99% Jeffrey E. Holman (2)  56,300,000,000   11.77%
Common Stock Christopher Santi (3)  4,711,732,180   19.99% Christopher Santi (3)  30,225,000,000   6.32%
Common Stock John Ollet (4)  4,500,000,000   15.33% John Ollet (4)  19,725,000,000   4.12%
Common Stock Dr. Anthony Panariello (5)  1,000,000,000   2.62% Dr. Anthony Panariello (5)  5,242,500,000   1.10%
Common Stock Clifford J. Friedman (6)  1,000,000,000   2.62% Clifford J. Friedman (6)  5,490,000,000   1.15%
 All directors and officers as a group (6 persons) (7)  15,233,464,360   55.13%
All directors and officers as a group (5 persons) (7)    116,982,500,000   24.46%
                
5% Stockholders:                
None  0   0%  -   0%
Total:  15,233,464,360   53.06%  116,982,500,000   24.46%

2629

 

(1) Beneficial Ownership. Applicable percentages are based on 29,348,867,108478,266,632,384 shares of common stock outstanding as of March 13, 2018.27, 2024. Beneficial ownership is determined under the rules of the SEC and generally includes voting or investment power with respect to securities. Shares of common stock subject to options, warrants, convertible notes and preferred stock currently exercisable or convertible or exercisable or convertible within 60 days are deemed outstanding for computing the percentage of the person holding such securities but are not deemed outstanding for computing the percentage of any other person. The table includes shares of common stock, options, warrants, and preferred stock exercisable or convertible into common stock and vested or vesting within 60 days. Unless otherwise indicated in the footnotes to this table, we believe that each of the stockholders named in the table has sole voting and investment power with respect to the shares of common stock indicated as beneficially owned by them. The table does not include: (i) restricted stock units that do not have the right to vote until they vest and the shares are delivered or (ii) unvested options that do not vest within 60 days of the date listed above in this footnote.

(2) Holman. Chairman and Chief Executive Officer. The option agreement includes a provision that prevents Mr. Holman from exercising the option into common stock to the extent (but only to the extent) that such conversion would result in the holder, or anyIncludes 39,000,000,000 vested options, 9,075,000,000 shares of its affiliates, beneficially owning (as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder) more than 19.9% of the Company’s outstandingvested restricted Common Stock (the “Exercise Blocker”). Without the Exercise Blocker, Mr. Holman would be deemed to beneficially ownand 50,000,000,000 shares of unvested restricted Common Stock pursuant to vested options.Stock.

(3) Santi. SantiPresident and Chief Operation Officer. The option agreement of Mr. Santi includes the Exercise Blocker. Without the Exercise Blocker, Mr. Santi would be deemed to beneficially own 25,000,000,000Includes 17,000,000,000 vested options, 6,600,000,000 shares of vested restricted Common Stock pursuant to vested options.and 25,000,000,000shares of unvested restricted Common Stock.

(4) Ollet. Chief Financial Officer. Includes 4,500,000,0005,000,000,000 vested options. He also holds 2,475,000,000 shares of vested restricted Common Stock and 18,000,000,000 shares of unvested restricted Common Stock.

(5) Panariello. A director. Includes 1,000,000,000 vested options. He also holds 662,500,000 shares of vested restricted Common Stock and 4,750,000,000 shares of unvested restricted Common Stock .

(6) Friedman. A director. Includes 1,000,000,000990,000,000 vested options.options, 750,000,000 shares of vested restricted Common Stock and 4,750,000,000 shares of unvested restricted Common Stock.

(7) Directors and Executive Officers. Includes executive officers who are not Named Executive Officers under the SEC’s rules and regulations.

Item 13. Certain Relationships and Related Transactions, and Director Independence.

During 2016,For the years ended December 31, 2023, the Company purchases, at rates comparable to market rates, e-liquids sold in its retail stores and wholesale operations, respectively from Liquid Science, Inc., a company in which Jeffrey Holman (the Company’s Chief Executive Officer), Gregory Brauser (the Company’s former President) and Michael Brauser each had a 15% beneficial ownership interest. During 2016, the Company made approximately 23% of its purchases of e-liquid from Liquid Science, which purchases equaled $356,000 in the aggregate. In 2016, the Company received approximately $94,000 in royalty income from Liquid Sciencedid not have any related to the use of the Company trademark. In April 2016, Mr. Holman sold all of his interest in Liquid Science.party transactions.

Policies and Procedures for Related Party Transactions

We have adopted a policy that our executive officers, directors, nominees for election as a director, beneficial owners of more than 5% of any class of our common stock and any members of the immediate family of any of the foregoing persons are not permitted to enter into a related person transaction with us without the prior consent of our audit committee. Our audit committee will review and oversee all transactions with an executive officer, director, nominee for election as a director, beneficial owner of more than 5% of any class of our common stock or any member of the immediate family of any of the foregoing persons and such person would have a direct or indirect interest. In approving or rejecting any such transactions, our audit committee is to consider the material facts of the transaction, including, but not limited to, whether the transaction is on terms no less favorable than terms generally available to an unaffiliated third party under the same or similar circumstances and the extent of the related person’s interest in the transaction.

30

Item 14. Principal Accounting Fees and Services.

Our Audit Committee pre-approves audit and permissible non-audit services performed by its independent registered public accounting firm, as well as the fees charged for such services. All of the services related to audit fees and audit-related fees charged were pre-approved by the Audit Committee. The following table shows the fees for the years ended December 31, 20172023 and 2016.2022.

  2017
($)
  2016
($)
 
Audit Fees (1) $140,000  $364,929 
Audit Related Fees  -   15,126 
All Other Fees  -   - 
Total $140,000  $380,055 
  2023  2022 
Audit (1) $1,122,000  $594,000 
Audit - Related  -   - 
Tax  -   - 
Other  -   - 
Total $1,122,000  $594,000 

(1)Audit fees — these fees relate to the audit of our annual financial statements and the review of our interim quarterly financial statements and our registration statements.

27

Audit-related fees - the aggregate fees billed for assurance and related services by the principal accountant that are related to the performance of the audit or review of the registrant’s financial statements and are not reported under paragraph (1) above.

Tax fees - the aggregate fees billed for professional services rendered by the principal accountant for tax compliance, tax advice, and tax planning.

Other fees - the aggregate fees billed other than the services reported in audit, audit-related and tax fees.

PART IV

Item 15. Exhibits, Financial Statement Schedules.

(a)Documents filed as part of the report.

(1)(1)Financial Statements. See Index to Consolidated Financial Statements, which appears on page F-1 hereof. The financial statements listed in the accompanying Index to Consolidated Financial Statements are filed herewith in response to this Item.

(2)(2)Financial Statements Schedules. All schedules are omitted because they are not applicable or because the required information is contained in the consolidated financial statements or notes included in this report.

(3)(3)Exhibits. The exhibits listed in the accompanying Exhibit Index are filed or incorporated by reference as part of this report.

2831

 

FINANCIAL STATEMENT INDEX

Report of Marcum LLP, Independent Registered Public Accounting Firm (PCAOB ID # 688)F-2
Consolidated Financial Statements
Report of Morrison, Brown, Argiz & Farra, LLCF-3
Financial Statements
Consolidated Balance Sheets as of December 31, 2017,2023 and 20162022F-4
Consolidated Statements of Operations for the Years Ended December 31, 20172023 and 20162022F-5
Consolidated Statements of Changes in Convertible Preferred Stock and Stockholders’ Equity for the Years Ended December 31, 20172023 and 20162022F-6
Consolidated Statements of Cash Flows for the Years Ended December 31, 20172023 and 20162022F-7

Notes to Consolidated Financial Statements

F-9F-8

F-1
 F-1

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Shareholders and Board of Directors of

Healthier Choices Management Corp.

Opinion on the Financial Statements

We have audited the accompanying consolidated balance sheetsheets of Healthier Choices Management Corp. (the “Company”) as of December 31, 2017,2023 and 2022, the related consolidated statements of operations, changes in convertible preferred stock and stockholders’ (deficit) equity and cash flows for each of the yeartwo years in the period ended December 31, 2017,2023, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2017,2023 and 2022, and the results of its operations and its cash flows for each of the yeartwo years in the period ended December 31, 2017,2023, in conformity with accounting principles generally accepted in the United States of America.

Explanatory Paragraph – Going Concern

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As more fully described in Note 2, the Company has a working capital deficiency, has incurred significant losses and needs to raise additional funds to meet its obligations to sustain its operations. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. Management’s plans regarding these matters are described in Note 2. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Basis for Opinion

These financial statements are the responsibility of the Company'sCompany’s management. Our responsibility is to express an opinion on the Company'sCompany’s financial statements based on our audit.audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB"(“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our auditaudits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the auditaudits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our auditaudits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company'sCompany’s internal control over financial reporting. Accordingly, we express no such opinion.

Our auditaudits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our auditaudits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our auditaudits provide a reasonable basis for our opinion.

Critical Audit Matter

The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing separate opinions on the critical audit matter or on the accounts or disclosures to which it relates.

F-2

Valuation of Intangible Assets for Business Combination

Description of the Matter

As disclosed in Note 8 to the financial statements, during the year ended December 31, 2023, the Company completed the acquisition of Ellwood Thompson’s Natural Market, L.C. for total consideration of approximately $1.5 million. The transaction was accounted for as a business combination in accordance with Accounting Standards ASC 805, Business Combinations. Accordingly, the purchase price was allocated to the assets acquired and liabilities assumed, based on their respective fair values identified, including intangible assets with an aggregate fair value (excluding goodwill) of approximately $0.3 million. The Company, with the assistance of a third-party valuation specialist, estimated the fair value of the identified intangible assets using valuation models which require significant assumptions. The significant assumptions used to estimate the fair value of the identified intangible assets included discount rates, royalty rates, economic lives, and financial projections.

Auditing management’s assessment of the acquisition date fair value of the identified intangible assets is highly subjective and judgmental. Based on the level of management judgment, we have determined the evaluation of the acquisition date fair value of the acquired intangible assets to be a critical audit matter.

How We Addressed the Matter in our Audit

Our audit procedures related to the accounting for valuation of intangible assets for business combinations to address this critical audit matter included the following:

We gained an understanding of the Company’s process with regards to the methodology used, and the factors considered around the inputs, sources of data used, assumptions and estimates used to determine the acquisition date fair value of the intangible assets acquired.
We tested the mathematical accuracy of the underlying schedules used in the valuation report. We tested the completeness, accuracy and relevance of source information underlying the data used in the models.
We evaluated the Company’s future revenue growth rates by comparing them to historical results and performed a sensitivity calculation to ensure the reasonableness of these forecasts.
We assessed the appropriateness of the overall approach and models used in determining the fair value of the intangible assets acquired.
We evaluated the reasonableness of the assumptions used by management.
We involved valuation professionals with specialized skills and knowledge in performing audit procedures to evaluate the reasonableness of the Company’s estimates and assumptions used by the specialist to determine the selection of revenue growth rates, discount rates, royalty rates and economic useful life.

/s/ Marcum LLP

/S/ Marcum LLP

We have served as the Company’s auditor since 2017.

New York, NYSaddle Brook, NJ

March 14, 2018 
27, 2024

F-3
 F-2

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Audit Committee of the
Board of Directors and Stockholders
of Healthier Choices Management Corp. (f/k/a Vapor Corp.)

We have audited the accompanying consolidated balance sheet of Healthier Choice Management Corp. (formerly known as Vapor Corp.) (the “Company”) as of December 31, 2016, and the related consolidated statements of operations, changes in stockholders’ (deficit) equity, and cash flows for the year then ended. These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these financial statements based on our audit.

We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audit provides a reasonable basis for our opinion.

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of Healthier Choice Management Corp. as of December 31, 2016, and the results of its operations and its cash flows for the year then ended in conformity with accounting principles generally accepted in the United States of America.

The Company has adjusted its 2015 consolidated financial statements to retrospectively apply the change in accounting related to the one-for-twenty thousand reverse split described in Note 11 and the presentation of discontinued operations as described in Note 3 to the consolidated financial statements. Other auditors reported on the consolidated financial statements before the retrospective adjustment. We also audited the adjustments to the 2015 consolidated financial statements to retrospectively apply the change in accounting as described in Notes 11 and 3. In our opinion, such adjustments are appropriate and have been properly applied. We were not engaged to audit, review, or apply any procedures to the Company's 2015 consolidated financial statements other than with respect to the adjustments and, accordingly, we do not express an opinion or any other form of assurance on the 2015 consolidated financial statements as a whole.

Morrison, Brown, Argiz & Farra, LLC
Miami, FL
March 23, 2017

F-3

 

HEALTHIER CHOICES MANAGEMENT CORP.

CONSOLIDATED BALANCE SHEETS

 December 31, 2017  December 31, 2016  

December 31,

2023

  

December 31,

2022

 
          
ASSETS                
CURRENT ASSETS                
Cash and cash equivalents $7,883,191  $13,366,272 
Due from merchant credit card processor  28,410   30,272 
Accounts receivable, net of allowance  75,568   25,798 
Cash $5,081,086  $22,911,892 
Accounts receivable  128,171   55,815 
Notes receivable  -   189,225 
Inventories  861,650   748,551   4,228,889   3,817,192 
Prepaid expenses and vendor deposits  63,808   93,229   1,668,324   322,182 
Other current assets  41,183   -   65,556   1,233,942 
Current assets from discontinued operations  -   52,903 
Restricted cash  553,232   1,778,232 
TOTAL CURRENT ASSETS  8,953,810   14,317,025   11,725,258   30,308,480 
                
Property and equipment, net of accumulated depreciation  589,506   638,926 
Property, plant, and equipment, net of accumulated depreciation  2,735,252   3,112,908 
Intangible assets, net of accumulated amortization  1,559,531   1,669,329   4,376,682   5,005,511 
Goodwill  481,314   481,314   -   5,747,000 
Right of use asset – operating lease, net  11,511,002   10,604,935 
Other assets  117,244   128,157   621,385   476,196 
        
TOTAL ASSETS $11,701,405  $17,234,751  $30,969,579  $55,255,030 
                
LIABILITIES AND STOCKHOLDERS’ EQUITY        
        
CURRENT LIABILITIES:        
Accounts payable $512,395  $520,586 
Accrued expenses  538,204   779,676 
Current portion of capital lease  -   53,054 
Current portion of loan payable  2,111   - 
Derivative liabilities - warrants  10,231,697   12,868,079 
Current liabilities from discontinued operations  -   555,810 
LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY        
CURRENT LIABILITIES        
Accounts payable and accrued expenses $8,024,664  $5,715,234 
Contingent consideration  -   774,900 
Contract liabilities  207,513   198,606 
Operating lease liability, current  2,842,829   2,228,852 
Line of credit  453,232   453,232 
Current portion of loan payment  702,701   536,542 
TOTAL CURRENT LIABILITIES  11,284,407   14,777,205   12,230,939   9,907,366 
                
Loan payable, net of current portion  10,459   -   2,403,807   2,378,061 
        
Operating lease liability, net of current  8,465,617   8,041,504 
TOTAL LIABILITIES  11,294,866   14,777,205   23,100,363   20,326,931 
                
COMMITMENTS AND CONTINGENCIES (SEE NOTE 9)        
COMMITMENTS AND CONTINGENCIES (SEE NOTE 13)  -   - 
        
CONVERTIBLE PREFERRED STOCK        
Series E convertible preferred stock, $1,000 par value per share, 14,722 shares authorized, 1,111 shares and 14,722 shares issued and outstanding as of December 31, 2023 and 2022; aggregate liquidation preference of $1.1 million and $14.7 million as of December 31, 2023 and 2022, respectively.  1,111,100   14,722,075 
                
STOCKHOLDERS’ EQUITY                
Common stock, $.0001 par value, 750,000,000,000 shares authorized, 29,348,867,108 issued and outstanding as of December 31, 2017 and 14,213,861,174 issued and outstanding as of December 31, 2016  2,934,887   1,421,386 
Series D convertible preferred stock, $1,000 par value per share, 5,000 shares authorized; 0 and 800 shares issued and outstanding as of December 31, 2023 and 2022, respectively.  -   800,000 
Common Stock, $0.0001 par value per share, 750,000,000,000 shares authorized; 478,266,632,384 and 339,741,632,384 shares issued and outstanding as of December 31, 2023 and 2022, respectively.  47,826,663   33,974,163 
Additional paid-in capital  10,080,238   3,782,818   21,028,274   29,045,802 
Accumulated deficit  (12,608,586)  (2,746,658)  (62,096,821)  (43,613,941)
TOTAL STOCKHOLDERS’ EQUITY  406,539   2,457,546   6,758,116   20,206,024 
        
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $11,701,405  $17,234,751 
TOTAL LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY $30,969,579  $55,255,030 

 

See notes to consolidated financial statementsstatements.

F-4
 F-4

HEALTHIER CHOICES MANAGEMENT CORP.

CONSOLIDATED STATEMENTS OF OPERATIONS

  For the Year Ended
December 31,
 
  2017  2016 
SALES:      
Vapor sales, net $5,867,202  $6,722,052 
Grocery sales, net  7,093,893   3,843,111 
Total Sales  12,961,095   10,565,163 
Cost of sales vapor  2,567,400   2,979,609 
Cost of sales grocery  4,114,914   2,352,201 
GROSS PROFIT  6,278,781   5,233,353 
         
EXPENSES:        
Advertising  110,694   92,124 
Selling, general and administrative  16,444,944   9,700,479 
Impairment of goodwill and intangible assets  -   3,955,362 
Retail store and kiosk closing costs  -   347,656 
Total operating expenses  16,555,638   14,095,621 
Operating loss  (10,276,857)  (8,862,268)
         
OTHER INCOME (EXPENSES):        
Amortization of debt discounts  -   21,599 
Gain (loss) on warrant repurchases  (94,955)  5,189,484 
Non-cash change in fair value of derivative liabilities  -   15,255,143 
Other income  200,129   640,000 
Interest income  33,774   45,723 
Other expense  (1,780)  - 
Interest expense  (3,722)  (15,386)
Total other income  133,446   21,136,563 
         
Net income (loss) from continuing operations  (10,143,411)  12,274,295 
Net income (loss) from discontinued operations  281,483   (1,589,803)
NET INCOME (LOSS) $(9,861,928) $10,684,492 
         
NET INCOME (LOSS) PER SHARE-BASIC AND DILUTED:        
Continuing operations  0.00   0.00 
Discontinued operations  0.00   0.00 
NET INCOME (LOSS) PER SHARE BASIC AND DILUTED $0.00  $0.00 
         
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING-        
BASIC  26,199,887,696   4,102,959,032 
DILUTED  26,199,887,696   640,656,219,521 
  2023  2022 
  For the Year Ended December 31, 
  2023  2022 
SALES:      
Vapor sales, net $617  $257,363 
Grocery sales, net  55,689,793   29,009,640 
TOTAL SALES, NET  55,690,410   29,267,003 
         
Cost of sales vapor  787   112,880 
Cost of sales grocery  35,341,569   18,929,905 
GROSS PROFIT  20,348,054   10,224,218 
         
OPERATING EXPENSES        
Selling, general and administrative  32,219,733   18,877,302 
Impairment of goodwill  6,104,000   - 
TOTAL OPERATING EXPENSES  38,323,733   18,877,302 
         
LOSS FROM OPERATIONS  (17,975,679)  (8,653,084)
         
OTHER INCOME (EXPENSE):        
Change in contingent consideration  774,900   333,100 
Other (expense) income, net  (1,485,612)  913,092 
Interest income (expense), net  211,996   202,653 
Loss on investment  (8,485)  (13,372)
Total other income (expense), net  (507,201)  1,435,473 
         
NET LOSS  (18,482,880)  (7,217,611)
         
Induced conversions of preferred stock  (152,500)  - 
         
Net loss attributable to common stockholders $(18,635,380) $(7,217,611)
         
NET LOSS PER SHARE BASIC AND DILUTED $0.00  $0.00 
         
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING        
BASIC AND DILUTED  429,919,440,601   339,741,632,384 

See notes to consolidated financial statementsstatements.

F-5
 F-5

HEALTHIER CHOICES MANAGEMENT CORP.

CONSOLIDATED STATEMENTS OF CHANGES IN CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY

FOR THE YEARS ENDED DECEMBER 31, 20162023 AND 20172022

  Shares  Amount  Shares  Amount  Shares  Amount  Capital  Deficit  Total 
  

Series E Redeemable Convertible

Preferred Stock

  

Series D Convertible

Preferred Stock

  Common Stock  

Additional

Paid-In

  Accumulated    
  Shares  Amount  Shares  Amount  Shares  Amount  Capital  Deficit  Total 
Balance – January 1, 2022  -  $-   800  $800,000   339,741,632,384  $33,974,163  $30,855,824  $(36,396,330) $29,233,657 
 Issuance of Series E Convertible Preferred stock in connection with the Securities Purchase Agreement, net of offering costs  14,722   14,722,075   -   -   -   -   (1,882,244)  -   (1,882,244)
Stock-based compensation expense  -   -   -   -           72,222   -   72,222 
Net loss  -   -   -   -   -   -   -   (7,217,611)  (7,217,611)
Balance – December 31, 2022  14,722  $14,722,075   800  $800,000   339,741,632,384  $33,974,163  $29,045,802  $(43,613,941) $20,206,024 
Balance  14,722  $14,722,075   800  $800,000   339,741,632,384  $33,974,163  $29,045,802  $(43,613,941) $20,206,024 
Series E convertible preferred stock redeemed  (12,026)  (12,025,975)  -   -   -   -   22,222   -   22,222 
Conversion of series E convertible preferred stock  (1,585)  (1,585,000)  -   -   15,850,000,000   1,585,000   -       1,585,000 
Series D Convertible Preferred Stock exercised  -   -   (800)  (800,000)  8,000,000,000   800,000   -   -   - 
Issuance of awarded stock  -   -       -   111,675,000,000   11,167,500   (11,167,500)  -   - 
Induced conversions of preferred stock  -   -       -   -   -   (152,500)  -   (152,500)
Stock-based compensation expense  -   -       -   -   -   3,430,250   -   3,430,250 
Issuance of common stock for legal service                  3,000,000,000   300,000   (150,000)      150,000 
Net loss  -   -   -   -   -   -   -   (18,482,880)  (18,482,880)
Balance – December 31, 2023  1,111  $1,111,100   -  $-   478,266,632,384  $47,826,663  $21,028,274  $(62,096,821) $6,758,116 
Balance  1,111  $1,111,100   -  $-   478,266,632,384  $47,826,663  $21,028,274  $(62,096,821) $6,758,116 

  Series A
Convertible
Preferred
Stock
  Treasury Stock   Common Stock    Additional
Paid-In
   Accumulated    
 SharesAmountSharesAmountSharesAmountCapitalDeficitTotal 
Balance – December 31, 2015        1  $       -   -  $  -   6  $  -  $846,943  $(13,431,150) $(12,584,207)
                                     
Issuance of common stock in connection with cashless exercise of Series A warrants  -   -   -   -   15,619,771,345   1,561,977   2,936,071   -   4,498,048 
Purchase of treasury stock made in conjunction with the sale of the wholesale business  -   -   (1,405,910,203)  (140,591)  -   -   (75,626)  -   (216,217)
Treasury stock cancellation  -   -   1,405,910,203   140,591   (1,405,910,203)  (140,591)  -   -   - 
Issuance of common stock in connection with conversion of Series A convertible preferred stock  (1)  -   -   -   26   -   -   -   - 
Stock-based compensation expense  -   -   -   -   -   -   75,430   -   75,430 
Net income  -   -   -   -   -   -   -   10,684,492   10,684,492 
Balance – December 31, 2016  -  $-   -  $-   14,213,861,174  $1,421,386  $3,782,818  $(2,746,658) $2,457,546 
                                     
Issuance of common stock in connection with cashless exercise of Series A warrants  -       -   -   15,125,005,934   1,512,501   (1,208,429)  -   304,072 
Issuance of stock options in connection with professional services  -       -   -   -   -   9,000   -   9,000 
Stock options exercised  -       -   -   10,000,000   1,000   -   -   1,000 
Stock-based compensation expense  -       -   -   -   -   7,496,849   -   7,496,849 
Net loss  -       -   -   -   -   -   (9,861,928)  (9,861,928)
Balance – December 31, 2017  -      $-  $-   29,348,867,108  $2,934,887  $10,080,238  $(12,608,586) $406,539 

See notes to consolidated financial statements.

F-6

HEALTHIER CHOICES MANAGEMENT CORP.

CONSOLIDATED STATEMENTS OF CASH FLOWS

  2023  2022 
  For the year ended December 31, 
  2023  2022 
OPERATING ACTIVITIES:        
         
Net loss $(18,482,880) $(7,217,611)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation and amortization  1,492,261   1,061,615 
Change in allowance for credit losses  15,425   - 
Loss on disposal of assets  2,073   - 
Loss on notes receivable settlement  10,931   - 
Loss on vendor settlement  91,291     
Issuance common stocks for services  150,000   - 
Amortization of right-of-use asset  2,590,325   1,164,027 
Loss on investment  8,485   13,372 
Write-down of obsolete and slow-moving inventory  2,471,653   1,507,213 
Stock-based compensation expense  3,430,250   72,222 
Change in contingent consideration  (774,900)  (333,100)
Non-cash interest expense  32,000   - 
Write off intangible assets  -   53,958 
Impairment of Goodwill  6,104,000   - 
Changes in operating assets and liabilities:        
Accounts receivable  (87,781)  (27,334)
Inventories  (2,032,838)  (1,357,169)
Prepaid expenses and vendor deposits  (177,374)  134,215 
Other current assets  1,068,610   (1,224,171)
Other assets  (145,189)  (390,759)
Accounts payable and accrued liabilities  1,974,429   4,072,386 
Contract liabilities  (21,604)  (317,921)
Lease liability  (2,458,303)  (1,077,025)
NET CASH USED IN OPERATING ACTIVITIES  (4,739,136)  (3,866,082)
         
INVESTING ACTIVITIES:        
Payment for acquisition  (750,000)  (10,291,674)
Collection of note receivable  178,294   58,690 
Purchases of patent  (12,500)  (12,500)
Purchases of property and equipment  (184,349)  (480,925)
NET CASH USED IN INVESTING ACTIVITIES  (768,555)  (10,726,409)
         
FINANCING ACTIVITIES:        
Proceeds from line of credit  -   35,196 
Payments for deferred offering costs  (833,767)  - 
Principal payments on loan payable  (558,095)  (88,816)
Proceeds from issuance of preferred stock  -   12,839,831 
Payment for series E preferred stock redemption  (12,003,753)  - 
Payment of induced conversions of preferred stock  (152,500)  - 
NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES  (13,548,115)  12,786,211 
         
NET DECREASE IN CASH AND RESTRICTED CASH  (19,055,806)  (1,806,280)
CASH AND RESTRICTED CASH — BEGINNING OF YEAR  24,690,124   26,496,404 
CASH AND RESTRICTED CASH — END OF YEAR $5,634,318  $24,690,124 
         
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:        
Cash paid for interest $205,449  $35,730 
Cash paid for income tax $-  $-
NON-CASH INVESTING AND FINANCING ACTIVITIES:        
Issuance of common stock in connection with series E preferred stock conversion $1,585,000  $- 
1% stated value reduction on preferred stock redemption  22,222   - 
Non-cash deferred offering cost  335,001   - 
Issuance of promissory note in connection with acquisition $718,000  $3,000,000 
Lease acquired $1,325,409  $8,225,033 
Contingent consideration relating to acquisition $-  $1,108,000 

See notes to consolidated financial statements

F-7
 F-6

HEALTHIER CHOICES MANAGEMENT CORP.

CONSOLIDATED STATEMENTS OF CASH FLOWS

  For the year ended
December 31,
 
  2017  2016 
OPERATING ACTIVITIES:        
         
Net income (loss) $(9,861,928) $10,684,492 
         
Adjustments to reconcile net income (loss) to net cash used in operating activities:        
(Income) loss from discontinued operations  (281,483)  1,589,803 
Change in allowances for bad debt  (14,372)  663,218 
Depreciation and amortization  350,647   374,388 
Loss on disposal of assets  1,456   103,312 
(Gain) loss on repurchase of Series A warrants  94,955   (5,189,484)
Accretion of discounts on note receivable from related party  -   (21,600)
Accrued interest on notes receivable from related party  -   (11,634)
Write-down of obsolete and slow-moving inventory  392,071   301,898 
Stock-based compensation expense  7,496,849   75,430 
Stock-based expense in connection with professional services  9,002   - 
Impairment of goodwill and intangible assets  -   3,955,362 
Non-cash change in fair value of derivative liabilities  -   (15,255,143)
Net cash used in discontinued operations  (221,424)  (3,739,171)
Changes in operating assets and liabilities:        
Due from merchant credit card processors  1,862   (20,797)
Accounts receivable  (35,398)  (197,908)
Inventories  (505,170)  (350,148)
Prepaid expenses and vendor deposits  29,421   121,421 
Other assets  (30,270)  37,040 
Accounts payable  (8,191)  332,012 
Accrued expenses  (241,472)  (786,328)
Customer deposits  -   17,850 
NET CASH USED IN OPERATING ACTIVITIES  (2,823,445)  (7,315,987)
         
INVESTING ACTIVITIES:        
Acquisition of grocery store business  -   (2,910,612)
Proceeds from sale of tradename  -   100,000 
Issuance of note receivable to related party in conjunction with sale of wholesale business  -   (500,000)
Collection of note receivable  -   173,395 
Purchases of tradename  -   (25,000)
Purchase of patent  (50,000)  - 
Purchases of property and equipment  (142,885)  (25,299)
NET CASH USED IN INVESTING ACTIVITIES:  (192,885)  (3,187,516)
         
FINANCING ACTIVITIES:        
         
Proceeds from loan payable  13,977   - 
Principal payments on loan payable  (1,407)  - 
Proceeds from exercise of stock options  1,000   - 
Payments for repurchase of Series A warrants  (2,427,267)  (3,278,827)
Principal payments of capital lease obligations  (53,054)  (66,389)
NET CASH USED IN FINANCING ACTIVITIES  (2,466,751)  (3,345,216)
         
DECREASE IN CASH  (5,483,081)  (13,848,719)
CASH AND CASH EQUIVALENTS — BEGINNING OF YEAR  13,366,272   27,214,991 
CASH AND CASH EQUIVALENTS — END OF YEAR $7,883,191  $13,366,272 
         
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:        
Cash paid for interest $4,000  $15,000 
NON-CASH INVESTING AND FINANCING ACTIVITIES:        
Issuance of common stock in connection with cashless exercise of Series A warrants $304,000  $4,498,000 

F-7

  FOR THE YEAR ENDED
DECEMBER 31,
2016
 
Purchase Price Allocation in connection with the grocery store acquisition:    
     
Amount allocated to goodwill $481,314 
Property and equipment  500,225 
Intangible assets – favorable lease  890,000 
Intangible assets – customer relations  60,000 
Intangible assets – tradenames and technology  824,500 
Inventory  253,524 
Accrued expenses  (98,951)
Cash used in the grocery store acquisition $2,910,612 
     
Sale of Vapor Wholesale Inventory and Business    
Consideration received:    
Note receivable from related party, net of discount $356,895 
Note receivable from related party, net of discount  470,485 
Treasury stock  140,591 
Total consideration  967,971 
Assets and liabilities transferred:    
Inventory  (258,743)
Accounts receivable, net  (244,735)
Vendor deposits  (40,949)
Accrued expenses  (35,273)
Customer deposits  17,850 
Loss on repurchase of treasury stock  61,850 
Cash used in the sale of wholesale business $500,000 

See notes to consolidated financial statements

F-8

HEALTHIER CHOICES MANAGEMENT CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Note 1. ORGANIZATION, GOING CONCERN, BASIS OF PRESENTATION, AND RECENT DEVELOPMENTS

Organization

Healthier Choices Management Corp. (the “Company”) is a holding company focused on providing consumers with healthier daily choices with respect to nutrition and other lifestyle alternatives. The

Through its wholly owned subsidiary HCMC Intellectual Property Holdings, LLC, the Company currently operates thirteen retail vape stores inmanages and intends to expand on its intellectual property portfolio. 

Through its wholly owned subsidiaries, the Southeast region of the United States, through which it offers e-liquids, vaporizers and related products. The Company also operates Ada’s Natural Market, a natural and organic grocery store, throughoperates:

Ada’s Natural Market, a natural and organic grocery store offering fresh produce, bulk foods, vitamins and supplements, packaged groceries, meat and seafood, deli, baked goods, dairy products, frozen foods, health & beauty products and natural household items.
Paradise Health & Nutrition’s three stores that likewise offer fresh produce, bulk foods, vitamins and supplements, packaged groceries, meat and seafood, deli, baked goods, dairy products, frozen foods, health & beauty products and natural household items.
Mother Earth’s Storehouse, a two-store organic and health food and vitamin chain in New York’s Hudson Valley, which has been in existence for over 40 years.
Greens Natural Foods’ eight stores in New York and New Jersey, offering a selection of 100% organic produce and all-natural, non-GMO groceries & bulk foods; a wide selection of local products; an organic juice and smoothie bar; a fresh foods department, which offers fresh and healthy “grab & go” foods; a full selection of vitamins & supplements; as well as health and beauty products
Ellwood Thompson’s, an organic and natural health food and vitamin store located in Richmond, Virginia. (www.ellwoodthompsons.com).

Through its wholly owned subsidiary, Healthy Choice Markets, Inc. Ada’s Natural Market offers fresh produce, bulk foods,Wellness, LLC, the Company operates a Healthy Choice Wellness Center in Kingston, NY and has a licensing agreement for a Healthy Choice Wellness Center located at the Casbah Spa and Salon in Fort Lauderdale, FL.

These centers offer multiple vitamin drip mixes and intramuscular shots for clients to choose from that are designed to help boost immunity, fight fatigue and stress, reduce inflammation, enhance weight loss, and efficiently deliver antioxidants and anti-aging mixes. Additionally, there are IV vitamin mixes and shots for health, beauty, and re-hydration.

Through its wholly owned subsidiary, Healthy Choice Wellness II, LLC, the Company entered into a joint venture with an established healthcare provider, and the joint venture is in the process of creating a structure whereby it will engage in telemedicine evaluations of patients for semaglutide therapy. The operation will encompass, generally: medical evaluations of patients; treatment of patients with semaglutide; coordination with providers and patients.

Through its wholly owned subsidiary, Healthy U Wholesale, the Company sells vitamins and supplements, packaged groceries, meatas well as health, beauty, and seafood, deli, baked goods, dairypersonal care products frozen foods, health & beauty productson its website www.TheVitaminStore.com.

Additionally, the Company markets its patented the Q-Cup™ technology under the vape segment; this patented technology is based on a small, quartz cup called the Q-Cup™, which a customer partially fills with either cannabis or CBD concentrate (approximately 50mg) purchased from a third party. The Q-Cup™ is then inserted into the Q-Cup™ Tank or Globe, that heats the cup from the outside without coming in direct contact with the solid concentrate. This Q-Cup™ technology provides significantly more efficiency and natural household items.an “on the go” solution for consumers who prefer to vape concentrates either medicinally or recreationally.

F-8

 

Going ConcernSourcing and LiquidityVendors

We source from multiple suppliers. These suppliers range from small independent businesses to multinational conglomerates. For the years ended December 31, 2023 and 2022, approximately 40% and 36% of our total purchases were from one vendor.

Spin-Off

The Company is planning to spin off its grocery segment and wellness business into a new publicly traded company (hereinafter referred to as “NewCo”). NewCo will continue the path of growth in the health verticals started by HCMC and explore other growth opportunities that comport with HCMC’s healthier lifestyle mission. HCMC will retain its entire patent suite, the Q-Cup® brand, and continue to develop its patent suite through R&D as well as continuing its path of enforcing its patent rights against infringers and attempting to monetize said patents through licensing deals.

At the time of the Spin-Off, HCMC will distribute all the outstanding shares of Common Stock held by it on a pro rata basis to holders of HCMC’s common stock. Each share of HCMC’s common stock outstanding as of the record date for the Spin-Off (the “Record Date”), will entitle the holder thereof to receive shares of Common Stock in NewCo. The distribution will be made in book-entry form by a distribution agent. Fractional shares of Common Stock will not be distributed in the Spin-Off and any fractional amounts will be rounded down. See more disclosure in Note 14 Stockholders’ Equity and Note 19 Subsequent Events.

Note 2. GOING CONCERN AND MANAGEMENT’S PLANS

The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”), which contemplate continuation of the Company as a going concern and realization of assets and satisfaction of liabilities in the normal course of business and do not include any adjustments that might result from the outcome of any uncertainties related to our going concern assessment. The carrying amounts of assets and liabilities presented in the financial statements do not necessarily purport to represent realizable or settlement values.

The Company incurred a loss from operations of approximately $10.3 million for the twelve months ended December 31, 2017. As of December 31, 2017,2023, the Company had cash of approximately $5.1 million and negative working capital of $0.5 million. Management has made plans to reduce certain costs and raise needed capital, however there can be no assurance the Company can successfully implement these plans. The Company anticipates its current cash and cash equivalents totaled approximately $7.9 million. While we anticipate that our current cash, cash equivalents, and cash to be generated from operations will not be sufficient to meet our projected operating plansexpenses for the foreseeable future through a year and a dayat least twelve months from the issuance of these auditedthe consolidated financial statements, should we require additional funds (either through equity or debt financings, collaborative agreements or from other sources) westatements.

The Company has incurred recurring net losses and operations have no commitmentsnot provided cash flows. In view of these matters, there is substantial doubt about our ability to obtain such additional financing, and we may not be ablecontinue as a going concern. In order to obtain any such additional financing on terms favorable to us, or at all. If adequate financing is not available,improve the Company will further delay, postpone or terminate product and service expansion and curtail certain selling,Company’s liquidity position, management’s plans include significantly reducing the use of outside consultants, which would result in a reduction of over $1,000,000 in general and administrative operations. The inability to raise additional financing may have a material adverse effectexpenses savings based on the future performance ofactual spend for the Company.

Sourcing and Vendors.

We source from multiple suppliers. These suppliers range from small independent businesses to multinational conglomerates. For the fiscal yearsyear ended December 31, 20172023. The Company contracted a third party consultant, whose expertise is streamlining operations, to identify areas of improvement and 2016, approximately 40%cost savings. The Company will enact the consultant’s recommendation in anticipation of our total purchases wererealizing savings and achieving profitability. The Company plans on continuing to expand via acquisition which will help achieve profitability. Also, the Company is formulating plans to raise capital from one vendor.outside investors, as it has done in the past, to fund operating losses and also provide capital for further business acquisitions. The result of the capital raise is to improve the Company’s operating and financial performance. The success of these plans is dependent upon various factors, foremost being the ability to reduce outside consulting expenses and the ability to secure additional capital from outside investors. There can be no assurance that such plans will be successful.

F-9

Note 3. BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation and Principles of Consolidation

The Company’s consolidated financial statements are prepared in accordance with GAAP.accounting principles generally accepted in the United States (“GAAP”). The consolidated financial statements include the accounts of all subsidiaries in which the Company holds a controlling financial interest as of the financial statement date.

The consolidated financial statements include the accounts of the Company Healthier Choices Management Corp., and its wholly-owned subsidiaries, Healthy Choice Markets, Inc., Healthy Choice Markets 2, LLC (“Paradise Health and Nutrition”), Healthy Choice Markets 3, LLC (“Mother Earth’s Storehouse”), Healthy Choices Markets 3 Real Estate LLC, Healthy Choice Markets IV, LLC (Green’s Natural Foods), Healthy Choice Markets V, LLC (Ellwood Thompson’s), HCMC Intellectual Property Holdings, LLC, Healthy Choice Wellness, LLC, Healthy Choice Wellness II, LLC, The Vitamin Store, LLC, Healthy U Wholesale, Inc., and The Vape Store, Inc. (“Vape Store”), Vaporin, Inc. (“Vaporin”), Smoke Anywhere U.S.A., Inc. (“Smoke”), Emagine the Vape Store, LLC (“Emagine”), IVGI Acquisition, Inc., Vapormax Franchising LLC, Vaporin LLC, and Vaporin Florida, Inc.. All intercompany accounts and transactions have been eliminated in consolidation.

F-9

Note 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Reclassifications

Certain prior period amounts in the consolidated financial statements related to stock splits and the sale of discontinued operations have been reclassified to conform to the current period’s presentation. No changes to the Company’s net loss were made as a result of such reclassifications.

Segment Reporting

Operating segments are identified as components of an enterprise about which separate discrete financial information is available for evaluation by the operating decision makers, or decision-making group, in making decisions on how to allocate resources and assess performance. The Company’s decision-making group are the senior executive management team. The Company and the decision-making group view the Company’s operations and manage its business as two operating segments. All long-lived assets of the Company reside in the U.S.

Use of Estimates in the Preparation of the Financial Statements

The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of net revenue and expenses during the reporting periods. Actual results could differ from those estimates. These estimates and assumptions include allowances, reservesinventory provisions, useful lives and write-downsimpairment of receivables and inventory, valuing equity securities and hybrid instruments, share-based payment arrangements,long-lived assets, goodwill, deferred taxes and related valuation allowances, and the valuation of the net assets and liabilities acquired in acquisitions.business combinations. Certain of ourmanagement’s estimates could be affected by external conditions, including those unique to our industry, and general economic conditions. It is possible that these external factors could have an effect on our estimates that could cause actual results to differ from our estimates. The Company re-evaluates all of its accounting estimates at least quarterly based on these conditions and records adjustments when necessary.

Revenue Recognition

The Company recognizes revenueRevenues from product sales orand services rendered, when the following four revenue recognition criteria are met: persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the selling price is fixed or determinable, and collectability is reasonably assured.

Product sales revenues, net of promotional discounts, manufacturer coupons and rebates, and return allowances, and sales and consumption taxes, are recorded when the products are shipped,delivered, title passes to customers and collection is reasonably assured. Retail sales revenues are recordedlikely to occur. Title passes to customers at the point of sale when both titlefor retail and riskupon delivery of loss is transferred to the customer.products for wholesale. Return allowances, which reduce product revenue, are estimated using historical experience. Revenue from product sales and services rendered is recorded net of sales and consumption taxes.

The Company recognizes revenue in accordance with the following five-step model:

identify arrangements with customers;
identify performance obligations;
determine transaction price;
allocate transaction price to the separate performance obligations in the arrangement, if more than one exists; and
recognize revenue as performance obligations are satisfied.

F-10

 

Shipping and Handling

Shipping charges billed to customers are included in net sales and the related shipping and handling costs are included in cost of sales. For the years ended December 31, 20172023 and 20162022, shipping and handling costs of approximately $100,000$117,000 and $105,000,$98,000, were included in cost of sales, respectively.

Cash and Cash Equivalents

The Company considers all highly liquid instruments with an original maturity of three months or less, when purchased, to be cash and cash equivalents. The majority of the Company’s cash and cash equivalents are concentrated in one large financial institution, which is in excess of Federal Deposit Insurance Corporation (FDIC) coverage. AtThe Company did not have any cash equivalents as of December 31, 20172023 and 2016,2022.

A summary of the financial institutions that had a cash in excess of FDIC limits of $250,000 per financial institution were approximately $7.1$250,000 as of December 31, 2023 and $12.9 million, respectively. 2022 is presented below:

SCHEDULE OF CASH AND CASH EQUIVALENTS IN EXCESS OF FDIC LIMIT

  

December 31,

2023

  

December 31,

2022

 
Total cash and restricted cash in excess of FDIC limits $3,814,426  $21,682,144 

The Company continually monitors its positions with, and the credit quality of, the financial institutions with which it invests, as deposits are held in excess of federally insured limits. The Company’s cash equivalent at December 31, 2017 and 2016 was a money market account. The Company has not experienced any losses in such accounts.

The following table provides a reconciliation of cash and restricted cash to amounts shown in consolidated statements of cash flow:

SCHEDULE OF CASH AND RESTRICTED CASH

  

December 31,

2023

  

December 31,

2022

 
Cash $5,081,086  $22,911,892 
Restricted cash  553,232   1,778,232 
Total cash and restricted cash $5,634,318  $24,690,124 

Restricted Cash

The Company’s restricted cash consisted of cash balances which were restricted as to withdrawal or usage under the August 18, 2022 security purchase agreement for the purpose of funding any amounts due under the Series E Certificate of Designation upon the redemption of the Series E Preferred Stocks. The balance also included cash held in the collateral account to cover the cash draw from the line of credit.

Accounts Receivable, Contract Assets and Contract Liabilities

 

Accounts receivables are claims to consideration which are unconditional; meaning no performance obligations remain for the Company and only the passage of time is necessary before collection. Contract assets are distinguished from accounts receivable as performance obligations remain before claims to consideration become unconditional. By nature of the Company’s operations, contract assets are typically not recognized. Contract liabilities are recorded when customers transfer consideration in advance of delivery of products or services, which the Company records for gift cards and loyalty reward programs. When one party to an arrangement performs before the other(s), the Company records an account receivable, contract asset or contract liability.

The majority of arrangements with customers contain one performance obligation: to provide a distinct set of products or services. Most performance obligations are satisfied simultaneously as the Company exchanges products or services for customer payment. Exceptions include gift cards and loyalty rewards, for which the Company has a performance obligation to deliver products or services at a future date. As gift cards are purchased and loyalty points earned, contract liabilities are recorded until the performance obligations are satisfied through delivery of products or services or breakage based on gift card and loyalty reward program term limits.

F-11
 F-10

The Company’s breakage policy is twenty-four months for gift cards, twelve months for Grocery loyalty rewards, and six months for Vapor loyalty rewards. Loyalty rewards are earned at five percent on qualifying purchases and the reward functions as an allocation of transaction price from the period earned by the customer to the period the performance obligation is satisfied by the Company. As such, all contract liabilities are expected to be recognized within a twenty-four month period.

Accounts Receivable and Concentration of Risk

Accounts receivable net is stated at the amount the Company expectsbalance represents credit sales, sales on account and billing to collect, or the net realizable value. The Company provides a provisionvendors for allowances that includes returns, allowances and doubtful accounts equal to the estimated uncollectible amounts. The Company estimates its provision for allowances based on historical collection experience and a review of the current status of trade accounts receivable. It is reasonably possible that the Company’s estimate of the provision for allowances will change.

advertising vendors’ products in our stores. Concentration of accounts receivable consist of the following:

SCHEDULE OF ACCOUNTS RECEIVABLE REPRESENTS CREDIT SALES

  

December 31,

2023

  

December 31,

2022

 
       
Customer A      2%       17%
Customer B  4%  -%
Customer C  -%  6%
Customer  -%  6%

Other Current Assets

  December 31, 2017  December 31, 2016 
Customers balances in excess of 10% of total accounts receivable        
Customer A  27%  - 
Customer B  21%  57%
Customer C  19%  11%
Customer D  -   15%

Other current assets are the non-trade related assets that the Company owns, benefits from, or uses to generate income that can be converted into cash within one business cycle. Included in “Other current assets” on our consolidated balance sheets are amounts primarily related to other receivables or non-trade receivable from government and other companies.

Due from Merchant Credit Card ProcessorInventories

Due from merchant credit card processor represents monies held by the Company’s credit card processors. The funds are being held by the merchant credit card processors pending satisfaction of their hold requirements and expiration of charge backs/refunds from customers.

Inventories

Inventories are statedmeasured at the lower of cost and net realizable value using the average cost.cost method. If the cost of the inventories exceeds their net realizable value, provisionsadjustments are recorded to write down excess inventory to itstheir net realizable value. The Company’s inventories consist primarily of merchandise available for resale. The Company’s inventory consists ofresale, such as vitamins, fresh produce, perishable grocery items and non-perishable consumable goods that are immediately available for sale.goods.

Property, Plant, and Equipment

Property, plant, and equipment isare stated at cost less accumulated depreciation. Depreciation is calculated using the straight-line method over the expected useful life of the respective asset, after the asset is placed in service. The Company generally usesRevenue earning property, plant, and equipment includes signage, furniture and fixtures, building, computer hardware, appliance, cooler, displays with useful lives range from two to ten years. Leasehold improvements are amortized over the following depreciable lives for its major classificationsshorter of property and equipment:the life of the asset or the term of the lease.

DescriptionUseful Lives
Warehouse fixtures2 years
Signage5 years
Furniture and fixtures5 years
Computer hardware3 years
Appliance3-5 years
Cooler5 years
Machinery5-7 years
Displays5-7 years
Leasehold improvementsLife of lease

Identifiable Intangible Assets and Goodwill

Identifiable intangible assets are recorded at cost, or when acquired as part of a business acquisition, at estimated fair value. Certain identifiable intangible assets are amortized over 3 and 15various periods of time, ranging from 4 years to 10 years. Similar to tangible personal property and equipment, the Company periodically evaluates identifiable intangible assets for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. Indefinite-lived intangible assets, such as goodwill are not amortized.

Impairment of Long-Lived Assets

The Company reviews all long-lived assets such as property, plant, and equipment and definite-lived intangible assets for impairment whenever events or changes in circumstances indicate that the carrying value of the asset may not be recoverable. In connection with this review, the Company also reevaluates the depreciable lives for these assets. The Company assesses recoverabilityRecoverability of assets to be held and used is measured by determining whether the net book valuea comparison of the relatedcarrying amount of an asset will be recovered throughto the projected undiscountedestimated future cash flows ofexpected to be generated by the asset. Ifasset or asset group. Impairment is measured by the Company determines thatamount by which the carrying value of the asset may not be recoverable, it measures anyasset(s) exceeds their fair value. The Company conducted the long-lived assets impairment test, and based on Step 1 qualitative assessment, the projected future discountedCompany concluded that the recurring losses coupled with the reduction in same store revenue and negative working capital were triggering events at December 31, 2023. The Company hired a third-party valuation firm to perform Step 2 quantitative assessment on long-lived assets. The Company used undiscounted cash flowsflow method at weighted average cost of capital of 16.5% as compareddiscount rate to calculate the asset’s carrying value.fair value of the total assets. Based on the Step 2 quantitative assessment, the Company’s long-lived assets were not impaired as of December 31, 2023.

F-12
 F-11

 

Goodwill

The Company assesses the carrying amounts of goodwill for recoverability on at least an annual basis or when events or changes in circumstances indicate evidence of potential impairment exists, using a fair value based test. Application of the goodwill impairment test requires significant judgments including estimation of future cash flows, which is dependent on internal forecasts, estimation of the long-term rate of growth for the businesses, and the useful life over which cash flows will occur. Changes in these estimates and assumptions could materially affect the determination of fair value and/or conclusions on goodwill impairment for the Company.

During the third quarter of 2017, we changed the date of our Our annual impairment test from December 31stis conducted on September 30 of each year or more often if deemed necessary.

The Company experienced recurring losses coupled with the reduction in same store revenue, a highly competitive industry and certain operational costs that have impacted our expectations such that future growth and profitability is lower than previous estimates. Furthermore, during the fourth quarter of 2023, the Company operated with negative working capital which, although not a determinant on its own, when combined with the other factors indicated that the Company’s goodwill of $6.1 million was determined to September 30th. We believebe impaired for the change in accounting principle related to changing our annual impairment testing date did not delay, accelerate, or avoid an impairment charge. We have determined that this change in accounting principle is preferable under the circumstances and does not result in adjustments to our financial statements when applied retrospectively. Our 2017 annual impairment test resulted in no impairment being recorded. Management also performed a qualitative analysis atyear ended December 31, 2017 to determine whether any triggering events have occurred since2023. See Note 10 - Goodwill and Intangibles. There was no impairment of goodwill during the annual test date of September 30, 2017 which would indicate an impairment. Management determined no triggering events had occurred throughyear ended December 31, 2017.2022.

Advertising

Advertising

The Company expenses advertising costs as incurred. For the years ended December 31, 2023 and 2022, the company incurred advertising expenses of $564,000 and $146,000, respectively.

Income Taxes

The Company uses the asset and liability method of accounting for income taxes in accordance with ASC 740, “Income Taxes” (“ASC 740”). Under this method, income tax expense is recognized as the amount of: (i) taxes payable or refundable for the current year and (ii) future tax consequences attributable to differences between financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the results of operations in the period that includes the enactment date. A valuation allowance is provided to reduce the deferred tax assets reported if based on the weight of available evidence it is more likely than not that some portion or all of the deferred tax assets will not be realized.

ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2023 or 2022. The Company had no uncertain tax positions as of December 31, 2023 and 2022.

Leases

 

Fair Value Measurements

Operating lease liabilities are recognized at the lease commencement date based on the present value of the fixed lease payments using the Company’s incremental borrowing rates. Related operating ROU assets are recognized based on the initial present value of the fixed lease payments, reduced by contributions from landlords, plus any prepaid rent and direct costs from executing the leases. Leases with an initial term of 12 months or less are not recorded on the balance sheet. The Company appliesrecognizes lease expense for these leases on a straight-line basis over the provisions of ASC 820, “Fair Value Measurements and Disclosures,” (“ASC 820”). The Company’s short term financial instruments include cash, due from merchant credit card processors, accounts receivable, accounts payable and accrued expenses, each of which approximate their fair values based upon their short-term nature. The Company’s other financial instruments include notes payable obligations and derivative liabilities. The carrying value of these instruments approximate fair value,lease term. Variable lease payments are recognized as lease expense as they bear termsare incurred.

The Company did not have finance leases in year 2023 and conditions comparable to market, for obligations with similar terms and maturities.

ASC 820 defines fair value as2022. If the exchange price that would be received for an asset or paid to transferCompany enters into a liability (an exit price)finance lease in the principal or most advantageous marketfuture, it will be accounted for the asset or liability in an orderly transaction between market participants on the measurement date.accordance with ASC 820 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes three levels of inputs that may be used to measure fair value:Topic 842.

F-13

Level 1 – quoted prices in active markets for identical assets or liabilities;

Level 2 – quoted prices for similar assets and liabilities in active market or inputs that are observable; and

Level 3 – inputs that are unobservable.

 

Stock-Based Compensation

The Company accounts for stock-based compensation for employees and directors under ASC Topic No. 718, “Compensation-Stock Compensation” (“ASC 718”). These standards define a fair value based method of accounting for stock-based compensation. In accordance with ASC 718, the cost of stock-based compensation is measured at the grant date based on the value of the award and is recognized over the vesting period. The value of the stock-based award is determined using an appropriate valuation model, whereby compensation cost is the fair value of the award as determined by the valuation model at the grant date. The resulting amount is charged to expense on the straight-line basis over the period in which the Company expects to receive the benefit, which is generally the vesting period. The Company considers many factors when estimating expectedrecognize forfeitures including typesas they are incur.

Fair Value Measurements

The fair value framework under FASB’s guidance requires the categorization of awards, employee class,assets and historical experience. Stock-based compensation for non-employees is measured atliabilities into three levels based upon the grant date, is re-measured at subsequent vesting dates and reporting dates, and is amortized overassumptions used to measure the service period.

F-12

Derivative Instruments

The Company accounts for free-standing derivative instruments and hybrid instruments that contain embedded derivative features in accordance with ASC Topic No. 815, “Derivative Instruments and Hedging Activities,” (“ASC 815”) as well as related interpretations of this topic. In accordance with this topic, derivative instruments and hybrid instruments are recognized as either assets or liabilities. Level 1 provides the most reliable measure of fair value, whereas Level 3, if applicable, would generally require significant management judgment. The three levels for categorizing assets and liabilities inunder the balance sheetfair value measurement requirements are as follows:

Level 1: Fair value measurement of the asset or liability using observable inputs such as quoted prices in active markets for identical assets or liabilities;
Level 2: Fair value measurement of the asset or liability using inputs other than quoted prices that are observable for the applicable asset or liability, either directly or indirectly, such as quoted prices for similar (as opposed to identical) assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active; and
Level 3: Fair value measurement of the asset or liability using unobservable inputs that reflect the Company’s own assumptions regarding the applicable asset or liability.

Nonfinancial assets such as goodwill, other intangible assets, and long-lived assets held and used are measured at fair values with gains or losses recognized in earnings. Embedded derivatives that are not clearlyvalue when there is an indicator of impairment and closely related to the host contract are bifurcated and are recognizedrecorded at fair value with changes in fair valuewhen impairment is recognized as eitheror for a gain or loss in earnings. business combination.

Business Combination

The Company determinesapplies the provisions of ASC Topic 805, Business Combinations (“ASC 805”) in the accounting for acquisitions of businesses. ASC 805 requires the Company to use the acquisition method of accounting by recognizing the identifiable tangible and intangible assets acquired and liabilities assumed, and measured at their acquisition date fair value of derivative instruments and hybrid instruments based on available market data using appropriate valuation models, giving consideration to allvalues. Goodwill as of the rights and obligationsacquisition date is measured as the excess of each instrument.

The Company estimates fair values of derivative instruments and hybrid instruments using various techniques (and combinations thereof) that are considered to be consistent with the objective of measuring fair values. In selecting the appropriate technique, the Company considers, among other factors, the nature of the instrument, the market risks that it embodies and the expected means of settlement. For complex instruments, the Company utilizes custom Monte Carlo simulation models. For less complex instruments, such as free-standing warrants, the Company generally uses the Binomial Lattice model, adjusted for the effect of dilution, because it embodies all of the requisite assumptions (including trading volatility, estimated terms, dilution and risk-free rates) necessary to fair value these instruments. Estimating fair values of derivative financial instruments requires the development of significant and subjective estimates that may, and are likely to, changeconsideration transferred over the duration of the instrument with related changesaforementioned amounts. Acquisition-related expenses were expensed as incurred and recorded in internalselling, general and external market factors. In addition, option-based techniques (such as the Binomial Lattice model or the Black-Scholes-Merton valuation model) are highly volatile and sensitive to changesadministrative expenses in the trading market priceconsolidated statements of the Company’s common stock. Since derivative financial instruments are initially and subsequently carried at fair values, the Company’s net income (loss) going forward will reflect the volatility in these estimates and assumption changes. Under ASC 815, increases in the trading price of the Company’s common stock and increases in fair value during a given financial period result in the application of non-cash derivative losses. Conversely, decreases in the trading price of the Company’s common stock and decreases in trading fair value during a given financial period result in the application of non-cash derivative gains.operations.

Recent Accounting Pronouncements

 

Sequencing Policy

Under ASC 815-40-35, the Company has adopted a sequencing policy, whereby,Public companies in the event that reclassification of contracts from equity to assets or liabilities is necessary pursuant to ASC 815 dueUnited States are subject to the Company's inability to demonstrate it has sufficient authorized shares, shares will be allocated on the basisaccounting and reporting requirements of the earliest issuance date of potentially dilutive instruments, with the earliest grants receiving the first allocation of shares.

Discontinued Operations

On July 31, 2016, the Company sold its wholesale inventory and related operations. The sale of the wholesale business qualifies as discontinued operations and accordingly the Company has excluded results for the wholesale business operations from the Company’s continuing operations in the consolidating Statements of Operations for all periods presented.

Adopted Accounting Pronouncements

In July 2015,various authorities, including the Financial Accounting Standards Board (FASB)(“FASB”) and the Securities and Exchange Commission (“SEC”). These authorities issue numerous pronouncements, most of which are not applicable to the Company’s current or reasonably foreseeable operating structure.

In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting StandardStandards Update (ASU)(“ASU”) No. 2015-11, “Simplifying2016-13, “Financial Instruments - Credit Losses (ASC 326)” This standard replaced the Measurement of Inventory”incurred loss methodology with an expected loss methodology that is referred to as the current expected credit loss (“ASU 2015-11”CECL”). ASU 2015-11 methodology. CECL requires an entityestimate of credit losses for the remaining estimated life of the financial asset using historical experience, current conditions, and reasonable and supportable forecasts and generally applies to measure inventory atcertain financial assets. The Company adopted ASC 326 on January 1, 2023, and estimated expected credit losses based on aging schedule, and provisioned approximately $15,000 credit loss for the loweryear ended December 31, 2023.

F-14

On November 27, 2023, FASB issued ASU 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures”, which requires public entities to consider relevant qualitative and quantitative factors when determining whether segment expense categories and amounts are significant, and identify segment expenses on the basis of costamounts that are regularly provided to the chief operating decision maker (CODM), and net realizable value. Net realizable value is the estimated selling pricesincluded in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. Subsequent measurement is unchanged for inventory measured using last-in, first-out (“LIFO”)reported segment profit or the retail inventory method. Itloss. The ASU is effective for annual reportingfiscal years beginning after Dec. 15, 2023, and interim periods within fiscal years beginning after Dec. 15, 2024. The Company does not believe this will have a material impact on the consolidated financial statements.

On December 14, 2023, the FASB issued ASU 2023-09 “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” related to improvements to income tax disclosures. The amendments in this update require enhanced jurisdictional and other disaggregated disclosures for the effective tax rate reconciliation and income taxes paid. The amendments in this update are effective for fiscal years beginning after December 15, 2016. The amendments should be applied prospectively with earlier application permitted as of the beginning of an interim or annual reporting period.2024. The adoption of ASU 2015-11 didthis pronouncement is not expected to have a significantmaterial impact on the Company’s consolidated financial statements.

In March 2016,

Reclassification

Certain amounts in the FASB issued ASU 2016-09, “Compensation – Stock Compensation (Topic 718)” (“ASU 2016-09”). ASU 2016-09 requires an entityconsolidated financial statements and related notes have been reclassified to simplify several aspects ofconform to the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. ASU 2016-09 is effective for fiscal years beginning after December 15, 2016, with early adoption permitted. The adoption of ASU 2016-09 didcurrent year presentation. Such reclassifications do not have a significant impact on the Company’s consolidatedpreviously reported financial statements.position or net loss. Below summarized reclassifications we made:

In January 2017, the FASB issued ASU 2017-01, “Business Combinations (Topic 805) Clarifying the Definition of a Business” (“ASU 2017-01”). The amendments in ASU 2017-01 are to clarify the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. The definition of a business affects many areas of accounting including acquisitions, disposals, goodwill, and consolidation. The guidance is effective for annual periods beginning after December 15, 2017, including interim periods within those periods, with early adoption permitted. The adoption of ASU 2017-01 did not have a significant impact on the Company’s consolidated financial statements.

F-13Change in contingent consideration of $333,100 was previously presented in the consolidated statement of operations in other (expense) income, net for the year ended December 31, 2022, and was reclassified out of other (expense) income, net, and presented under change in contingent consideration.
Investment for the amount of $9,771 was previously presented as Investment within total current assets in the December 31, 2022 consolidated balance sheet was reclassified to other current assets.

Note 4. DISAGGREGATION OF REVENUES

In January 2017,

The Company reports the FASB issued ASU 2017-04, “Intangibles - Goodwillfollowing segments in accordance with management guidance: Vapor and Other (Topic 350): SimplifyingGrocery. When the Test for Goodwill Impairment” (“ASU 2017-04”). ASU 2017-04 eliminates Step 2 along with amending other parts ofCompany prepares its internal management reporting to evaluate business performance, we disaggregate revenue into the goodwill impairment test. Under ASU 2017-04, an entity should perform its annual or interim goodwill impairment test by comparing the fair value of the reporting unit with its carrying amount, and should recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value with the loss not exceeding the total amount of goodwill allocated tofollowing categories that reporting unit. ASU 2017-04 is effective for annual periods beginning after December 15, 2019, and interim periods therein with early adoption permitted for interim or annual goodwill impairment tests performed after January 1, 2017. At adoption, this update will require a prospective approach. The adoption of ASU 2017-04 did not have a significant impact on the Company’s consolidated financial statements.

Recently Issued Accounting Pronouncements

In May 2014, the FASB issued ASU No. 2014-09, “Revenue from Contracts with Customers”, which was subsequently modified in August 2015 by ASU No. 2015-14, “Revenue from Contracts with Customers: Deferral of the Effective Date”. As a result, the ASU No. 2014-09 is effective retrospectively for fiscal years and interim periods within those years beginning after December 15, 2017. The core principle of ASU No. 2014-09 is that companies should recognize revenue when the transfer of promised goods or services to customers occurs in an amount that reflects what the company expects to receive. It requires additional disclosures to describedepict how the nature, amount, timing and uncertainty of revenue and cash flows from contracts with customers. are affected by economic factors.

SCHEDULE OF DISAGGREGATION OF REVENUES

  

December 31,

2023

  

December 31,

2022

 
       
Vapor sales, net $617  $257,363 
Grocery sales, net  55,689,793   29,009,640 
Total revenue $55,690,410  $29,267,003 
         
Retail Vapor $-  $257,363 
Retail Grocery  47,243,163   25,867,061 
Food service/restaurant  8,440,245   3,126,709 
Online/e-Commerce  6,385   15,870 
Wholesale Vapor  617   - 
Total revenue $55,690,410  $29,267,003 

Note 5. INVESTMENT

In 2016,2018, the FASB issued additional ASUs that clarify the implementation guidance on principal versus agent considerations (ASU 2016-08)Company invested $150,000 in 85,714 common stock shares at MJ Holdings, Inc. (“MJNE”), on identifying performance obligations and licensing (ASU 2016-10), and on narrow-scope improvements and practical expedients (ASU 2016-12) as well asa publicly traded company. The investment was made based on the revenue recognition criteria and other technical corrections (ASU 2016-20).assumption of an increase in MJNE stock due to the sales agreement with the Company. The Company will adoptrecorded the standardinvestment in MJNE at fair value with changes in the fair value reported through the income statement as the stock is traded on Januarythe OTC market. Investment is classed with Level 1 2018 using the retrospective transition method. The Company performed an evaluation of the impact of adoptingvaluation hierarchy. Fair value for the new standard and believes there will be no impact to the consolidated statements of operations and an immaterial impact to theinvestment is based on quoted prices in active markets. Investment is presented in other current assets in consolidated balance sheets for reclassifying contract liabilities from accrued expenses. Contract liabilities will consist of gift card and loyalty point program liabilities. See – Note 8 ACCRUED EXPENSES. The Company does not expect the adoption of the new standard will have a material impact on its consolidated financial statements.sheets.

In February 2016, the FASB issued ASU No. 2016-02, “Leases (Topic 842)” (“ASU 2016-02”). ASU 2016-02 establishes a right-of-use (“ROU”) model that requires a lessee to record a ROU asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement. ASU 2016-02 is effective for annual periods beginning after December 15, 2018, and annual and interim periods thereafter, with early adoption permitted. A modified retrospective transition approach is required for lessees for capital and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available. The Company is currently evaluating the impact that the adoption of this new standard will have on its consolidated financial statements.

In August 2016, the FASB issued ASU 2016-15 (Topic 230), “Statement of Cash Flows Classification of Certain Cash Receipts and Cash Payments”. The new standard will make eight targeted changes to how cash receipts and cash payments are presented and classified in the statement of cash flows. The new standard is effective for fiscal years beginning after December 15, 2017. The Company will require adoption on a retrospective basis unless it is impracticable to apply, in which case the Company would be required to apply the amendments prospectively as of the earliest date practicable. The Company does not expect that the adoption of this new standard will have a material impact on its consolidated financial statements.

In July 2017, the FASB issued a two-part ASU No. 2017-11, I “Accounting for Certain Financial Instruments with Down Round Features” and II “Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests With a Scope Exception”. The ASU is effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. Early adoption is permitted. The Company is currently evaluating the impact that the adoption of this new standard will have on its consolidated financial statements.

F-15
 F-14

Note 3. ACQUISITION AND DISPOSAL

Retail Stores and Kiosks

Retail Stores

During 2016, after evaluating retail store operations, management decided to close two of its Atlanta area vape retail stores on February 15, 2016, and September 30, 2016, respectively, and five of its Florida retail vapor stores were closed between May 31 and September 30, 2016. An additional Georgia retail location was closed duringThe following table summarizes the fourth quarter of 2016.

Retail Kiosks

The Company opened eight mall retail kiosks for its vaping products in October and November 2014. The Company’s management decided to close the kiosks after evaluating the short-term performance of the locations and to focus expansion efforts on retail stores. During 2015 the Company closed all of its mall kiosks. In connection with the kiosk closings, for the year ended December 31, 2016, the Company incurred $347,656 of loss on disposal.

ADA’S Whole Food Market

On June 1, 2016, the Company’s wholly owned subsidiary Healthy Choice Markets Inc., entered into a Business Sale Agreement with Ada’s Whole Food Market LLC (the “Seller”) to purchase the certain operating assets and assumed certain payables and a store lease obligation related to that constituted the business of Ada’s Natural Market grocery store (the “Grocery Acquisition”). The Company operates the grocery store under the same name, location, and management. The Company also entered into an employment agreement with the store manager.

The Grocery Acquisition was accounted for under the acquisition method of accounting. Accordingly, the acquired assets and assumed liabilities were recordedinvestment measured at their estimated fair values, and operating results for Ada’s Whole Food Market are included in the consolidated financial statements from the effective date of acquisition of June 1, 2016. The allocation of the purchase price is summarized as follows:

Purchase Consideration   
Cash paid: $2,910,612 
     
Identifiable assets acquired and liabilities assumed at fair value    
Property and equipment  500,225 
Intangible assets - favorable lease  890,000 
Intangible assets - tradenames and technology  820,000 
Intangible assets - customer relationships  60,000 
Intangible assets - website  4,500 
Inventory  253,524 
Accrued expenses  (98,951)
Net indentifiable assets acquired $2,429,298 
     
Total allocated to goodwill $481,314 

Goodwill arising from the transaction mainly consists of the expected operational synergies upon acquisition of the combined entity and intangibles not qualifying for separate recognition. Goodwill is not expected to be deductible for income tax purposes in the tax jurisdiction of the acquired business. The favorable lease will be amortizedvalue on a straight-linerecurring basis over its expected useful life of 15 years, which represents the remaining lease term. The tradename will be amortized on a straight-line basis over its expected useful life of ten years. Customer relationships will be amortized on a straight-line basis over their expected useful lives of five years. The website will be amortized on a straight-line basis over its expected useful life of three years.

The following presents the unaudited pro-forma combined results of operations of the Company with Ada’s Whole Food Market as if the acquisition occurred on January 1, 2016.

  2016 
    
Retail sales, net $6,722,052 
Grocery sales, net $7,149,223 
Net income (loss) from continuing operations $12,274,295 
Net income (loss) from discontinued operations $(1,589,803)
Net income (loss) allocable to common shareholders $10,684,492 
Net loss per share:    
Continuing operations $(0.01)
Discontinued operations $(0.00)
Net loss allocable to common shareholders $(0.01)
Weighted average number of shares outstanding  2,506,158,054 

F-15

The unaudited pro-forma results of operations are presented for information purposes only and are based on estimated financial operations. The unaudited pro-forma results of operations are not intended to present actual results that would have been attained had the acquisition been completed as of January 1, 2016 or to project potential operating results as of any future date or for any future periods.

Sale of Wholesale Business

On July 29, 2016, the Company entered into an Asset Purchase Agreement (the “Wholesale Business Purchase Agreement”) with VPR Brands, L.P. (the “Purchaser”) and the Purchaser’s Chief Executive Officer, Kevin Frija (the former Chief Executive Officer of the Company) pursuant to which the Company sold its wholesale inventory and the related business operations (collectively, “Wholesale Business Assets”), which previously operated at 3001 Griffin Road, Dania Beach, Florida 33312. The sale transaction was approved by the Company’s Board of Director’s on July 26, 2016 and completed on July 31, 2016. The consideration for the Wholesale Business Assets is (i) a secured, one-year promissory note in the principal amount of $370,000 (the “Acquisition Note”) bearing an interest rate of 4.5%, which payments thereunder are $10,000 monthly, with such payments commencing on October 28, 2016, with a balloon payment of the remainder of principal and interest on July 29, 2017; (ii) A secured, 36-month promissory note in the principal amount of $500,000 bearing an interest rate of prime plus 2%, resetting annually on July 29th,which payments thereunder are $14,000 per month, with such payments deferred and commencing on January 26, 2017, with subsequent installments payable on the same day of each month thereafter and in the 37th month, a balloon payment for all remaining accrued interest and principal; (iii) the assumption by the Purchaser of certain liabilities related to the Company’s wholesale operations, including but not limited to the month-to-month lease for the premises. Pursuant to the Wholesale Business Purchase Agreement, the Company shall continue to own its accounts receivable from its wholesale operations as of July 29, 2016. The Company agreed to use its commercially reasonable efforts, consistent with standard industry practice, to collect such accounts receivable, and any and all amounts so collected (i) up to $150,000 (net of any refunds) in the aggregate shall be credited against payment of the Acquisition Note; and (ii) in excess of $150,000 (up to $95,800) will be transferred to the Purchaser’s Chief Executive Officer as additional consideration for the transfer to the Company by Mr. Frija of 1,405,910,203 shares of the Company’s common stock (the “Retired Shares”) that he had acquired on the open market. As of December 31, 2017, the balloon payments had not been received. The Company collected $285,000 during 20172023 and $180,000 during 2016 on the notes. The 2016 collections include the $150,000 credit on collection of outstanding accounts receivable as of the date of sale of the wholesale business.2022:

SCHEDULE OF FAIR VALUE OF INVESTMENT

Description 

Fair Value

Measurements

Using Quoted Prices in

Active Market

(Level 1)

  

Mark to

Market

  

December 31,

2023

 
Investment $9,771  $(8,485) $1,286 

Description 

Fair Value

Measurements

Using Quoted Prices in

Active Market

(Level 1)

  

Mark to

Market

  

December 31,

2022

 
Investment $23,143  $(13,372) $9,771 

The sale of the wholesale business qualifies as discontinued operations and, accordingly, the Company has excluded results for the wholesale business operations from the Company’s continuing operations in the consolidated statements of operations for all periods presented. The following table shows the results of the Company’s wholesale operations included in the loss from discontinued operations.Note 6. INVENTORIES

  December 31, 2016 
    
Wholesale vapor sales, net $3,135,158 
     
Cost of sales – vapor wholesale  2,832,564 
Expenses – selling general and administrative  1,262,547 
Other Expense  629,850 
Total  4,724,961 
Loss from discontinued operations attributable to the wholesale business $(1,589,803)

The major classes of assets and liabilities of discontinued operations on the balance sheet are as follow:

  December 31, 2016 
Assets:    
Accounts receivable $39,493 
Due from merchant credit card processor, net  13,410 
Current assets of discontinued operations $52,903 
Liabilities:    
Accrued expenses $555,810 
Total current liabilities of discontinued operations $555,810 

F-16

Note 4. INVENTORIES

Inventories are statedmeasured at the lower of cost and net realizable value using the average cost.cost method. If the cost of the inventories exceeds their market value, provisionsadjustments are recorded to write down excess inventory to its net realizable value. The Company, as a result of its physical inventory observations recorded the write down of inventories amounting to approximately $2.5 million and $1.5 million in 2023 and 2022, respectively. The Company’s inventories consist primarily of merchandise available for resale.

SCHEDULE OF INVENTORIES

 December 31, 2017  December 31, 2016  

December 31,

2023

  

December 31,

2022

 
Inventories:        
     
Vapor Business $386,593  $399,702  $66,671  $66,828 
Grocery Business  475,057   348,849   4,162,218   3,750,364 
Total $861,650  $748,551  $4,228,889  $3,817,192 

Note 5.7. NOTES RECEIVABLE AND OTHER INCOME

OtherOn September 6, 2018, the Company entered into a secured, 36-month promissory note (the “Note”) with VPR Brands L.P. for $582,260. The Note bears an interest rate of 7%, which payments thereunder are $4,141 weekly. The Company records all proceeds related to the interest of the Note as interest income as proceeds are received.

On August 31, 2022, the Company amended and restated the Secured Promissory Note (the “Amended Note”) to extend the maturity date for one year. The outstanding balance for the twelve months endedamended note is $211,355. The Amended Note bears an interest rate of 7%, which payments thereunder are $1,500 weekly, with such payments commencing as of September 3, 2022. The Amended Note has a balloon payment of $145,931 for all remaining accrued interest and principal balance due in the final week of the 1-year extension of the Amended Note.

In August 2023, VPR Brands L.P. settled with the Company for the remaining notes receivable balance of $145,931 by making a balloon payment of $135,000 cash. The Company recognized a loss of $10,931 from this settlement which is included in other (expense) income net in the accompanying unaudited condensed consolidated statements of operations.

A summary of the Amended Note as of December 31, 2017 primarily consists of collection of notes receivable related to sale of the Wholesale business. See Note 3 – ACQUISITION AND DISPOSAL – “Sale of Wholesale Business”. Management determined notes receivable were uncollectable based on payment history2023 and recorded a valuation allowance to fully reserve notes receivable on December 31, 2016. As notes receivable were fully reserved for the twelve months ended December 31, 2017, collections of $285,000 were recorded to other income. Management believes the valuation allowance2022 is appropriate at December 31, 2017.presented below:

SUMMARY OF AMENDED NOTES

  December 31, 
Description 2023  2022 
Promissory Note $    -  $189,225 

 

Other income of $640,000 for the twelve months ended December 31, 2016 is a reversal of contingent earnings payable related to Vape Store acquisitions as earnings targets were not met.

Note 6. PROPERTY & EQUIPMENT and CAPITAL LEASE OBLIGATIONS

Property and equipment consists of the following:

  Year Ended
December 31,
 
  2017  2016 
       
Appliances $41,771  $41,771 
Computer hardware & equipment  114,930   160,184 
Furniture and fixtures  239,855   242,005 
Machinery  93,957   92,825 
Displays  297,900   302,700 
Vehicles  20,477   - 
Leasehold improvements  102,195   20,647 
Signage  72,192   72,192 
   983,277   932,324 
Less: accumulated depreciation and amortization  (393,771)  (293,398)
Total property and equipment $589,506  $638,926 

DuringFor the years ended December 31, 20172023 and 2016,2022, the Company had notes receivable collections of approximately $178,000 and $59,000, respectively.

F-16

Note 8. ACQUISITIONS

The purchase method of accounting in accordance with ASC 805, Business Combinations, was applied for the Mother Earth’s Storehouse, Green’s Natural Foods and Ellwood Thompson’s acquisitions. This requires the total cost of an acquisition to be allocated to the tangible and identifiable intangible assets acquired and liabilities assumed based on their respective fair values at the date of acquisition with the excess cost accounted for as goodwill. Goodwill arising from the acquisition is attributable to expected operational synergies from combining the operations of the acquired business with those of the Company. Acquisition costs are expensed as incurred and recorded in selling, general and administrative expenses in the consolidated statements of operations.

Mother Earth’s Storehouse

On February 9, 2022, the Company through its wholly owned subsidiary, Healthy Choice Markets 3, LLC (“HCM3”), entered into an Asset Purchase Agreement with Mother Earth’s Storehouse Inc. and its shareholders. Pursuant to the Purchase Agreement, HCM3 acquired certain assets and assumed certain liabilities related to Mother Earth’s grocery stores in Kingston and Saugerties, New York. The Company intends to continue to operate the grocery stores under their existing name. The cash purchase price under the Asset Purchase Agreement was $4,472,500, with an additional $677,500 paid for inventory at closing. In addition, the Company assumed a lease obligation for the Kingston, NY store and entered into an employment agreement with the store manager.

The following table summarizes the purchase price allocation based on fair values of the net assets acquired at the acquisition date:

SUMMARY OF PURCHASE PRICE ALLOCATION BASED ON FAIR VALUES OF THE NET ASSETS ACQUIRED

Purchase Consideration   
Cash consideration paid $5,150,000 
     
Purchase price allocation    
Inventory $805,000 
Property, plant, and equipment  1,278,000 
Intangible assets  1,609,000 
Right of use asset - operating lease  1,797,000 
Other liabilities  (283,000)
Operating lease liability  (1,797,000)
Goodwill  1,741,000 
Net assets acquired $5,150,000 
     
Finite-lived intangible assets    
Trade Names (8 years) $513,000 
Customer Relationships (6 years)  683,000 
Non-Compete Agreement (5 years)  413,000 
Total intangible assets $1,609,000 

The acquisition is structured as asset purchase in a business combination, and goodwill is tax-deductible, and amortizable over 15 years for tax purpose.

The results of operations of Mother’s Earth have been included in the consolidated statements of operations as of the effective date of operations.

F-17

Revenue and net income for year ended December 31, 2022 from date of acquisition were $11.9 million and $0.30 million, respectively. Acquisition-related expenses of $157,000 were expensed as incurred and recorded in selling, general and administrative expenses in the consolidated statements of operations for the year ended December 31, 2022. The expenses primarily related to legal and other professional fees.

Green’s Natural Foods

On October 14, 2022, the Company through its wholly owned subsidiary, Healthy Choice Markets IV, LLC, entered into an Asset Purchase Agreement (the “Purchase Agreement”) with Dean’s Natural Food Market of Shrewsbury, Inc., a New Jersey corporation, Green’s Natural Foods, Inc., a Delaware corporation, Dean’s Natural Food Market of Chester, LLC, a New Jersey limited liability company, Dean’s Natural Food Market of Basking Ridge, LLC, a New Jersey limited liability company, and Dean’s Natural Food Market, Inc., a New Jersey corporation (collectively, the “Sellers”), and shareholders of the Sellers. Pursuant to the Purchase Agreement, the Company acquired certain assets and assumed certain liabilities of an organic and natural health food and vitamin chain with eight store locations in New York and northern and central New Jersey (the “Stores”).

The cash purchase price under the Asset Purchase Agreement was $5,142,000, with an additional $3,000,000 provided by the seller financing in the form of a promissory note. In addition, the seller is entitled to a contingent earn-out based on a certain revenue threshold within the one-year period of the closing.

The Company recorded $1,108,000 of contingent consideration based on the estimated financial performance for the one year following closing. The contingent consideration was discounted at an interest rate of 3.8%, which represents the Company’s weighted average discount rate. Contingent consideration related to the acquisition is recorded at fair value (level 3) with changes in fair value recorded in other expense (income), net.

The following table summarizes the change in fair value of contingent consideration from acquisition date to December 31, 2023:

SCHEDULE OF CHANGE IN FAIR VALUE OF CONTINGENT CONSIDERATION

  

Fair Market

Value - Level 3

 
Balance as of October 14, 2022 $1,108,000 
Remeasurement  (333,100)
Balance as of December 31, 2022 $774,900 
Remeasurement  (774,900)
Balance as of December 31, 2023 $- 

The following table summarizes the purchase price allocation based on fair values of the net assets acquired at the acquisition date:

SUMMARY OF PURCHASE PRICE ALLOCATION BASED ON FAIR VALUES OF THE NET ASSETS ACQUIRED

  October 14, 2022 
Purchase Consideration    
Cash consideration paid $5,142,000 
Promissory note  3,000,000 
Contingent consideration issued to Green’s Natural seller  1,108,000 
Total Purchase Consideration $9,250,000 
     
Purchase price allocation    
Inventory $1,642,000 
Property and equipment  1,478,000 
Intangible assets  3,251,000 
Right of use asset - Operating lease  6,427,000 
Other liabilities  (211,000)
Operating lease liability  (6,427,000)
Goodwill  3,090,000 
Net assets acquired $9,250,000 
     
Finite-lived intangible assets    
Trade Names (8 years) $1,133,000 
Customer Relationships (6 years)  1,103,000 
Non-Compete Agreement (5 years)  1,015,000 
Total intangible assets $3,251,000 

F-18

The acquisition is structured as asset purchase in a business combination, and goodwill is tax-deductible, and amortizable over 15 years for tax purpose.

Revenue and net income for year ended December 31, 2022 were $6.3 million and $0.05 million, respectively, from the date of acquisition through December 31, 2022. Acquisition-related expenses of $906,000 were expensed as incurred and recorded in selling, general and administrative expenses in the consolidated statements of operations for the year ended December 31, 2022. The expenses primarily related to legal and other professional fees.

Ellwood Thompson’s

On October 1, 2023, the Company through its wholly owned subsidiary, Healthy Choice Markets V, LLC, entered into an Asset Purchase Agreement with (i) ET Holding, Inc., d/b/a Ellwood Thompson’s Local Market, a Virginia corporation, (ii) Ellwood Thompson’s Natural Market, L.C., a Virginia limited liability company, and (iii) Richard T. Hood, an individual resident of the Commonwealth of Virginia. Pursuant to the Purchase Agreement, the Company acquired certain assets and assumed certain liabilities related to Ellwood Thompson’s grocery stores in Richmond, Virginia. The Company intends to continue to operate the grocery stores under their existing name.

The cash purchase price under the Asset Purchase Agreement was $750,000, and a promissory note with a fair value of $718,000 provided by the seller. The principle amount of the promissory note was $750,000 with a fair value was $718,000, and the Company expensed the discount associated with the promissory note and recognized interest expense of approximately $32,000 for the year ended December 31, 2023. In addition, the Company entered into a new lease agreement with the landlord and entered into an employment agreement with the store manager.

The following table summarizes the purchase price allocation based on fair values of the net assets acquired at the acquisition date:

SUMMARY OF PURCHASE PRICE ALLOCATION BASED ON FAIR VALUES OF THE NET ASSETS ACQUIRED

  October 1, 2023 
Purchase Consideration    
Cash consideration paid $750,000 
Promissory note  718,000 
Total Purchase Consideration $1,468,000 
     
Purchase price allocation    
Inventory $851,000 
Intangible assets  291,000 
Right of use asset - Operating lease  1,325,000 
Other liabilities  (31,000)
Operating lease liability  (1,325,000)
Goodwill  357,000 
Net assets acquired $1,468,000 
     
Finite-lived intangible assets    
Trade Names (8 years) $291,000 
Total intangible assets $291,000 

F-19

The acquisition is structured as asset purchase in a business combination, and goodwill is tax-deductible, and amortizable over 15 years for tax purposes.

Revenue and net income were $3.1 million and $0.3 million, respectively, from the date of acquisition through December 31, 2023. Acquisition-related expenses of $131,000 were expensed as incurred and recorded in selling, general and administrative expenses in the consolidated statements of operations for the year ended December 31, 2023. The expenses primarily related to legal and other professional fees.

Revenue and Earnings

The following unaudited pro forma summary presents consolidated information of the Company, including Mother Earth’s Storehouse, Green’s Natural Foods and Ellwood Thompson’s, as if the business combinations had occurred on January 1, 2022, the earliest period presented herein:

SCHEDULE OF SUPPLEMENTAL PRO FORMA INFORMATION

  2023  2022 
  December 31, 
  2023  2022 
Sales $65,262,783  $68,786,398 
Net loss  (18,670,111)  (4,171,713)

The pro forma financial information includes adjustments that are directly attributable to the business combinations and are factually supportable. The pro forma adjustments include incremental amortization of intangible and remove non-recurring transaction costs directly associated with the acquisitions, such as legal and other professional service fees. The proforma data gives effects to actual operating results prior to the acquisition. These proforma amounts do not purport to be indicative of the results that would have actually been obtained if the acquisitions occurred as of the beginning of each period presented or that may be obtained in future periods. For the year ended December 31, 2022, the pro forma financial information excludes $1,063,000 of non-recurring acquisition-related expenses. For the year ended December 31, 2023, the pro forma financial information excludes $131,000 of non-recurring acquisition-related expenses.

Note 9. PROPERTY, PLANT, AND EQUIPMENT

Property, plant, and equipment consist of the following:

SCHEDULE OF PROPERTY PLANT AND EQUIPMENT

  2023  2022 
  Year Ended December 31, 
  2023  2022 
       
Displays $312,146  $312,146 
Building  575,000   575,000 
Furniture and fixtures  596,355   560,256 
Leasehold improvements  1,925,385   1,910,719 
Computer hardware & equipment  190,019   160,210 
Other  688,774   587,602 
Property and equipment, gross  4,287,679   4,105,933 
Less: accumulated depreciation and amortization  (1,552,427)  (993,025)
Total property, plant, and equipment $2,735,252  $3,112,908 

The Company incurred approximately $191,000$0.6 million and $194,000, respectively,$0.3 million of depreciation expense.expense for the years ended December 31, 2023 and 2022, respectively.

F-20

Note 7. 10. GOODWILL AND INTANGIBLE ASSETS

Goodwill representsThe Company tests goodwill for impairment annually on September 30 or more frequently if there are indicators that the premium paid overcarrying amount of the goodwill exceeds its estimated fair value.

The Company experienced recurring losses coupled with the reduction in same store revenue, a highly competitive industry and certain operational costs that have impacted our expectations such that future growth and profitability is lower than previous estimates. Furthermore, during the fourth quarter of 2023, the Company operated with negative working capital which, although not a determinant on its own, when combined with the other factors indicated that the Company’s goodwill may be impaired.

Because the qualitative test indicated that the Company’s goodwill was determined to be impaired, a second phase of the goodwill impairment test (“Step 2”) was performed. Under Step 2, the fair value of the intangible and net tangible assets acquired inCompany was estimated for the Merger and other retail business acquisitions.purpose of deriving an estimate of the implied fair value of goodwill. The implied fair value of the goodwill was then compared to the recorded goodwill to determine the amount of the impairment. The Company assessesevaluated the carryingfair value of its equity through the use of Guideline Public Company Method and Discounted Cash Flow Method. These two methods first calculated market value of invested capital, then the Company applied 50% of weighting to each method to derive the weight equity value. The Guideline Public Company Method calculated the Company’s equity using public markets’ relevant comparable set with market multiples that are applicable to the company. The Discounted Cash Flow Method discounted projected free cashflows of the Company at a computed weighted average cost of capital of 16.5% as the discount rate. The Discounted Cash Flow Method requires the use of significant estimates and assumptions to calculate projected future cash flow, weighted average cost of capital, and future economic and market conditions. The Company based the forecasts on its knowledge of the industry, recent performance and expected future performance, and other assumptions management believes to be reasonable but that are unpredictable and inherently uncertain. Actual future results may differ from those estimates.

As a result, the entire $6.1 million carrying amount of the Company’s goodwill on at least an annual basis.

Duringwas recognized as a non-cash impairment charge during the third quarter of 2017, we changed the date of our annual impairment test from December 31st to September 30th. We believe the change in accounting principle related to changing our annual impairment testing date did not delay, accelerate, or avoid an impairment charge. We have determined that this change in accounting principle is preferable under the circumstances and does not result in adjustments to our financial statements when applied retrospectively. Our 2017 annual impairment test resulted in no impairment being recorded for the nine monthsyear ended September 30, 2017. Management also performed a qualitative analysis at December 31, 2017 to determine whether any triggering events have occurred since2023. There was no impairment of goodwill during the annual test date of September 30, 2017 which would indicate an impairment. Management determined no triggering events had occurred throughyear ended December 31, 2017.2022.

F-17

The changes in the carrying amount of goodwill for the years ended December 31, 20172023 and 20162022 are as follows:

SCHEDULE OF CHANGES IN CARRYING AMOUNT OF GOODWILL

 December 31, 2023  

December 31,

2022

 
 December 31,
2017
  December 31,
2016
      
Beginning balance $481,314  $3,177,017  $5,747,000  $916,000 
Goodwill from acquired grocery business  -   481,314 
Impairment of goodwill-retail business  -   (3,177,017)
Acquisitions  357,000   4,831,000 
Impairment  (6,104,000)  - 
Ending balance $481,314  $481,314  $-  $5,747,000 

Intangible assets, consist of the following:net are as follows:

SCHEDULE OF INTANGIBLE ASSETS, NET

December 31, 2023 Useful Lives (Years) 

Gross Carrying

Amount

  Accumulated Amortization  

Net Carrying

Amount

 
Customer relationships 4-6 years $2,669,000  $(1,330,972) $1,338,028 
Trade names 8-10 years  2,860,000   (1,035,443)  1,824,557 
Patents 10 years  397,165   (199,001)  198,164 
Non-compete 4-5 years  1,602,000   (586,067)  1,015,933 
Intangible assets, net   $7,528,165  $(3,151,483) $4,376,682 

F-21
 Useful Lives
Favorable lease15
Trade names and technology10
Customer relationships5
Website3

December 31, 2022 Useful Lives (Years) 

Gross Carrying

Amount

  Accumulated Amortization  

Net Carrying

Amount

 
Customer relationships 4-6 years $2,669,000  $(1,033,306) $1,635,694 
Trade names 8-10 years  2,569,000   (725,723)  1,843,277 
Patents 10 years  384,665   (159,658)  225,007 
Non-compete 4-5 years  1,602,000   (300,467)  1,301,533 
Intangible assets, net   $7,224,665  $(2,219,154) $5,005,511 

Upon completion of the annual impairment analysis as of December 31, 2016, the Company determined that certain intangible assets were impaired. Accordingly, the Company recorded an impairment charge of $778,345 during the year ended December 31, 2016. The Company determined that thereAmortization expense was not an impairment to intangible assets during the year ended December 31, 2017,approximately $0.9 million and as such, no impairment charge has been recorded for the year ended December 31, 2017.

The changes in the carrying amount of intangible assets$0.8 million for the years ended December 31, 20172023 and 2016 are as follows:2022, respectively.

  

Favorable

Lease

 

Trade Names

and Technology

  Customer
Relationships
  Website  Total 
Beginning balance, January 1, 2016 $- $929,000  $-  $-  $929,000 
Additions from acquired grocery business  890,000  845,000   60,000   4,500   1,799,500 
Sale of tradename  -  (100,000)  -   -   (100,000)
Impairment  -  (778,345)  -   -   (778,345)
Amortization expense  (33,859)(139,092)  (7,000)  (875)  (180,826)
Ending balance, December 31, 2016 $856,141 $756,563  $53,000  $3,625  $1,669,329 
                    
Purchase of patents  -  50,000   -   -   50,000 
Amortization expense  (58,361) (87,937)  (12,000)  (1,500)  (159,798)
Ending balance, December 31, 2017 $797,780 $718,626  $41,000  $2,125  $1,559,531 

The weighted-average remaining amortization period of the Company’s amortizable intangible assets is approximately 305 years as of December 31, 2017.2023. The estimated future amortization of the intangible assets is as follows:

SCHEDULE OF FUTURE ANNUAL ESTIMATED AMORTIZATION EXPENSE

For the years ending December 31,   
2018 $161,361 
2019  160,486 
2020  159,861 
2021  152,861 
2022  147,861 
Thereafter  777,101 
Total $1,559,531 
  - 
For the years ending December 31,   
2024 $959,391 
2025  953,891 
2026  875,910 
2027  731,489 
2028  412,819 
Thereafter  443,182 
Total $4,376,682 

Note 11. CONTRACT LIABILITIES

The Company’s contract liabilities consist of customer deposits, gift cards and loyalty rewards, for which the Company has a performance obligation to deliver products when customers redeem balances or terms expire through breakage.

A summary of the contract liabilities activity for the years ended December 31, 2023 and 2022 is presented below:

SUMMARY OF CONTRACT LIABILITIES ACTIVITY

  2023  2022 
  Year ended December 31, 
  2023  2022 
Beginning balance as of January1, $198,606  $23,178 
Issued  891,060   859,383 
Redeemed  (812,694)  (628,012)
Breakage recognized  (69,459)  (55,943)
Ending balance as of December 31, $207,513  $198,606 

Note 12. DEBT

The following table provides a breakdown of the Company’s debt as of December 31, 2023 and 2022 is presented below:

SCHEDULE OF BREAKDOWN OF DEBT

  2023  2022 
  December 31, 
  2023  2022 
Promissory note $3,106,508  $2,460,556 
Line of credit  453,232   453,232 
Other debt  -   815 
Total debt  3,559,740   2,914,603 
Current portion of long-term debt  (1,155,933)  (536,542)
Long-term debt $2,403,807  $2,378,061 

F-22
 F-18

Revolving Line of Credit

Note 8. ACCRUED EXPENSES

On November 3, 2021, the Company entered into an agreement for a new revolving line of credit of $2.0 million and a blocked/restricted deposit account (“blocked account”) with Professional Bank in Coral Gables, Florida. The agreement included a variable interest rate that it is based on a rate of 1.0% over what is earned on the collateral account. Based on the agreement with the bank, each draw request from the credit line will be 100% cash secured with moneys held from the blocked account. The outstanding balance was $453,232 as of December 31, 2023 and 2022, respectively. The line of credit will expire in November 2024.

Accrued expenses are comprised

Promissory Note

In connection with the Green’s Natural Foods acquisition, on October 14, 2022, the Company issued a secured promissory note (the “Greens Note”) in the principal amount of $3,000,000 as a portion of the following:purchase price. The Greens Note has a five-year term, an interest rate of 6.0% per annum and is secured by the assets of the Green’s Natural Foods. The outstanding balance was approximately $2,378,000 and $2,914,000 as of December 31, 2023 and 2022, respectively. The Company incurred approximately $160,000 and $30,000 interest expense for the years ended December 31, 2023 and 2022, respectively.

  For the Year Ended
December 31,
 
  2017  2016 
Accrued Board of Directors $14,000  $29,000 
Accrued Loyalty and Gift Cards  99,070   85,274 
Accrued severance  -   37,440 
Accrued payroll and related employee expenses  72,522   229,768 
Accrued Delaware Franchise Tax  36,000   121,617 
Accrued Litigation and Settlements  18,150   70,872 
Accrued legal and professional fees  111,783   131,833 
Accrued sales returns for wholesale activities  168,693   - 
Other accrued liabilities  17,986   73,872 
Total $538,204  $779,676 

In connection with the Ellwood Thompson’s acquisition, on October 1, 2023, the Company issued a secured promissory note (the “Ellwood Note”) in the principal amount of $750,000, and discounted present value of $718,000 as a portion of the purchase price. The Ellwood Note has a five-year term, an interest rate of 6.0% per annum. The outstanding balance of the Ellwood Note was approximately $728,000 in principle amount as of December 31, 2023. The Company expensed the discount on promissory note and recognized interest expense of approximately $39,000 for the year ended December 31, 2023.

The Company may, at its option, at any time or from time to time prepay the outstanding principal amount or any accrued but unpaid interest, in each case in whole or in part, without penalty or premium, provided that any such prepayment of any outstanding amount of principal shall be accompanied by the payment of all accrued but unpaid interest on the amount of principal being prepaid, plus any costs and fees incurred.

The following table summarizes the 5-year repayment schedule:

SCHEDULE OF MATURITIES OF LONG TERM DEBT

  - 
For the years ending December 31,   
2024 $702,701 
2025  746,042 
2026  792,056 
2027  724,333 
2028  141,376 
Total $3,106,508 

Note 9. 13. COMMITMENTS AND CONTINGENCIES

 

Lease Commitments

The Company leases its Florida office and warehouse facilities under a three-year lease. The lease provides for annual rental payments, including taxes, of approximately $100,000 per year. The Company also leases its Vape and Grocery stores.

Future minimum lease payments under non-cancelable operating leases that have initial or remaining terms in excess of one year at December 31, 2017 are due as follows:

2018 $595,000 
2019  428,000 
2020  325,000 
2021  131,000 
Total $1,479,000 

Rent expense for the year ended December 31, 2017 and 2016 was approximately $741,000 and $777,000, respectively, is included in selling, general and administrative expenses in the accompanying consolidated statement of operations. 

During the year ending 2016, the Company closed seven of its retail Vape Stores. The majority of the Vape stores closed were in the Orlando, Florida area and the others were in Georgia. The cost incurred with the closing of these stores amounted to $308,965.

Employment Agreements 

On December 12, 2016,August 13, 2018, the Company entered into a three-yearamended and restated its existing employment agreement with John Ollet. Mr. Ollet’s initial base salary shall be $180,000, $190,000 and $200,000 in years one, two and three, respectively. Mr. Ollet shall be eligible to receive a one-time sign-on bonus of $5,500. Mr. Ollet shall also be entitled to bonuses and other incentives at the discretion of the Company, based in part on Mr. Ollet’s performance.

On August 10, 2015, the Company entered into three-year Employment Agreements with Jeffrey Holman, the Company’s Chief Executive Officer (the “Holman Employment Agreement”). The Holman Employment Agreement is for an additional three year term and Gregory Brauser, the Company’s President. Each of the Employment Agreements provideprovides for an annual base salary of $300,000$450,000 and a target bonus for 2020 only in an amount ranging from 20%20% to 200%200% of theirhis base salaries subject to the Company meeting certain adjusted earnings before interest, taxes depreciation and amortization (“Adjusted EBITDA”) performance milestones. Adjusted EBITDAMr. Holman is defined in the Employment Agreements as earnings (loss) from continuing operations before interest expense, income taxes, collateral valuation adjustment, bad debt expense, one-time expenses, depreciation and amortization and amortization of stock compensation or Adjusted EBITDA defined in any filing of the Company with the SEC subsequent to the date of the Employment Agreements. Holman and Brauser are also entitled to receive severance payments, including 2two years of theirhis then base salary and other benefits in the event of a change of control, termination by the Company without cause, termination for good reason by the executive or non-renewal by the Company. Mr. Holman was also granted 11 billion shares of restricted common stock pursuant to the Holman Employment Agreement Amendment on the condition that 11 billion of his options to purchase Company common stock are forfeited. This restricted stock will vest one year following the date of issuance provided that the grantee remains an employee of the Company through each applicable vesting date. On August 12, 2019, the Company agreed to extend the expiration date of the vesting period for the restricted stock by six months to February 13, 2020. On August 12, 2020, the Company agreed to extend for a second time the expiration date of the vesting period for the restricted stock by six months to February 13, 2021.The term of the employment agreement shall be automatically renewed for successive one-year terms unless notice of non-renewal is given by either party at least 30 days before the end of the Term.

F-23

Effective December 12, 2012,On February 26, 2021, the Company entered into a three-yearan amended and restated employment agreement (the “Employment Agreement Amendment”) with Christopher Santi, the Company’s President and Chief Operating Officer. The employment agreement paid a beginning base salary of $156,000 which increased to $170,000 beginning in December 2016. In accordance with this employment agreement, Mr. Santi received a 10-year option to purchase up to 57 shares of the Company’s common stock at an exercise price of $437.50, vesting monthly at the rate of approximately 2 shares per month. As of the date of this report, the options are fully vested. On January 30, 2017, the Company entered into a new employment agreement with Mr. Santi for a three-year term beginning January 30, 2017.Officer, Christopher Santi. Pursuant to the new employment agreement,Employment Agreement Amendment, Mr. Santi will continue to be employed as the Company’s President and Chief Operating Officer through January 30, 2024. Mr. Santi will receive a base salary of $225,000, increasing$0.4 million for 2021 and his salary will increase 10% in each subsequent year. The term of the amended employment agreement shall be automatically renewed for successive one-year terms unless notice of non-renewal is given by either party at least 30 days before the end of the Term.

On February 02, 2022, the Company entered into a second amended and restated employment agreement (the “Employment Agreement Amendment”) with the Company’s Chief Financial Officer, John Ollet. Pursuant to $250,000the Employment Agreement Amendment, Mr. Ollet will continue to be employed as the Company’s Chief Financial Officer through February 14, 2025. Mr. Ollet will receive a base salary of $0.3 million for 2022 and $275,000, respectively,his salary will increase 10% in each subsequent calendar year. The term of the amended and restated employment agreement shall be automatically renewed for successive one-year terms unless notice of non-renewal is given by either party at least 30 days before the end of the Term.

Legal Proceedings

On November 30, 2020, the Company filed a patent infringement lawsuit against Philip Morris USA, Inc., and Philip Morris Products S.A. in the U.S. District Court for the secondNorthern District of Georgia. The lawsuit alleges infringement on HCMC-owned patent(s) by the Philip Morris product known and third yearsmarketed as “IQOS®”. Philip Morris claims that it is currently approaching 14 million users of its IQOS® product and has reportedly invested over $3 billion in their smokeless tobacco products. On December 3, 2021, the District Court for the Northern District of Georgia effectively dismissed HCMC’s patent infringement action against Philip Morris USA, Inc., and Philip Morris Products S.A. On December 14, 2021, the Company filed an appeal of the employment agreement. Mr. Santi is also eligible to earn an annual bonus atDistrict Court for the discretionNorthern District of Georgia’s dismissal of the Company’s Boardpatent infringement action against Philip Morris USA, Inc., and Philip Morris Products S.A.

On December 31, 2021, the District Court for the Northern District of Directors.Georgia effectively dismissed HCMC’s patent infringement action against Philip Morris USA, Inc. and Philip Morris Products S.A. In connection with such dismissal, the defendants sought to recover attorney’s fees from the Plaintiff. On February 22, 2022, the District Court for the Northern District of Georgia granted the defendant’s an award of approximately $575,000 in attorneys’ fees to be paid by the Company. The Company fully provisioned this amount as of December 31, 2021. HCMC appealed this ruling on June 22, 2022.

Legal Proceedings On April 12, 2023, the U.S. Court of Appeals for the Federal Circuit ruled in favor of HCMC on two separate appeals it had filed in its patent infringement action against Philip Morris USA, Inc. and Philip Morris Products S.A. pending in the district court for the Northern District of Georgia.

In the first appeal, HCMC appealed the ruling of the District Court dismissing HCMC’s patent infringement action and denying HCMC’s motion to amend its pleading. In the second appeal, HCMC appealed the District Court’s award of attorneys’ fees to Philip Morris. In its decisions, the Federal Circuit ruled for HCMC by reversing both of those decisions and remanded the case back to the District Court for further proceedings. As a result of the ruling, the Company reversed the $575,000, which was previously fully provisioned, during the three months ended March 31, 2023.

F-24

There were two lawsuits in connection with alleged claimed battery defects for an electronic cigarette device. One has been dismissed by the court wherein the plaintiff settled with the Company’s insurance carrier with no economic impact to the Company. In the second lawsuit, as of December 31, 2023, the Company has reached an arrangement with the plaintiff to resolve the matter, limiting potential exposure to $1.5 million.  While this arrangement is presently not formalized by a signed agreement, the Company has accrued a liability of $1.5 million, reflected in accounts payable and accrued expenses, to represent management’s estimate of the probable settlement amount based on the current status of discussions.  The settlement remains subject to finalization, and until a definitive agreement is executed, no assurance can be given that the outcome will differ from this accrual. The case has been removed from the courts trial calendar.

On September 26, 2023, HCMC filed a patent infringement lawsuit against R.J. Reynolds Vapor Company (“RJR”) in the U.S. District Court for the Middle District of North Carolina in connection with HCMC’s assertions that RJR’s Vuse electronic cigarette infringes one of HCMC’s patents.

From time to time the Company may beis involved in various claims and legal actionsproceedings arising in the ordinary course of our business. WithWe believe that there is no other litigation pending that is likely to have, individually or in the aggregate, a material adverse effect on our financial condition or results of operations. As of December 31, 2023, with respect to legal costs, we record such costs as incurred.

F-19

Fontem License Agreement

Effective December 16, 2015,On July 7, 2023, the Company entered into a confidential Settlement Agreement andpatent licensing agreement for one of its patents in the vape segment. The Company as the licensor, grants to licensee during the term a non-exclusive royalty-bearing confidential Global License Agreement (“License Agreement”) with Fontem Ventures B.V. (“Fontem”) resultingright and license under the Licensed Patents to make, use, offer to sell, sell, and import licensed products in the dismissalterritory of the United States of America. The licensee will pay to the licensor a royalty based on net sales of all of the aforementioned patent infringement cases by Fontem against the Company. The estimated settlement fee of approximately $1.7 million was included in selling, general and administrative expenses and in accrued expense at December 31, 2015. On January 15, 2016, the Company made a payment of $1.7 million under the terms of the Settlement and License Agreements. In connection with the License Agreement, Fontem granted the Company a non-exclusive license to certain of its products. As consideration, the Company will make quarterly license and royalty payments to Fontem based on the sale of qualifyinglicensed products as defined in the License Agreement. Theterritory during the term of the License Agreement will continue until allagreement. Either party can cancel the agreement with 60-days written notice. The Company is still in the process of building this operation, and no product sales or no royalties earned as of the patents on the products subject to the agreement are no longer enforceable. Asdate of December 31, 2017, the Company has made royalty payments in the amount of $1.9 million.this filing.

The Company has a non-exclusive license to certain products with Fontem Ventures B.V. “Fontem”. The Company will make quarterly license and royalty payments in perpetuity to Fontem based on the sale of qualifying products as defined in the license agreement at a royalty rate of 5.25%Note 14. STOCKHOLDERS’ EQUITY

For the years ended December 31, 2017 and 2016, the Company incurred royalty expenses of approximately $76,000 and $78,000.

Other Matters

 

On March 2, 2016, Hudson Bay Master Fund Ltd. (“HB”), filed an action against the Company in the Supreme Court of the State of New York, County of New York, captioned Hudson Bay Master Fund Ltd. versus Vapor Corp., Index No. 651094/2016. This action alleged that the Company failed to timely effect exercises of its Series A Warrants delivered by the plaintiff and sought damages of $339,810. On May 10, 2016, solely to avoid the costs, risks and uncertainties inherent in litigation, the Company entered into a settlement agreement with respect to all claims included in the action by HB (the “HB Settlement”). The HB Settlement provided, among other things, that the parties would enter into and file a stipulation of discontinuance that provides for the dismissal of the action against the Company (the “HB Stipulation”). This action by HB was dismissed with prejudice.

On June 2, 2016, four Series A Warrant holders, filed an action against the Company in the Supreme Court of the State of New York, County of New York, captioned Empery Asset Master, LTD, Empery Tax Efficient, LP, Empery Tax Efficient II, LP and Intracoastal Capital, LLC versus Vapor Corp., Index No. 652950/2016. This action alleged that the Company failed to timely effect exercises of its Series A Warrants delivered by the plaintiffs and sought aggregate damages of approximately $603,000. Between June 17, 2016 and June 22, 2016, solely to avoid the costs, risks and uncertainties inherent in litigation, the Company entered into settlement agreements with respect to all claims included in the Complaints (the “Settlements”). The Settlements provide, among other things, that the parties would enter into and file a stipulation of discontinuance that provides for the dismissal of the Complaint (the “Stipulation”), and the holders would surrender the balance of their Series A Warrant upon receipt of settlement payments. These actions were dismissed with prejudice.

Note 10. STOCKHOLDERS’ EQUITY

Amendments to Certificate of Incorporation

On February 1, 2016, the Company filed an amendment to its Certificate of Incorporation to increase its authorized Common Stock to 5,000,000,000, and change the par value to $0.0001. On March 4, 2016, the Company filed an amendment to its Certificate of Incorporation to effectuate a one-for-seventy reverse stock split to its Common Stock. On June 1, 2016, the Company filed an amendment to its Certificate of Incorporation to effectuate a one-for-twenty thousand reverse stock split to its Common Stock. On August 4, 2016, the Company filed an amendment to its Amended and Restated Certificate of Incorporation to increase the number of shares of the authorized common stock from 5,000,000,000 to 750,000,000,000. Each share entitles the holder to one vote.

All warrant, convertible preferred stock, option, common stock shares and per share information included in these consolidated financial statements gives retroactive effect to the aforementioned reverse splits of the Company’s common stock.

Equity Compensation Plans

The Company’s 2015 Equity Incentive Plan, as amended (the “2015 Plan”), awards grants to employees. On July 7, 2015,April 23, 2023, the stockholdersBoard of Directors (the “Board”) of HCMC approved the Second Amendment to the 2015 Equity Incentive Plan (the “2015“Amended Plan”), which is a broad-based plan and awards granted may be restricted stock, restricted stock units, options and stock appreciation rights. On November 21, 2016, the 2015. The Amended Plan was amended to increaseincreased the number of shares of HCMC common stock availableauthorized for grantsissuance under the Amended Plan to 100,000,000,000. The 2015 Plan had 13,823,999,996225,000,000,000 shares, of common stockand currently 2.5 billion shares are available for grant as of December 31, 2017.2023.

The Company’s 2009 Equity Incentive Plan (the “2009 Plan”) was duly adopted by the stockholders on November 24, 2009. The 2009 Plan provides for the granting of incentive stock options to employees, the granting of non-qualified stock options to employees, non-employee directors and consultants, and the granting of restricted stockawards grants to employees, non-employee directors and consultants in connection with their retention and/or continued employment by the Company. Options issued under the 2009 Plan generally have a ten-year term and generally become exercisable over a four-year period. Shares subject to awards that expire unexercised or are forfeited or terminated will again become available for issuance under the 2009 Plan. No participant in the 2009 Plan can receive option grants and/or restricted shares for more than 20% of the total shares subject to the 2009 Plan. The 2009 Plan had no shares of common stock available for grant as of December 31, 2017.2023.

F-20

Series D Convertible Preferred Stock

The Company’s amendedOn February 7, 2021, the Company entered into a Securities Purchase Agreement, pursuant to which the Company sold and restated articles of incorporation authorizes the Company’s Board of Directors to issue up to 1,000,000issued 5,000 shares of “blank check” preferred stock, having a $0.001 par value, in oneits Series D Convertible Preferred Stock (the “Preferred Stock”) to accredited investors for $1,000 per share or more series without stockholder approval. Each such seriesan aggregate subscription of preferred stock may have such number$5.0 million. In 2021, 4,200 shares of shares, designations, preferences, voting powers, qualifications,Series D Convertible Preferred Stock were exercised and special or relative rights or privileges as determined byconverted into common stocks. As of December 31, 2023, the Company’s Board of Directors. See below for details associated with the designation of the 1,000,000Company issued 8.0 billion shares of the Series A preferred stock.

Series A Unit Public Offering 

On July 29, 2015, the Company closed a public offering of Units for gross proceeds of approximately $41.4 million and net proceeds of approximately $38.7 million. On January 25, 2016, the Units automatically separated into an aggregate of 0.672 shares of Series A. Preferred Stock, which were convertible in to an aggregate of 27 shares ofCompany’s common stock and five-year Series A Warrants, exercisable into 54 shares of common stock. Except in the event of a “cashless exercise” as described below, each Series A Warrant is exercisable into one share of common stock at an exercise price of $1,736,000 per share and expires on July 23, 2020. See the Warrants section of this footnote for details related to warrant activity.

The Series A Preferred Stock (a) ranks equal to the common stock on an as converted basis with regard to the payment of dividends or upon liquidation; (b) automatically converts into common stock upon the consummation of a Fundamental Transaction, as defined; (c) has no voting rights, except related to the amendment of the terms of the Series A preferred stock; and (d) has conversion limits whereby the holder may not beneficially own in excess of 4.99% of the common stock. Through December 31, 2016, 0.630 shares of Series A Preferred Stock were converted and the Company issued 26 shares of common stock to settle these conversions, leaving 0.042 shares of Series A Preferred Stock outstanding.

The Series A warrants were originally determined to be derivative liabilities because there is a potential cash settlement provision which isn’t under the Company’s control (see Note 11). Utilizing a Monte Carlo valuation method, the issuance date value of the Series A warrant liabilities was calculated to be $79.4 million. Since the value of the Series A warrant liabilities exceeded the gross proceeds from the public offering, the Company recorded a $38.1 million deemed dividend on the preferred stock. Each Series A warrant may be exercised on a cashless basis for the Black Scholes value defined in the warrant agreement. The number of shares of common stock that the Company will issue in connection with the exercise of the remaining 800 shares of the Series A warrantsD Convertible Preferred Stock at a conversion price of $0.0001 per share. As of December 31, 2023, all Series D preferred stocks have been converted. The Series D Stocks have no voting rights.

Series E Redeemable Convertible Preferred Stock

On August 18, 2022, the Company entered into a Securities Purchase Agreement (“HCMC Preferred Stock”) pursuant to which the Company sold and issued 14,722 shares of its Series E Convertible Preferred Stock to institutional investors for $1,000 per share or an aggregate subscription of $13.25 million. The number of shares issued to each participant is primarily based on subscription amount multiplied by conversion rate of 1.1111. The Company also incurred offering costs of approximately $410,000, which covers legal and consulting fees.

F-25

For the year ended December 31, 2023, 1,585 shares of Series E preferred stock were converted into 15,850,000,000 shares of common stock as a result of the Series E preferred stock conversion. 12,026 shares of Series E preferred stock were redeemed and approximately $12,004,000 was paid for redemption.

The HCMC Preferred Stock have voting rights on as converted basis at the Company’s next stockholders’ meeting. However, as long as any shares of HCMC Preferred Stock are outstanding, the Company shall not, without the affirmative vote of the holders of a majority of the then outstanding shares of the HCMC Preferred Stock, (a) alter or change adversely the powers, preferences or rights given to the HCMC Preferred Stock or alter or amend the Certificate of Designation, (b) increase the number of authorized shares of HCMC Preferred Stock, or (c) enter into any agreement with respect to any of the foregoing. Each share of Preferred Stock shall be convertible, at any time and from time to time at the option of the Holder thereof, into that number of shares of Common Stock (subject to the beneficial ownership limitations). The conversion price for the HCMC Preferred Stock shall equal $0.0001.

Upon any liquidation, dissolution or winding-up of the Company, whether voluntary or involuntary that is not a Fundamental Transaction (as defined in the Certificate of Designation), the holders of HCMC Preferred Stock shall be entitled to receive out of the assets, whether capital or surplus, of the Company an amount equal to $1,000 per share of HCMC Preferred Stock.

Unless earlier converted or extended as set forth below, a holder may require the redemption of all or a portion of the stated value of the HCMC Preferred Stock either (1) six months after closing bidor (2) the time at which the balance is due and payable upon an event of default.

On March 1, 2023, the Company entered into a First Amendment to HCMC Series E Preferred Stock with each purchaser (“Purchaser”) identified as those who participated in the HCMC Series E Preferred Stock, dated as of August 18, 2022. The parties amended the HCMC Preferred Stock related to the conversion payment whereby upon conversion of the Series E Preferred Stock prior to the record date for the Spin-Off, the Company will pay the Purchaser ten percent (10%) of the stated value of the Series E Preferred Stock converted. The record date was May 1, 2023.

On May 15, 2023, the Company and the Purchaser entered into the Second Amendment to the Securities Purchase Agreement, pursuant to which the Company agreed to extend the time period for the Conversion Payment eligibility to December 1, 2023. The Company filed an amendment to the Certificate of Designation to make the redemption price of the Preferred Stock (the “Redemption Price”) equal the Stated Value regardless of the date on which it is redeemed. Prior to this amendment, the Redemption Price was discounted by 1% for each month after the seven-month anniversary of the Issue Date that the Purchaser elected not to redeem.

On October 30, 2023, the Company entered into a Third Amendment to the Securities Purchase Agreement with its Series E Redeemable Convertible Preferred Stock purchasers. The parties agreed to: (1) set the initial conversion price for the Series A Preferred Stock to be the 5-day volume weighted average price measured using the 5 trading days preceding the purchase of the Series A Preferred Stock, (2) on the 40th calendar day (the “Reset Date”) after the sale of the Series A Preferred Stock, reset the conversion price in the event the closing price of the Class A common stock two days prioron such date is less than the initial conversion, (3) have the reset conversion price equal a 10% discount to the date5-day volume weighted average price measured using the 5 trading days preceding the Reset Date; provided, however, in no instance will the conversion price be reset below 30% of the exercise. If (a) allinitial conversion price, and (4) amend the date on which the obligation to acquire the Series A Preferred Stock ceases to March 1, 2024.

On February 20, 2024, the Company entered into a Fourth Amendment to the Securities Purchase Agreement with its Series E Redeemable Convertible Preferred Stock purchasers, pursuant to which the Company and such parties agreed to amend the date on which the obligation to acquire the Series A Preferred Stock ceases to June 1, 2024.

Spin-Off

The Company is planning to spin off its grocery segment and wellness business into a new publicly traded company (hereinafter referred to as “NewCo”). NewCo will continue the path of growth in the health verticals started by HCMC and explore other growth opportunities that comport with HCMC’s healthier lifestyle mission. HCMC will retain its entire patent suite, the Q-Cup® brand, and continue to develop its patent suite through R&D as well as continuing its path of enforcing its patent rights against infringers and attempting to monetize said patents through licensing deals.

F-26

At the time of the warrants were exercised simultaneously whenSpin-Off, HCMC will distribute all the Company’soutstanding shares of Common Stock held by it on a pro rata basis to holders of HCMC’s common stock. Each share of HCMC’s common stock traded belowoutstanding as the record date for the Spin-Off (the “Record Date”), will entitle the holder thereof to receive shares of Common Stock in NewCo. The distribution will be made in book-entry form by a certain price per share, or (b)distribution agent. Fractional shares of Common Stock will not be distributed in the Company does not continueSpin-Off and any fractional amounts will be rounded down.

Pursuant to meet certain Equity Conditions (as defined), the Company may not have sufficient authorized common stock and couldSecurities Purchase Agreement, purchasers of the Series E Convertible Preferred Stock will also be required to use cash to pay warrant holders.

In connection with the closing of this offering, the Company incurred $4,779,003 of issuance costs, including cash underwriting fees of $2,722,687, other cash costs of approximately $503,898, and the issuance date value of $1,552,418 (utilizing the Black-Scholes-Merton valuation model) of the underwriter’s five-year Series A unit purchase option, which gives the underwriter the option to purchase 0.034 shares of Series A Convertible Preferred Stock which were convertible into 1 share of common stock, plus(“NewCo Series A Warrants. AllStock”) of a newly created NewCo resulting from spin off of HCMC’s grocery and wellness businesses in the issuance costs were allocated tosame subscription amounts that the Series A warrant liabilities because no carrying value was attributed toPurchasers paid for the Series A preferred stock and, asHCMC Preferred Stock.

On October 27, 2023, the Company filed a result, the issuance costs were expensed immediately.

Innew registration statement on Form S-1 (the “Spin-off S-1”) in connection with the closingspin-off of this offering, on August 3, 2015,all of the existing HCWC common stock by Healthier Choices Management Corp. with the Securities and Exchange Commission (the “Commission”).

On October 30, 2023, the Company paid Chardan Capital Markets, LLC (“Chardan”filed Amendment No. 1 to its registration statement on Form S-1 (the “IPO S-1”) $500,000 in satisfaction of an agreement between Chardan andwith the Commission.

On December 20, 2023, the Company pursuantfiled Amendment No. 1 to which Chardan waived certain rights to participate in the public offering that were granted to Chardan under its previous agreementsSpin-off S-1 with the Company. The $500,000 cost was recorded in other expenses onCommission.

On December 21, 2023, the consolidated statement of operations forCompany filed Amendment No. 2 to its IPO S-1 with the year ended December 31, 2015.  Commission.

Restricted Stock

Warrants

DuringOn January 1, 2022, the year ended December 31, 2017, Series A Warrants to purchase 1 share of common stock have been exercised through the cashless exercise provision in the Series A Warrants, resulting in the issuance of 15,125,005,934 shares of the Company’s common stock. In addition, Series A Warrants to purchase 8Company granted 1,500,000,000 restricted shares of common stock were repurchased, whichto a non-employee for service rendered with fair value of $150,000 that would have resulted invest 25% each quarter starting from June 30, 2023 through March 31, 2024.

On December 14, 2022, the Company granted 4,000,000,000 shares of restricted stocks with fair value of $400,000 to the two Directors of the Company that would vest starting from the first anniversary of the grant date at 12.5% for each calendar quarter for two years.

On April 23, 2023, HCMC’s board of directors has approved the issuance of approximately 114,796,220,280107,675,000,000 shares of the Company’s common stock if such Series A Warrants had not been repurchased as of the date of this report.

The shares issuable upon the exercise of the Series A Warrants are calculated (1) using a Black Scholes Value of $1,520,919 per share and a closing stock bid price of $0.0001 per share and (2) assuming the Company delivers only common stock upon exercise of the Series A Warrants and not cash payments as permitted under the terms of the Series A Warrants.

At the years ended December 31, 2017 and 2016, the warrants were valued at the tender offer price of $0.22 per warrant. Management believes the tender offer price is the best indicator of fair value as it is a level 2 valuation and no material events indicating the fair value has changed occurred through December 31, 2017.

Holders (the “Holders”) of approximately 90% of the Series A Warrants are subject to the Amended and Restated Standstill Agreements (the “Standstill Agreements). These Standstill Agreements permit the Holders to effect a “cashless” exercise of the Series A Warrants only on dates when the closing bid price used to determine the “net number” of shares to be issued upon exercise is at or above $0.0001 per share. Pursuant to the terms of the Standstill Agreements, the Holders agreed in certain circumstance to receive only common stock (and not cash) pursuant to such cashless exercise pursuant to Section 1(d) of their Series A Warrants. Those circumstances include if the Company is deemed not to meet the “Equity Conditions” of the Series A Warrants because of the failure of the Companyrestricted common stock to be listed or quoted on an eligible national securities exchange.

F-21

A summarythe employees and executive officers of warrant activity for the years ended December 31, 2017 and 2016 is presented below:

  Number of
Warrants
  Weighted
Average
Exercise
Price
  Weighted
Average
Remaining
Term (Yrs.)
 
Outstanding at January 1, 2016  54  $1,736,000   4.6 
Warrants exercised  (5)  1,736,000     
Warrants repurchased  (7)  1,736,000     
Outstanding at December 31, 2016  42  $1,736,000   3.6 
Warrants exercised  (1)  320,540     
Warrants repurchased  (8)  1,532,038     
             
Outstanding at December 31, 2017  33  $1,520,919   2.6 
             
Exercisable at December 31, 2017  33  $1,520,919   2.6 

A summaryHCMC. Each grant of restricted common stock will commence vesting of 12.5% of the approximate outstanding warrantaward on February 1, 2024 and will vest in 12.5% increments on the last day of each calendar quarter thereafter through September 30, 2025. All shares of restricted common stock equivalents for the years ended December 31, 2017 and 2016 are as follows:

  December 31, 2017  December 31, 2016 
Warrants outstanding  33   42 
Black Scholes value *  1,520,919   1,519,297 
Closing bid stock price $0.0001  $0.0001 
Warrant common stock equivalent **  505,246,000,000   634,754,000,000 

* Pursuant to the Series A warrant agreement, the Black Scholes value is calculated by a third-party and utilized in calculating the warrant common stock equivalents at the point of cashless exercise

** As such, the value is computed at the end of each reporting period to determine the amount of warrant common stock equivalents outstanding using the formula below:

(Series A warrants * Black Scholes Value) / closing common stock bid price as of two trading days prior.

See Note 11 – Fair Value Measurements for additional details related to the Series A Warrants that were exchanged

Compensatory Common Stock Summary 

During the years ended December 31, 2017 and 2016, the Company recognized stock-based compensation expense related to compensatory Common Stock in the amount of $0 and $75,000, respectively. Stock-based compensation expense is included as part of selling, general and administrative expense in the accompanying consolidated statements of operations. All compensatory Common Stock was fully vestedApril 23, 2023 issuance remain unvested as of December 31, 2016 and no compensatory common stock was issued2023.

The following table reflects the activity for all unvested restricted stocks during the year ended December 31, 2017.2023:

 SCHEDULE OF UNVESTED RESTRICTED STOCK

  Shares  

Weighted

Average

Grant Date

Fair Value

 
Unvested at January 1, 2023  5,500,000,000  $550,000 
Granted  107,675,000,000   10,767,500 
Vested  (1,625,000,000)  (162,500)
Forfeited  -   - 
Unvested at December 31, 2023  111,550,000,000  $11,155,000 

F-27

Stock Options

During December 2016, the Company granted options for the purchase of 5,001,000,004 shares of its common stock to employees, at an aggregate grant date value of $500,100 or $0.0001 per option share. During the year ended December 31, 2017, the Company granted options for the purchase of 82,893,750,000 shares of its common stock to employees, at an aggregate grant date value of $8,289,375 or $0.0001 per option shares. On February 1, 2017, pursuant to the 2015 Plan, the Company issued a total of 77,000,000,000 options to purchase common stock to certain officers and directors. Twenty-five percent of the options vested upon issuance and the remainder vest equally at the end of the following three calendar quarters.

The fair value of employee stock options was estimated using the following Black-Scholes assumptions:

  For the Year Ended
  December 31,
  2017 2016
Expected term (years) 5 – 6 years 5 - 6 years
Risk free interest rate 1.83% – 2.22% 1.98% - 2.03%
Dividend yield 0% 0%
Volatility 0.0% 428.10%

F-22

A summary of option activity during the years ended December 31, 20172023 and 20162022 is as follows:

SUMMARY OF OPTION ACTIVITY

    Weighted Weighted  Number of Options  

Weighted Average

Exercise

Price

  Weighted Average Remaining Term (Yrs.)  Aggregate Intrinsic Value 
    Average Average          
 Number of Exercise Remaining 
 Options  Price  Term (Yrs) 
       
Outstanding, January 1, 2016  0.028  $5,101,040   6 
Outstanding, January 1, 2022  67,587,230,680  $0.0001   5  $- 
Options granted  5,001,000,004.000   0.0001       -   0.0001       - 
Options forfeited or expired  (0.017)  11,625,400           0.0001       - 
Outstanding, December 31, 2016  5,001,000,004.011  $0.0001   10 
Outstanding, December 31, 2022  67,587,230,680  $0.0001         4  $       - 
Options granted  82,893,750,000   0.0001       -   0.0001       - 
Options exercised  (10,000,000)  0.0001       -   0.0001       - 
Options forfeited or expired  (729,741,524.011)  0.0001       (8,480)  0.0001       - 
Outstanding, December 31, 2017  87,165,008,480.000  $0.0001   9 
            
Exercisable at December 31, 2017  83,221,258,480.000  $0.0001   9 
Outstanding, December 31, 2023  67,587,222,200  $0.0001   3   - 
Exercisable on December 31, 2023  67,587,222,200  $0.0001   3  $- 

During the years ended December 31, 20172023 and 2016,2022, the Company recognized stock-based compensation expense of approximately $7.5 million$3,430,000 and $13.7 thousand,$72,000, respectively, in connection with the amortization of stock options, net of recovery of stock-based charges for forfeitedrestricted stocks and stock options. Stock-based compensation expense is included as part of selling, general and administrative expense in the accompanying consolidated statements of operations. The weighted average grant date fair value of options granted during the year ended December 31, 2017 was $0.0001 per share.

At December 31, 2017, the amount of unamortized stock-based compensation expense on unvested stock options granted to employees, directors and consultants was approximately $1.3 million, which will be amortized over a weighted average period of 0.43 years.

Income (Loss) per Share

Basic income (loss) per share is computed by dividing the net income (loss) available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted income (loss) per share is computed using the weighted average number of common shares and, if dilutive, potential common shares outstanding during the period. Potential common shares consist of the incremental common shares issuable upon (a) the exercise of stock options (using the treasury stock method); (b) the conversion of Series AD and Series E convertible preferred stock;stocks; (c) the exercise of warrants (using the if-converted method); (d) the vesting of restricted stock units; and (e) the conversion of convertible notes payable. Diluted income (loss) per share excludes the potential common shares, as their effect is antidilutive. The following table summarizes the Company’s securities that have been excluded from the calculation of basic and dilutive income (loss) per share as their effect would be anti-dilutive:

  December 31, 
  2017  2016 
       
Stock options  88,893,899,200   - 
Warrants  505,246,312,541   - 
Total  594,140,211,741   - 

Shares used in calculating basic and diluted net income (loss) per share are as follows:

  Year Ended
December 31,
 
  2017  2016 
       
Basic  26,199,887,696   4,102,959,032 
Effect of exercise stock options  -   5,000,999,976 
Effect of exercise warrants  -   631,552,260,513 
Diluted  26,199,887,696   640,656,219,521 

On February 1, 2017, pursuant to the 2015 Plan, the Company issued a total of 77,000,000,000 options to purchase common stock to certain officers and directors. Twenty-five percent of the options vested upon issuance and the remainder vest equally at the end of the following three calendar quarters.

SCHEDULE OF DILUTIVE LOSS PER SHARE

  2023  2022 
  December 31, 
  2023  2022 
       
Preferred stock  11,111,000,000   148,470,000,000 
Stock options  67,587,222,200   67,587,230,680 
Restricted stock  113,175,000,000   5,500,000,000 
Total  191,873,222,200   221,557,230,680 

F-28
 F-23

Note 11. FAIR VALUE MEASUREMENTS15. LEASES

The Company has various lease agreements with terms up to 20 years, including leases of retail stores, headquarters and equipment. All the leases are classified as operating leases.

The following table presents nonfinancial assets measuredinformation about the amount, timing and recorded at fair value on a nonrecurring basis duringuncertainty of cash flows arising from the Company’s operating leases as of December 31, 2023.

 SCHEDULE OF MATURITY OF LEASE LIABILITIES

Maturity of Lease Liabilities by Fiscal Year    
2024 $3,212,909 
2025  2,862,488 
2026  2,521,339 
2027  1,535,080 
2028  834,710 
Thereafter  1,363,363 
Total undiscounted operating lease payments $12,329,889 
Less: Imputed interest  (1,021,443)
Present value of operating lease liabilities $11,308,446 

The following summarizes the Company’s operating leases:

SCHEDULE OF BALANCE SHEET CLASSIFICATION AND OTHER INFORMATION

Balance Sheet Classification 

December 31,

2023

  

December 31,

2022

 
Right of use asset $11,511,002  $10,604,935 
         
Operating lease liability, current $2,842,829  $2,228,852 
Operating lease liability, net of current  8,465,617   8,041,504 
Total operating lease liabilities $11,308,446  $10,270,356 

The amortization of the right-of-use asset of approximately $2,590,000 and $1,164,000 for the years ended December 31, 20172023 and 2016:2022, respectively, were included in operating cash flows.

  2017  2016 
Description Fair Value
Measurements Using
Significant
Unobservable Inputs
(Level 3)
  Loss  Fair Value
Measurements Using
Significant
Unobservable Inputs
(Level 3)
  Loss 
Goodwill $       -  $         -  $       -  $(3,177,017)
Intangible assets  -   -   -   (778,345)
Total $-  $-  $-  $(3,955,362)
Other Information
Weighted-average remaining lease term for operating leases5 years
Weighted-average discount rate for operating leases3.98%

Rent expense for the years ended December 31, 2023 and 2022 was approximately $3,500,000 and $1,500,000, respectively, is included in selling, general and administrative expenses in the accompanying consolidated statement of operations.

The following table summarizesrepresents the liabilities measured at fair value on a recurring basiscomponents of lease cost are as offollows for twelve months ended December 31, 2017:2023:

SCHEDULE OF LEASE EXPENSE

  Level 1  Level 2  Level 3  Total 
LIABILITIES:            
Warrant liabilities $-  $10,231,697  $-  $10,231,697 
Total derivative liabilities $-  $10,231,697  $-  $10,231,697 
  December 31, 2023 
Operating lease cost $2,265,820 
Variable lease cost  944,987 
Short-term lease cost  324,507 
Total rent expense $3,535,313 

The following table summarizesaggregate cash payments under the liabilities measured at fair value on a recurring basis as of December 31, 2016:

  Level 1  Level 2  Level 3  Total 
LIABILITIES:                
Warrant liabilities $-  $12,868,079  $-  $12,868,079 
Total derivative liabilities $-  $12,868,079  $-  $12,868,079 

Level 3 Valuation Techniques

The Company’s derivative liabilities are carried at fair value and were classified as Level 3 in the fair value hierarchy due to the use of unobservable inputs.

The following table sets forth a summary of the changes in the fair value of our Level 3 financial liabilities that are measured at fair value on a recurring basis:

  For the Year Ended
December 31, 2015
 
Balance at December 31, 2015 $41,089,580 
Cash paid to repurchase warrants  (3,278,827)
Gain on repurchase of warrants  (5,189,484)
Fair value of Series A Warrants repurchased  (8,468,311)
Warrant exercises  (4,498,048)
Change in fair value of derivative liabilities  (15,255,142)
Reclassification of Series A warrant liability to Level 2  (12,868,079)
Balance at December 31, 2016 $- 

Duringleasing arrangement was approximately $2,458,000 for the year ended December 31, 2016, Series A warrants to purchase an aggregate of 42023 and 7 shares of Common Stock which had been accounted for as a derivative liability were exercised and exchanged, respectively. The exercised warrants had an aggregate exercise date value of $4,498,048, which was reclassified to stockholders’ deficit. The exchanged warrants had an aggregate value at exchange date of $8,468,310 which was derecognized and the Company paid $3,278,827 ofincluded in operating cash plus Series B warrants with a nominal value, with a resulting extinguishment gain of $5,189,484. The terms of the Series B warrant were agreed upon, but the warrants have not been issued. During the year ended December 31, 2016, certain holders of Series A Warrants executed Standstill Agreements, which were subsequently amended and restated whereby the holders agreed not to exercise Series A Warrants for a specified period of time and under certain circumstances.flows.

F-29
 F-24

As of December 31, 2016, the Company transferred the remaining derivative liability related to its Series A Warrants out of Level 3 and into Level 2 in the fair value hierarchy. Level 2 financial liabilities consist of derivative liabilities for which the determination of fair value is based on observable inputs for the liability. Specifically, the Company determined that its offer to purchase its Series A Warrants for $0.22 per warrant was the best indicator of the fair value of the derivative liability as of December 31, 2016. Accordingly, the Company transferred $12,868,079 from the Level 3 fair value hierarchy to the Level 2 fair value hierarchy as of December 31, 2016.

The Company uses a sensitivity analysis model to measure the impact of a 10% movement in the per share fair value per warrant. A hypothetical 10% change in the per share fair value of the warrant as of December 31, 2016 would result in $1,286,808 recorded other income (expenses).

Note 12.16. INCOME TAXES

The Company did not have a provision for income taxes (current or deferred tax expense) for tax years ended December 31, 2017 and 2016. The following is a reconciliation of thes expected tax expense (benefit) at the U.S. statutory rate to the actual tax expense (benefit) reflected in the accompanying statement of operations:

  For the Years Ended December 31,
  2017 2016
U.S. federal statutory rate  (3,353,056)  3,632,727 
State and local taxes, net of federal benefit  (334,994)  (227,984)
Change in fair value of derivatives  -   (5,186,749)
Settlement of warrants  -   (1,764,424)
Goodwill impairment  -   1,080,186 
Change in valuation allowance  (3,717,877)  2,756,495 
True-up & deferred adjustment  1,619   (220,327)
Stock based compensation  258,394   15,826 
Other permanent items  5,697   (214,142)
Forfeitures & expiration of stock comp  45,915   118,691 
Stock issuance costs & compensation wavers  -   78,640 
Change in tax rate  7,036,850   (36,381)
Other  57,452   (32,558)
   -   - 

SCHEDULE OF INCOME TAX RECONCILIATION EXPECTED EXPENSE (BENEFIT)

  2023  2022 
  Year Ended December 31, 
  2023  2022 
       
U.S. federal statutory rate $(3,881,403) $(1,515,700)
State and local taxes, net of federal benefit  (1,036,963)  (359,643)
Change in valuation allowance  4,999,204   2,733,655 
True-up & deferred adjustment  (19,998)  144 
Other permanent items  2,928   - 
Change in tax rate  (63,768)  (252,392)
Other  -   (606,064)
Total income tax benefit $-  $- 

As of December 31, 20172023 and 2016,2022, the Company’s deferred tax assets and liabilities consisted of the effects of temporary differences attributable to the following:

  Years Ended December 31,
  2017 2016
Current deferred tax assets:    
NOL & AMT credit carryforward $11,106,460  $15,853,308 
Inventory reserves and allowances  209,345   504,104 
Accrued expenses & deferred income  -   35,413 
Charitable contribution  3,767   2,110 
Stock based compensation  1,712,623   46,168 
Net book value of intangible assets  639,731   931,417 
Net book value of fixed assets  6,727   24,010 
Total current deferred tax assets  13,678,653   17,396,530 
Current deferred tax liabilities:        
Net book value of intangible assets  -   - 
Total current deferred tax liabilities  -   - 
Net current deferred tax assets  13,678,653   17,396,530 
Valuation allowance  (13,678,653)  (17,396,530)
Net deferred tax assets $-  $- 

SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES

  2023  2022 
  Year Ended December 31, 
  2023  2022 
Deferred tax assets:        
Net operating losses $19,684,763  $17,030,852 
Unrealized loss on investment  39,580   36,436 
Accrued Expenses and Deferred Income  -   149,402 
Charitable contribution  8,330   5,737 
Stock based compensation  3,029,964   2,099,241 
Net book value of intangible assets  1,801,150   314,775 
UNICAP 263a Adjustment  53,284   - 
ASC 842 - Lease Accounting  65,172   44,484 
Total deferred tax assets  24,682,243   19,680,927 
         
Deferred tax liabilities:        
Net book value of fixed assets  (29,652)  (27,540)
Total deferred tax liabilities  

(29,652

)  (27,540)
         
Net deferred tax assets  24,652,591   19,653,387 
Valuation allowance  (24,652,591)  (19,653,387)
Net deferred tax assets $-  $- 

F-25

In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. After consideration of all of the positive and negative evidence available, management has determined that a valuation allowance of $13,678,653 and $17,396,530 areis required at December 31, 20172023 and 2016, respectively,2022 to reduce the deferred tax assets to amounts that are more likely than not to be realized. The Company’s valuation increased by $4,999,204 and $2,733,655 for the tax years ended 2023 and 2022, respectively. Should the factors underlying management’s analysis change, future valuation adjustments to the Company’s net deferred tax assets may be necessary.

F-30

At December 31, 20172023 the Company had U.S. federal and state net operating loss carryforwards (“NOLS”) of $46,362,439$79.5 million and $35,081,878,$64.8 million, respectively. TheseFederal NOLs of $46.3 million expire beginning in 2030.2030 through 2037 and $33.2 million do not expire and are subject to 80% of taxable income under Internal Revenue Code Section 172. State NOLs of $36.3 million expire beginning in 2030 through 2037 and $28.5 million do not expire and maybe subject to income limitations under each State statute. Utilization of our NOLS may be subject to an annual limitation under section 382 and similar state provisions of the Internal Revenue Code due to changes of ownership that may have occurred or that could occur in the future, as defined under the regulations.

As required byOn August 16, 2022, the provisions of ASC 740, the Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more likely than not threshold, the amount recognized in the consolidated financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority. Differences between tax positions taken or expected to be taken in a tax return and the net benefit recognized and measured pursuant to the interpretation are referred to as “unrecognized benefits.” A liability is recognized (or amount of NOL or amount of tax refundable is reduced) for an unrecognized tax benefit because it represents an enterprise’s potential future obligation to the taxing authority for a tax position that was not recognized as a result of applying the provisions of ASC 740.

If applicable, interest costs and penalties related to unrecognized tax benefits are required to be calculated and would be classified as interest and penalties in general and administrative expense in the statement of operations. As of December 31, 2017 and 2016, no liability for unrecognized tax benefit was required to be reported. No interest or penalties were recorded during the years ended December 31, 2017 and 2016. The Company does not expect any significant changes in its unrecognized tax benefits in the next year. The Company files U.S. federal and Alabama, Connecticut, Florida, Georgia, Massachusetts, New York, North Carolina, and Tennessee state income tax returns. As of December 31, 2017, the Company’s U.S. and state tax returns remain subject to examination by tax authorities beginning with the tax year ended December 31, 2014.

On December 22, 2017, the Tax Cuts and JobsInflation Reduction Act of 20172022 (“Tax Act”IRA”) was signed into law. Among other provisions, the IRA includes a 15% corporate alternative minimum tax on applicable corporations and 1% excise tax on stock repurchases made after December 31, 2022. The IRA is not expected to have a material impact on the consolidated financial statements.

The Company believes the impact of the inclusion of accumulated post-1986 foreign earnings on which U.S. income tax is currently deferred tofiles a one-time transition tax on December 31, 2017 would not be material to the Company. The measurement of the transition tax liability requires extensive effort on the calculation of the foreign earnings and profit on a cumulative basis. The Company has made reasonable efforts to determine that there would be no material financial impact on this one-time transition tax as the Company believes its existing tax attributes can be used to offset the transition tax without limitation, but an election is available to not claim the net operating loss deduction against the mandatory foreign earnings inclusion at December 31, 2017.

Under ASC 740, Accounting for Income Taxes, the enactment of the Tax Act also requires companies, to recognize the effects of changes in tax laws and rates on deferred tax assets and liabilities and the retroactive effects of changes in tax laws in the period in which the new legislation is enacted. There is no further change to its assertion on maintaining a full valuation allowance against its U.S. deferred tax assets. Due to the change in the federal tax rate from 34% to 21%, which in turn changes the effective state tax rate from 3.69% to 4.41%, the Company’s gross deferred tax assets of approximately $20.7 million will be revalued to approximately $13.7 million with a corresponding offset to the valuation allowance. Any potential other taxes arising due to the Tax Act will result in reductions to its net operating loss carryforward and valuation allowance. Upon completion of our 2017 U.S. income tax return and income tax returns in 2018 we may identify additional remeasurement adjustments to our recorded deferredvarious state tax liabilitiesjurisdictions and the one-time transition tax. We will continue to assess our provisionCompany is generally no longer subject examinations by federal and state tax authorities for income taxes as future guidance is issued, but do not currently anticipate significant revisions will be necessary. Any such revisions will be treated in accordance with the measurement period guidance outlined in Staff Accounting Bulletin No. 118.years before 2020.

Note 13. CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS

See Note 3 – ACQUISITION AND DISPOSAL – “Sale of Wholesale Business” as this qualifies as a related party transaction.

During 2016, the Company purchased, e-liquids sold in its vape retail stores and wholesale operations, respectively from Liquid Science, Inc., a company in which Jeffrey Holman (the Company’s Chief Executive Officer) had a 15% beneficial ownership interest. During the twelve months ended December 31, 2016, the Company made approximately $356,000 or 23% of its purchases of e-liquid from Liquid Science for its continuing operations. Jeffrey Holman sold his ownership interest in Liquid Science, Inc. in April 2016. During 2016, the Company received royalty income from Liquid Science pursuant to the terms of a royalty agreement; approximately $52,000 received during the three months ended March 31, 2016 and $42,000 of royalty income received in July 2016. Pursuant to the royalty agreement between the Company and Liquid Science, as consideration for use of a Company trademark, Liquid science paid a 15% royalty on sales of licensed products sold directly to consumers. The royalty revenue was recorded when received. On July 21, 2016, Liquid Science entered into an asset purchase and license agreement with the Company, whereby the Company irrevocably sold, assigned, transferred, certain trademark, intellectual property, formulations, technology and granted rights to sell and distribute certain brand named products internationally. In conjunction with the sale, the royalty agreement between the Company and Liquid Science was terminated.

F-26

Note 14. 17. SEGMENT INFORMATION

Prior to the second quarter of 2016, the Company had a single reportable business segment, as it was a distributor and retailer of vapor products including vaporizers, e-liquids and electronic cigarettes. On June 1, 2016, the Company completed the Grocery Acquisition and added a reportable segment. On July 31, 2016, the Company sold its wholesale inventory and related operations. The Company has excluded the results for the wholesale business, as discontinued operations, from the Company’s continuing operations for all periods presented. Management determines the reportable segments based on the internal reporting used by our Chief Operating Decision Makersexecutives to evaluate performance and to assess where to allocate resources. The Company evaluates segment performance based on the segment gross profit before corporate expenses.

Summarized below are the Net Salestotal net sales and Segment Operating Profitsegment operating results for each reporting segment:

SCHEDULE OF INFORMATION ABOUT REPORTABLE SEGMENTS

  Year Ended 
  Net Sales  Segment Gross Profit 
  December 31, 2023  December 31, 2022  December 31, 2023  December 31, 2022 
Vapor $617  $257,363  $(170) $144,483 
Grocery  55,689,793   29,009,640   20,348,224   10,079,735 
Total $55,690,410  $29,267,003   20,348,054   10,224,218 
Corporate expenses          38,323,733   18,877,302 
Operating loss          (17,975,679)  (8,653,084)
Corporate other (expense) income, net          (507,201)  1,435,473 
Net loss          (18,482,880)  (7,217,611)

  Year Ended 
  Net Sales  Segment Gross Profit 
  December 31,
2017
  December 31,
2016
  December 31,
2017
  December 31,
2016
 
Vapor $5,867,202  $6,722,052  $3,299,802  $3,742,443 
Grocery  7,093,893   3,843,111   2,978,979   1,490,910 
Total $12,961,095  $10,565,163   6,278,781   5,233,353 
Corporate expenses          16,555,638   14,095,621 
Operating loss          (10,276,857)  (8,862,268)
Corporate other income (expense), net          133,446   21,136,563 
Net income (loss) from continuing operations          (10,143,411)  12,274,295 
Net income (loss) from discontinued operations          281,483   (1,589,803)
Net income (loss)         $(9,861,928) $10,684,492 

For the year ended December 31, 20172023 depreciation and amortization was $67,281approximately $18,000 and $266,777$1.5 million for Vapor and Grocery, respectively.

For the year ended December 31, 20162022 depreciation and amortization was $174,376approximately $19,000 and $200,012$1.0 million for Vapor and Grocery, respectively.

Note 18. EMPLOYEE RETENTION CREDITS

Congress passed programs to provide financial assistance to companies during the COVID-19 pandemic, including the employee retention credit (ERC). The ERC provides eligible employers with credits per employee based on qualified wages and health insurance benefits paid. In December 2022, the Company filed application for Employee Retention Credits with the Internal Revenue Service. The company is reasonably assured the eligibility is met. The total amount eligible is $930,000. The amount was recorded in other current assets in consolidated balance sheet and other income in statement of operation in 2022. As of December 31, 2023, the Company received the payment in full eligible amount.

Note 19. SUBSEQUENT EVENTS

In connection with the spin off, on January 18, 2024, the Company entered into Securities Purchase Agreement with institutional investors whereby the Company issued a total of approximately $1.9 million in unsecured promissory notes (the “Notes). The Notes were issued at a 10% original issue discount and accrue interest at a rate of 10% per annum. All principle and accrued interest on the Notes shall be due and payable upon the earlier of (1) the closing of the potential initial public offering (“IPO”), (2) the one-year anniversary of issuance or (3) the time at which the balance is due and payable upon an event of default. The investors agreed to acquire $1,700,000 of Class A common stock in the IPO, and the Company will issue 188,889 shares of Class A common stock (assuming an IPO offering price of $10 per share) to institutional investors upon IPO.

On February 13, 2024, the Company filed Amendment No. 2 to its Spin-off S-1 with the Commission with respect to the Spin-Off.

On February 13, 2024, the Company filed Amendment No. 3 to its IPO S-1 with the Commission with respect to the IPO.

On February 20, 2024, the Company entered into a Fourth Amendment to the Securities Purchase Agreement with its Series E Redeemable Convertible Preferred Stock purchasers, pursuant to which the Company and such parties agreed to amend the date on which the obligation to acquire the Series A Preferred Stock ceases to June 1, 2024.

On February 9, 2024, in order to maximize profitability and improve operation efficiency, management made decision to close the Saugerties store. The building that the store is located is owned by the Company, and it is currently for sale. At the time of the filing, no sales agreement has been signed.

F-31
 

EXHIBIT INDEX

Exhibit   Incorporated by Reference Filed or Furnished
No. Exhibit Description Form Date Number Herewith
           
1.1 Form of Underwriting Agreement S-1 7/10/15 1.1  
2.1(a) Business Sale Offer and Acceptance Agreement, dated April 11, 2016, by and between Vapor Corp. and Ada’s Whole Food Market LLC 8-K 5/23/16 2.1  
2.1(b) Asset Purchase Agreement, dated July 29, 2016, by and between Vapor Corp. and VPR Brands, L.P. 8-K 8/3/16 1.1  
2.1(c) Asset Purchase Agreement, dated November 19, 2018, by and among the Company and Paradise Health Foods, Inc. 8-K 11/21/18 2.1  
2.1(d) Membership Interest Purchase Agreement, dated December 14, 2018, by and among Healthy U Wholesale, Inc. and the Sellers named therein 8-K 12/26/18 2.2  
2.1(e) Asset Purchase Agreement, dated February 8, 2022, by and among the Healthy Choice Markets 3, LLC, Mother Earth’s Storehouse Inc., Christopher Schneider and Kevin Schneider 8-K 2/8/22 2.1  
2.1(f) Commercial Contract of Sale, dated of 9th day of February, 2022, between Mother Earth’s Storehouse, Inc. and Healthy Choice Markets 3 Real Estate LLC        
3.1 Certificate of Incorporation 10-Q 11/16/15 3.1  
3.1(a) Certificate of Amendment to Certificate of Incorporation 8-K 3/03/17 3.1  
3.1(b) Certificate of Amendment to Certificate of Incorporation S-1 7/10/15 3.2  
3.1(c) Certificate of Amendment to Certificate of Incorporation S-4 12/11/15 3.2  
3.1(d) Certificate of Amendment to Certificate of Incorporation 8-K 2/2/16 3.1  
3.1(e) Certificate of Amendment to Certificate of Incorporation 8-K 3/9/16 3.1  
3.1(f) Certificate of Amendment to Certificate of Incorporation 8-K 6/1/16 3.1  
3.1(g) Certificate of Amendment to Certificate of Incorporation 8-K 8/5/16 3.1  
3.1(h) Certificate of Designation of Preferences, Rights And Limitations of Series D Convertible Preferred Stock 8-K 2/8/21 2.1  
3.1(i) Cancellation of Certificate of Designations        
3.2 Bylaws 8-K 12/31/13 3.4  
10.1 Form of Securities Purchase Agreement dated March 3, 2015 8-K 3/05/15 10.1  
10.2* 2015 Equity Incentive Plan S-1 6/01/15 10.28  
10.3 Form of Letter Agreement dated June 19, 2015 8-K 6/25/15 10.4  
10.4 Form of Letter Agreement dated June 19, 2015 8-K 6/25/15 10.5  
10.9 RLOC Credit Agreement, dated December 23, 2021, by and among Healthier Choices Management Corp. and Professional Bank        
10.10 Revolving Credit Note, dated December 31, 2019, issued by Healthier Choices Management Corp. in favor of Professional Bank        

F-2732
 

Exhibit   Incorporated by Reference Filed or Furnished
No. Exhibit Description Form Date Number Herewith
10.11* Amendment to Vapor Corp. 2015 Equity Incentive Plan S-8 2/8/17 4.2  
10.12* Form of Restricted Stock Award Agreement 8-K 8/20/18 10.4  
10.13* Second Amended and Restated Employment Agreement, entered into as of February 26, 2021 by and between the Company and Christopher Santi 8-K 3/5/21 10.1 
10.14* Third Amended and Restated Restricted Stock Agreement dated as of February 12, 2021 by and between Healthier Choices Management Corp. and Jeffrey Holman 10-K 3/8/21 

 10.12

 

  
10.15* Third Amended and Restated Restricted Stock Agreement dated as of February 12, 2021 by and between Healthier Choices Management Corp. and Christopher Santi 10-K 3/8/21  10.13  
10.16* Third Amended and Restated Restricted Stock Agreement dated as of February 12, 2021 by and between Healthier Choices Management Corp. and John Ollet 10-K 3/8/21  10.14  
10.17* Third Amended and Restated Restricted Stock Agreement dated as of February 12, 2021 by and between Healthier Choices Management Corp. and Anthony Panariello 10-K 3/8/21  10.15  
10.18* Second Amended and Restated Employment Agreement, dated as of February 2, 2022 by and between the Company and John Ollet 8-K 2/2/22 10.1  
10.19* Amended and Restated Employment Agreement, dated as of March 13, 2018 by and between the Company and Jeffrey Holman 8-K 8/20/18 10.3  
10.20 Securities Purchase Agreement, dated as of August 18, 2022, by and between Healthier Choices Management Corp. and the purchasers named therein 8-K 8/18/2022 10.1  
10.21 First Amendment to Securities Purchase Agreement, dated as of March 1, 2023, by and between Healthier Choices Management Corp. and the purchasers named therein 8-K/A 3/6/23 10.1 
10.22 Second Amendment to Securities Purchase Agreement, dated as of May 15, 2023, by and between Healthier Choices Management Corp. and the purchasers named therein 8-K/A 5/19/23 10.1  
10.23 Third Amendment to Securities Purchase Agreement, dated as of October 30, 2023, by and between Healthier Choices Management Corp. and the purchasers named therein 

8-K/A

 

11/3/23

 10.1  
10.24 Fourth Amendment to Securities Purchase Agreement, dated as of February 20, 2024, by and between Healthier Choices Management Corp. and the purchasers named therein 

8-K/A

 

2/23/24

 10.1  
21.1 List of Subsidiaries       X
23.1 Consent of Marcum LLP       Filed
31.1 Certification of Principal Executive Officer (302)       Filed
31.2 Certification of Principal Financial Officer (302)       Filed
32.1 Certification of Principal Executive Officer and Principal Financial Officer (906)       Furnished**
101.INS XBRL Instance Document       Filed
101.SCH XBRL Taxonomy Extension Schema Document       Filed
101.CAL XBRL Taxonomy Extension Calculation Link base Document       Filed
101.DEF XBRL Taxonomy Extension Definition Link base Document       Filed
101.LAB XBRL Taxonomy Extension Label Link base Document       Filed
101.PRE XBRL Taxonomy Extension Presentation Link base Document       Filed

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on March 14, 2018. 

Healthier Choices Management Corp.
By:/s/Jeffrey Holman
Jeffrey Holman

Chief Executive Officer

(Principal Executive Officer)

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

SignatureTitleDate
/s/Jeffrey HolmanPrincipal Executive OfficerMarch 14, 2018
Jeffrey Holmanand Director
/s/ John A. OlletChief Financial OfficerMarch 14, 2018
John A. Ollet(Principal Financial and Accounting Officer)
/s/ Clifford J. FriedmanDirectorMarch 14, 2018
Clifford J. Friedman
/s/Anthony PanarielloDirectorMarch 14, 2018
Anthony Panariello
29

EXHIBIT INDEX

Exhibit   Incorporated by Reference Filed or
Furnished
No. Exhibit Description Form Date Number Herewith
           
1.1 Form of Underwriting Agreement S-1 7/10/15 1.1  
2.1(a) Business Sale Offer and Acceptance Agreement, dated April 11, 2016, by and between Vapor Corp. and Ada’s Whole Food Market LLC 8-K 5/23/16 2.1  
2.1(b) Asset Purchase Agreement, dated July 29, 2016, by and between Vapor Corp. and VPR Brands, L.P. 8-K 8/3/16 1.1  
3.1 Certificate of Incorporation 10-Q 11/16/15 3.1  
3.1(a) Certificate of Amendment to Certificate of Incorporation 8-K 3/03/17 3.1  
3.1(b) Certificate of Amendment to Certificate of Incorporation S-1 7/10/15 3.2  
3.1(c) Certificate of Amendment to Certificate of Incorporation S-4 12/11/15 3.2  
3.1(d) Certificate of Amendment to Certificate of Incorporation 8-K 2/2/16 3.1  
3.1(e) Certificate of Amendment to Certificate of Incorporation 8-K 3/9/16 3.1  
3.1(f) Certificate of Amendment to Certificate of Incorporation 8-K 6/1/16 3.1  
3.1(g) Certificate of Amendment to Certificate of Incorporation 8-K 8/5/16 3.1  
3.1(h) Certificate of Designation of Series A Preferred Stock S-1 7/10/15 3.4  
3.1(i) Certificate of Correction to the Certificate of Designation of Series A Preferred Stock 8-A12B 7/27/15 3.5  
3.2 Bylaws 8-K 12/31/13 3.4  
4.1 Form of Series A Warrant S-1 7/10/15 4.2  
4.2 Form of Unit Purchase Agreement S-1 7/10/15 4.3  
10.4 Form of Securities Purchase Agreement dated March 3, 2015 8-K 3/05/15 10.1  
10.5 2015 Equity Incentive Plan S-1 6/01/15 10.28  
10.9 Form of Letter Agreement dated June 19, 2015 8-K 6/25/15 10.4  

30

10.10 Form of Letter Agreement dated June 19, 2015 8-K 6/25/15 10.5  
10.11 Form of Warrant dated June 22, 2015 8-K 6/25/15 10.6  
10.12 Form of Registration Rights Agreement dated June 22, 2015 8-K 6/25/15 10.7  
10.14 Employment Agreement with Jeffrey Holman 10-Q 11/16/15 10.1  
10.16 Employment Agreement with Christopher Santi 8-K 2/6/17 10.1  
10.17 Form of Fifth Amended and Restated Series A Standstill Agreement 10-K 3/27/17 10.17  
10.18 Executive Service Consulting Agreement, dated April 11, 2016, by and between Gregory Brauser and Vapor Corp. 8-K 4/11/16 10.1  
10.19 Amendment to Vapor Corp. 2015 Equity Incentive Plan S-8 2/8/17 4.2  
16.1 Letter from Morrison, Brown, Argiz & Farra, LLC, dated April 26, 2017 8-K 4/28/17 16.1  
21.1 List of Subsidiaries       Filed
23.1 Consent of Morrison, Brown, Argiz & Farra, LLC       Filed
23.2 Consent of Marcum L.L. P       Filed
31.1 Certification of Principal Executive Officer (302)       Filed
31.2 Certification of Principal Financial Officer (302)       Filed
32.1 Certification of Principal Executive Officer and Principal Financial Officer (906)       Furnished**
101.INS XBRL Instance Document       Filed
101.SCH XBRL Taxonomy Extension Schema Document       Filed
101.CAL XBRL Taxonomy Extension Calculation Link base Document       Filed
101.DEF XBRL Taxonomy Extension Definition Link base Document       Filed
101.LAB XBRL Taxonomy Extension Label Link base Document       Filed
101.PRE XBRL Taxonomy Extension Presentation Link base Document       Filed

* Management contract or compensatory plan or arrangement.

** This exhibit is being furnished rather than filed and shall not be deemed incorporated by reference into any filing, in accordance with Item 601 of Regulation S-K.

Copies of this report (including the financial statements) and any of the exhibits referred to above will be furnished at no cost to our stockholders who make a written request to our Corporate Secretary at 3800 North 28th Way, Hollywood, Florida 33020.

33

SIGNATURES

31

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on March 27, 2024.

Healthier Choices Management Corp.
By:/s/ Jeffrey Holman
Jeffrey Holman
Chief Executive Officer
(Principal Executive Officer)

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

SignatureTitleDate
/s/ Jeffrey HolmanPrincipal Executive Officer and DirectorMarch 27, 2024
Jeffrey Holman
/s/ John A. OlletChief Financial OfficerMarch 27, 2024
John A. Ollet(Principal Financial and Accounting Officer)
/s/ Clifford J. FriedmanDirectorMarch 27, 2024
Clifford J. Friedman
/s/ Anthony PanarielloDirectorMarch 27, 2024
Anthony Panariello

34